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Resumo  
Salmonelose permanece uma das causas mais frequentes de infeção gastrintestinal 
no mundo e representa um enorme impacto económico não só em países em 
desenvolvimento, mas também em países desenvolvidos. Assim, a vigilância epidemiológica 
e laboratorial de Salmonella é essencial para o controlo da infeção e para a diminuição dos 
custos associados à doença. Desde 1950 que o Instituto Nacional de Saúde Doutor Ricardo 
Jorge tem tido um papel relevante na vigilância laboratorial desta doença. 
O principal objetivo deste trabalho prendeu-se com a contribuição para o melhor 
conhecimento de alguns dos serotipos de Salmonella que circulam em Portugal, quer mais 
frequentes, quer serotipos com características vantajosas para a sua perseverança. De 
forma a cumprir este objetivo, primeiramente foram analisados os dados acumulados ao 
longo de décadas de vigilância laboratorial e foram determinadas as tendências dos 
serotipos circulantes no país. Foi também implementada, no Laboratório Nacional de 
Referência, a sequenciação genómica aplicada à vigilância de Salmonella enterica, e foi feita 
a avaliação da substituição das técnicas clássicas de tipagem. A sequenciação genómica, 
como método altamente discriminatório permitiu, não só a confirmação de surtos 
previamente identificados, como também a sinalização de potenciais surtos não sinalizados 
pelas autoridades de saúde. Neste trabalho, identificámos também vários isolados com 
múltiplos marcadores de resistência e diversos elementos genéticos móveis que conferem 
a capacidade de persistência e disseminação a estas bactérias. 
Esta dissertação destaca a necessidade de revisão da regulamentação associada a 
géneros alimentícios e de estabelecimento de novas medidas de controlo de infeção na 
produção animal, de maneira a evitar a disseminação de marcadores de multirresistência e 
persistência, que contribuem grandemente para o aumento da severidade das infeções 
causadas por Salmonella, e também da disseminação dessas características altamente 
transmissíveis. Este trabalho representa uma importante contribuição para o conhecimento 
dos isolados de Salmonella enterica circulantes em Portugal, e também para o reforço da 
capacitação do Laboratório Nacional de Referência. 
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Abstract 
Salmonellosis remains one of the most common causes of gastrointestinal infection 
in the world, and represents a considerable burden in developing and developed countries. 
As such, Salmonella surveillance is essential to control infection and decrease the economic 
burden of the disease, and the Portuguese National Institute of Health has been working in 
this field roughly since 1950. 
Considering the importance of the surveillance of Salmonella enterica, the main goal 
of this work was to contribute to a better knowledge of relevant serovars circulating in 
Portugal, either the most common, or serovars exhibiting important fitness traits that 
confer ecological advantages over other strains. In order to achieve this objective, first we 
analysed decades of data and established the trends of Salmonella enterica serovars 
circulating in Portugal. Additionally, whole-genome sequencing (WGS) was implemented at 
the National Reference Laboratory to the surveillance of Salmonella enterica, and was 
evaluated as a substitute of traditional typing methods, such as serotyping and multiple-
locus variable number tandem repeat analysis. WGS proved to be a highly discriminatory 
method for the detection of suspected outbreaks and even previously undetected clusters. 
We identified several isolates carrying multiple resistance markers and mobile genetic 
elements that confer the potential of persistence and spread of these bacteria. 
This PhD dissertation highlights the need for the adjustment of the existing 
regulations for foodstuffs monitoring and the investigation of safe control measures in 
animal production, as a means to control the spread of resistant and persistent clones that 
may contribute to the increase of severe infections and to the spread of those markers to 
other bacteria. This work stands as an important contribution for the insight on Salmonella 
enterica isolates circulating in Portugal, as well as a contribution for the reinforcement of 
the capacitation of the Portuguese National Reference Laboratory. 
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Notes of the author: thesis organization, format and outline 
This PhD dissertation is composed of six chapters, including an Introduction, four research 
studies, and a final discussion. The main body is based on two studies that were already 
submitted to peer reviewed international journals, and are presented as individual 
chapters. In summary, the PhD dissertation includes: 
Chapter 1 
This chapter consists of an overview of the state of the art regarding the context of this 
dissertation. It describes the major aspects of Salmonella spp. taxonomy, a description of the 
transition from the classic typing methods to whole-genome sequencing (WGS), insights of 
Salmonella evolution and genome structure, and a summary of all aspects related to human 
disease, such as diagnostic, epidemiology and treatment. Finally, this chapter presents the 
general and specific aims of this PhD dissertation. 
Chapter 2 
This chapter gives insight on the surveillance of Salmonella spp. performed at the National 
Reference Laboratory of Gastrointestinal Infections of the National Institute of Health 
Doutor Ricardo Jorge, over the last 21 years. It is not presented in the form of a classical 
manuscript (i.e., with an Abstract, methods section, etc.) since it is not our intent to submit 
it for publication (in contrast with the subsequent chapters), and because it enrols 
methodologies that changed over time, and its description would be a cumbersome task and 
completely irrelevant taking the objective of the chapter into account.  
Chapter 3 
This chapter, also written in an unconventional manner, focuses on the practical advantages 
that WGS brought to the National Reference Laboratory in terms of Salmonella surveillance. 
Two studies are approached in this chapter, i) the transition from a traditional molecular 
typing method, Multiple-locus variable number tandem repeat analysis (MLVA), to WGS and 
what it entails for surveillance of one of the most common serovars in Portugal, Salmonella 
enterica serovar Enteritidis, ii) and an ongoing study of an outbreak of Salmonella enterica 
serovar Newport and the preliminary findings. 
Chapter 4 
This chapter is based on a manuscript (“Silveira L., Pinto M., Isidro J., Pista A., Themudo P., 
Vieira L., Machado J. and Gomes J.P.. Multidrug resistant Salmonella enterica serovar Rissen 
clusters detected in Azores archipelago, Portugal”) published in the International Journal of 
Genomics. The main objective in this chapter was to identify potential epidemiological 
 xxii 
clusters of S. enterica serovar Rissen linking samples from multiple sources, while gaining 
insight on the genetic diversity of Portuguese isolates. 
Chapter 5 
This chapter, also based on a manuscript (“Leonor Silveira, Alexandra Nunes, Ângela Pista, 
Joana Isidro, Cristina Belo Correia, Margarida Saraiva, Rita Batista, Isabel Castanheira, Jorge 
Machado, João Paulo Gomes. Characterization of multidrug-resistant isolates of Salmonella 
enterica serovars Heidelberg and Minnesota from imported poultry meat in Portugal”, under 
review in Microbial Drug Resistance), consists in the phenotypic and genotypic 
characterization of isolates recovered from imported poultry meat. 
Chapter 6 
Finally, this chapter provides an overview of the main results of this PhD dissertation. Since 
Chapters 4, and 5 have their own Discussion and Conclusion sections, only the main results 
are discussed and the main conclusions highlighted, to avoid excessive redundancy. Also, in 
this section future perspectives are approached.  
 
The chapters were all formatted in the same style, and the references are cited by sequential 
numbers and listed in a single “References” section. The supplemental tables are also 
presented in a section at the end of this dissertation. 
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CHAPTER 1 
General introduction 
  
 2 
CHAPTER 1 – GENERAL INTRODUCTION 
3 
1. General introduction 
 The genus Salmonella spp. 
1.1.1. The discovery of Salmonella 
Salmonella is a genus of rod-shaped Gram-negative intracellular facultative bacteria, 
within the Enterobacteriaceae family. Several Historical accounts point to Salmonella as the 
cause of death of many important personalities and civilizations. In 430 BC, the Plague of 
Athens decimated around 75,000 to 100,000 people during the second year of the 
Peloponnesian War (against Sparta) and had enormous political, economic and social 
ramifications, since it was the main reason for Athens losing the war. This outbreak spread 
from Ethiopia into Egypt, Libya, the Near East and finally the port of Athens. It was also, at 
that time, the cause of death of the Athenian leader Pericles in 429 BC1. A few years later, in 
323 BC, Alexander the Great died at 33 years old, most likely due to typhoid fever2. In 2001, 
a mass grave with victims from the Plague was found, and the DNA of Salmonella enterica 
serovar Typhi was detected in three squeletons3. Just recently, in 2018, Nature Ecology & 
Evolution published a study that suggests that S. enterica serovar Paratyphi C was 
introduced in the New World by the European colonizers and was the cause of death of the 
Aztecs in the 1500s4. On November 11th 1861, the beloved Portuguese king D. Pedro V died 
at the age of 24 years old, from typhoid fever, along with two of his brothers, D. Fernando 
and D. João5. One month later, on December 14th 1861, his cousin, and Queen Victoria’s 
husband, Prince Consort Albert of Saxe-Coburg and Gotha, died from the same illness6. 
The attribution of the discovery of Salmonella is still debatable since many were the 
scientists that contributed to the characterization of typhoid fever and its propagation. In 
1873, William Bud, a medical doctor who studied cholera and intestinal fever, stated that 
typhoid fever was transmitted through faeces, and contaminated hands and water were the 
probable propagation routes. Bud indicated disinfection as a preventive measure of spread 
of this disease7. Later in 1879, Karl Joseph Eberth described a bacillus in the abdominal 
lymph nodes and in the spleen of patients with typhoid fever8. However, it was only in 1885 
that this microorganism was isolated and identified by Theobald Smith as Bacillus 
choleraesuis, the etiologic agent of hog cholera9,10. Nevertheless, typhoid fever was still 
believed to be transmitted through polluted water, milk, putrefying organic matter or even 
sewer gas11. Later, during the 1900s, the work of sanitary engineer George Soper on the 
typhoid outbreaks caused by Mary Mallon cleared much of the mystery surrounding the 
transmission of typhoid fever. Mary Mallon was an Irish woman who worked as a cook in 
several private homes in New York. She was an asymptomatic carrier of S. enterica serovar 
Typhi and was responsible for several outbreaks and the contamination of at least 122 
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people before she was forcibly admitted in North Brother Island, where she lived until her 
death in 193812. 
1.1.2. Taxonomy 
The nomenclature of Salmonella is somewhat complex and suffered several changes 
through time. Bacillus choleraesuis was initially included in the group Bacterium or Bacillus, 
until 1900, Lignières proposed it should be considered a genus and named it Salmonella, 
after Theobald Smith’s supervisor Daniel Salmon9,13. In 1931, Kauffman proposed one of the 
first Salmonella taxonomic classification methods, the Kauffmann-White Schema, based on 
the identification of cell wall (O) and flagellar (H) antigens, and according to which serovars 
were considered different species14. At that time, novel Salmonella species were given 
names according to, for example, the disease caused (Salmonella typhi), host specificity 
(Salmonella abortus-ovis), and later after the geographical area where the strain was first 
isolated (Salmonella london)14–16. By 1940, the number of Salmonella species was becoming 
unmanageable, hence Borman et al proposed the consideration of only three species, 
determined by serological methods: S. choleraesuis for the type species, Salmonella typhosa 
and Salmonella kauffmannii, containing all known serovars. This classification was ignored 
until 1952, when Kauffmann and Edwards proposed the consideration of three species 
according to their biochemical properties, Salmonella choleraesuis, Salmonella typhosa and 
Salmonella enterica17,18. Subsequent taxonomic classifications divided the serovars in four 
species or subgenera: Salmonella kauffmannii, subgenera I; Salmonella salamae, subgenera 
II; Salmonella arizonae, subgenera III; and Salmonella houtenae, or subgenera IV16. The 
concept of few species was well accepted, until 1973 DNA hybridization techniques 
demonstrated that all serovars, except for group V, Salmonella bongori, were related at 
species level19. The species name Salmonella enterica came up later on, in 1986, since 
Salmonella choleraesuis could easily be confused with the serovar Salmonella enterica 
serovar Choleraesuis20. 
Currently, the genus Salmonella comprises two species, S. bongori and S. enterica, 
the latter being divided in six subspecies: enterica (I), salamae (II), arizonae (IIIa), 
diarizonae (IIIb), houtenae (IV), and indica (VI)15. According to the White-Kauffman-Le 
Minor scheme, these subspecies are further divided into serovars15. More than 2600 
serovars of S. enterica have been described to date while only 22 serovars of S. bongori are 
known15. 
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 From classical typing to genomic characterization 
Typing is by definition the analysis of the phenotype and/or genotype of bacteria in 
a more specific level, and usually contributes to the detection of outbreaks, definition of 
transmission patterns, and determination of source of infection21. In the following points, a 
few of the most commonly used methods for typing of Salmonella will be described. 
1.2.1. Classical typing 
The White-Kauffman-Le Minor scheme has been the gold standard method for 
Salmonella serotyping for almost 90 years. It consists, as explained previously, on the 
identification of O and H antigens, by slide agglutination with specific antisera15. The O 
antigen is part of the lipopolysaccharide that composes the outer membrane of Gram-
negative bacteria. There are sixty-seven O groups, 1 to 67, that basically vary in their 
chemical structure15,22. Some bacterial cells can express several O antigens 
simultaneously23. In addition, there are one hundred and fourteen flagellins, that differ in 
their epitopes24. Moreover, most Salmonella enterica serovars are diphasic, meaning they 
have the ability to express two different flagellar filament proteins, FljB and FliC, in a 
process, controlled by the Hin recombinase, known as flagellar phase variation25. All these 
variations make Salmonella serotyping a complex process, since serovars are determined 
by the combination of O, H1, and H2 antigens. Among several limitations, serotyping is not 
a discriminatory method when trying to differentiate species, subspecies, or strains, so 
additional testing is usually required. A typing technique often used to differentiate strains 
from specific serovars, namely S. enterica serovar Enteritidis and S. enterica serovar 
Typhimurium, was phage typing23. Phage typing is based on the capacity of certain 
bacteriophages to selectively infect strains, and consequently, a phage type is assigned upon 
the variety of phages that are able to infect a specific strain26. The complexity of the 
technique, which calls for active phage stocks, and the subjective interpretation of the 
results, eventually limited the use of this technique to a few reference laboratories23,26. 
1.2.2. Molecular typing 
The development of molecular techniques, based on the genomic differences 
between bacterial genomes, allowed for the identification and fingerprinting of species, 
subspecies, and strains in general. Several techniques have been used for Salmonella 
molecular typing, amongst others, Pulsed Field Gel Electrophoresis (PFGE), Restriction 
Fragment Length Polymorphism analysis (RFLP), Multilocus Sequence Typing (MLST), and 
Multiple-Locus Variable number tandem repeat Analysis (MLVA)23,26. PFGE, used for many 
years for outbreak detection, is, in a simplistic manner, based on the restriction pattern of 
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the bacterial genome. The bacterial DNA, internalized in agarose, is isolated and fragmented 
by restriction enzymes, and then separated by alternating polarities, generating a 
restriction profile characteristic to each genome26. This technique is labour intensive and 
time-consuming and studies have now shown its discriminatory limitations27–29. RFLP is 
somewhat similar to PFGE, but after the electrophoresis, the fragments are transferred by 
southern blotting to a membrane with labelled DNA probes that hybridize with repeat 
motifs26. This method, like PFGE, is also currently obsolete. Contrarily, a technique still in 
use in the great majority of European laboratories is MLVA. MLVA is based on the premise 
that each strain has a distinct number of tandem repeats in various loci of specific regions 
of its genome (variable number tandem repeats, VNTR)30. Several schemes for many 
bacteria have been established, including S. enterica serovar Enteritidis and S. enterica 
serovar Typhimurium31,32. This technique is quite robust, simple, and has high 
reproducibility, among other advantages, making it an elected tool for worldwide outbreak 
detection to this day33. Finally, MLST is a typing technique based on the variations that 
naturally occur in the sequence of bacterial housekeeping genes. The most accepted scheme 
for Salmonella is based on 7 housekeeping genes, aroC, dnaN, hemD, hisD, purE, sucA, and 
thrA, and has a high correlation with serotype, making it an alternative to classical 
serotyping for some laboratories28. This molecular typing technique, presents lower 
resolution than PFGE and MLVA due to the fact that housekeeping genes have a slow 
mutation rate35. 
1.2.3. Genomic era 
In the 1970’s the first sequencing technologies started to arise, but the need for toxic 
and radioactive reagents limited their use, and when Sanger sequencing was developed it 
quickly prevailed in the following 30 years. Later, the demand for faster, higher throughput 
and a cheaper solution to determine the human genome sequence, in the context of the 
Human Genome Project, prompted the development of next-generation sequencing (NGS)36. 
During the 2010’s, whole-genome sequencing (WGS) of bacterial pathogens started being 
used in several public health laboratories following its application in the resolution of two 
major outbreaks, the cholera outbreak in Haiti and the Escherichia coli O104:H4 outbreak37–
39. 
1.2.3.1. Illumina sequencing technology 
Throughout the years, several sequencing platforms, have been developed by 
different companies, differing in their method of immobilization of DNA and in the 
sequencing approach, sequencing by ligation or sequencing by synthesis40,41. However, 
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these second-generation technologies all share the capability for massively parallel 
analysis, generating an output of millions of short reads in a couple days, at a lower cost 
than first generation sequencing, and eliminating the need for electrophoresis upon 
sequencing37,41. The Illumina technology, the most popular in the market, and also used in 
this work, will be described in more detail. Illumina sequencing is based on a sequencing by 
synthesis approach37. It starts with the random fragmentation of DNA and the simultaneous 
ligation of adapters to both ends of each fragment (tagmentation)41. These adaptors allow 
ligation to a complementary sequence on the flow cell, PCR amplification, binding of 
sequencing primers, and indexing. After hybridization of forward and reverse primers to 
the flow cell, bridge amplification begins, in which millions of clusters of clonal sequences 
are synthetized40. Sequencing follows, with the incorporation of fluorescently labelled 
reversible terminators. These modified nucleotides are blocked at their 3’ hydroxyl ends in 
order to guaranty that incorporation is achieved one nucleotide at a time41. During each 
cycle of incorporation, a laser excites the nucleotide and the signal is detected, followed by 
cleavage of the fluorescent tag and the restoration of the 3’ hydroxyl end, which allows 
further incorporation of complementary nucleotides42. The output of this sequencing 
platform consists in millions of paired-end reads of 2x150 bp. 
1.2.3.2. Application and bioinformatic tools for Salmonella typing 
The major applications of NGS in infectious diseases genomic studies, are (i) the 
characterization of the pathogen, (ii) molecular epidemiology, and (iv) pathogenomics43. 
The importance of Salmonella as a foodborne human pathogen has made this bacteria one 
of the most studied pathogens by WGS, with many bioinformatic tools and pipelines being 
developed recently44–46. 
Identification of microorganisms by WGS in routine laboratories is still very unlikely 
given the costs when comparing to current diagnostic methods such as matrix-assisted laser 
desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS). Nonetheless, it 
can still be a useful tool to identify pathogens that are unidentifiable by traditional methods, 
unculturable or slow growth microorganisms, and to perform culture-independent 
metagenomics directly from clinical samples47. Specific features of Salmonella can be 
extracted from the high throughput data generated by NGS technologies using freely 
available online platforms, before or after assembly of the reads, depending on the tool43,46. 
Centre for Genomic Epidemiology (CGE) is an online platform where several tools for 
Salmonella typing are available. Serovar (SeqSero or SISTR) and ST (MLST) determination, 
identification of resistance markers (ResFinder or CARD), mobile genetic elements 
(PlasmidFinder, PHASTER), and Salmonella pathogenicity islands (SPIFinder) are useful 
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tools for Salmonella fingerprinting that can be used in place of traditional typing methods48–
54.  
Comparative genomic analysis based on gene-by-gene approaches (extended MLST 
schemes), or single nucleotide polymorphisms (SNP), have not only been invaluable tools 
for infection control, outbreak detection and source attribution, but have also allowed to 
shed light on the micro and macroevolution processes of several Salmonella serovars29,55–60. 
Both approaches can be indexed to core or accessory genome, and easily visualized in 
software like PHILOViZ or GrapeTree61,62. When concerning outbreak detection, core 
genome MLST (cgMLST) is proving to be the method of choice rather than whole-genome 
MLST (wgMLST) or SNP typing, since it provides the resolution needed for epidemiological 
investigations and is slightly less computationally demanding63,64. However, when studying 
evolution of bacterial lineages by accessing the most common recent ancestor and 
determining transmission events, a combination of core and accessory genomes analysis is 
more useful47,65. Contrary to traditional typing methods, it is difficult to define thresholds of 
similarity between strains analysed by WGS, essentially due to the natural occurring 
variability of the genomes over time. It is fundamental to perform large scale studies 
including epidemiologically verified outbreak isolates and evaluate significant differences 
case by case45,66. An example of such a study is the INNUENDO project, in which a dynamic 
cgMLST scheme with three levels of differences for Salmonella enterica was established, 
with 0.5% allele differences discriminating outbreak cases from sporadic cases45. However, 
these thresholds should not be considered absolute and static, since the genomic variability 
in different Salmonella enterica serovars is significant. 
 Salmonella evolution and genome structure 
Any bacterial genome is characterized by a common set of gene families, the core 
genome, and a set of genes subjected to variability, the accessory genome. The core genome 
together with the accessory genome constitute the pan-genome66. Salmonella is a close 
relative of Escherichia coli, both species sharing 90% of their core genomes, which suggests 
the existence of a common ancestor 100 million years ago67,68. Bacterial evolutionary 
processes are strongly correlated with adaptation to new niches and hosts, and it is believed 
to have occurred in three phases in Salmonella69. Genome variation in general, results from 
point mutations (SNP, insertions, and deletions), horizontal gene transfer (HGT), large 
insertions and deletions, duplications and rearrangements. However, it was mostly HGT 
that played an important role in Salmonella evolution70. The acquisition of Salmonella 
pathogenicity island 1 (SPI 1), which encodes several proteins related to invasion of 
epithelial cells, by plasmid-or phage-mediated HGT, marked the divergence of E. coli and 
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Salmonella9,69. The subsequent acquisition of SPI-2, which contributes to survival and 
replication inside host cells, through a similar mechanism, resulted in the divergence of the 
two Salmonella species, Salmonella enterica and Salmonella bongori9,69. Finally, the 
acquisition of virulence genes was essential in the divergence of the different Salmonella 
subspecies, evolving primarily from a strictly gastrointestinal pathogen in cold-blooded 
animals, to then expand to other hosts like warm-blooded animals and also developing the 
ability to cause systemic infection69,70. In some serovars, host restriction was compensated 
by the ability to increase longevity of transmission, such is the case of S. enterica serovar 
Typhi, as shall be elucidated in the following sections70. Other important mark in Salmonella 
evolution was the acquisition of the fljAB/hin locus, which conferred the bacteria the ability 
to change flagellar phases, to elude the host immune system71. In addition to the SPIs it is 
also possible to find Insertion sequence (IS) elements, bacteriophages, transposons and 
plasmids in Salmonella genome71. 
Salmonella genome ranges from approximately 4.4 to 5.8 Megabases (Mb)72. The 
core genome evolved from a lower percentage of guanines and cytosines (% G+C) to a G+C 
rich genome, with approximately 55% G+C content. The acquired virulence islands are 
clearly identified as regions with higher adenine and thymine content73. The pan-genome 
consists on the entire set of gene families present in all the strains within a clade, therefore 
it includes the core genome, the genes present in all strains of the clade, and the accessory 
genome, strain specific genes74. Salmonella has what is considered to be a closed pan-
genome, which means that the average number of gene families specific to each particular 
strain is lower than the average genome size (Figure 1-1)75. 
Figure 1-1 – Plot of Salmonella pan- and core-genomes, adapted from (76). 
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 Host preference and human disease 
Salmonella spp. is a well-adapted pathogen with a wide range of hosts and niches, 
and depending on the serovar, different pathogenicity. While the main niche of Salmonella 
spp. is the intestinal tract of humans and farm animals, these Enterobacteriaceae are widely 
distributed in nature and have been isolated from a wide variety of animals and their food 
products9,77. S. bongori, as well as subspecies salamae, arizonae, diarizonae, houtenae, and 
indica, are mainly associated with cold-blooded animals and the environment, while S. 
enterica subsp. enterica, that accounts for more than 99.5% of isolated Salmonella strains, 
is usually associated with warm-blooded animals9. However, Salmonella spp. adapts quite 
easily to different environments and non-enterica subspecies can also be found in warm-
blooded animals9. Salmonella can cause two types of salmonellosis in humans: 
gastroenteritis, commonly associated with non-typhoidal Salmonella (NTS), and enteric 
fever, caused by S. enterica serovar Typhi or S. enterica serovar Paratyphi A, B or C78. 
The main vehicle of NTS infection is the ingestion of contaminated food or 
contaminated water, and by direct contact with animals. NTS is further widespread due to 
faecal contamination as it is excreted to the environment in the faeces of its hosts77. As a 
result, Salmonella can also be found in a variety of fruits and vegetables10. Although most 
animal hosts are asymptomatic, others exhibit signs of infection. For instance, S. enterica 
serovar Gallinarum causes Pullorum disease and S. enterica serovar Pullorum fowl typhoid 
in poultry, S. enterica serovar Typhimurium and S. enterica serovar Dublin cause 
salmonellosis in cattle and S. enterica serovar Cholerasuis causes septicaemia in pigs77. The 
majority of Salmonella infections, caused by NTS, lead to gastroenteritis, presenting self-
limiting diarrhoea, associated with fever and abdominal cramping, 12 to 72 hours after 
infection10. However, in immunocompromised individuals, some of those strains may cause 
systemic infections, frequently lacking diarrheal symptoms, for example, bacteraemia, 
osteomyelitis and meningitis78–80.  
Typhoid and paratyphoid, serovars S. enterica serovar Typhi and S. enterica serovar 
Paratyphi A, B and C, are exclusively human pathogens, meaning that humans are their only 
reservoir. In endemic countries, typhoid and paratyphoid Salmonella are usually 
transmitted indirectly due to poor hygiene and poor sanitary conditions, which lead to the 
contamination of the environment either by sewage released in water supplies, or with use 
of human faeces as fertilizer, or even with untreated piped water10,81,82. Other transmission 
route may be the direct contamination of food and water by a carrier or infected person82. 
The incubation period is often 7 to 14 days and symptoms can sometimes be very similar to 
other febrile illnesses82,83. Enteric fever can be characterized by a wide range of clinical 
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severity, but the most frequent symptoms include prolonged high fever, nausea, vomiting, 
and headache. Neurological complications and even death, usually due to intestinal 
perforation and peritonitis or severe toxic encephalopathy associated with myocarditis and 
hemodynamic shock, may occur in more severe cases68,79,80. Typhoidal Salmonella 
proliferation in the host may endure for extended periods, due to its capacity to invade 
monocytes and macrophages, and to colonize the gall bladder, with an estimated 5 to 10% 
of patients experiencing a relapse79. Some individuals may even present asymptomatic 
shedding for several years10. 
 Epidemiology 
Salmonellosis is a major public health concern, with huge economic burden in both 
developed and underdeveloped countries. Salmonella is estimated to be responsible for 9% 
of the 1.9 billion cases of diarrhoea that occur each year worldwide. Nonetheless, 41% of 
deaths with diarrhoeal causes are attributed to Salmonella84. In the European 
Union/European Economic Area (EU/EEA), it remains the second most common cause of 
gastroenteritis, right after Campylobacter85,86. NTS is estimated to cause 93.8 million cases 
of gastroenteritis globally per year, of which 80.3 million are considered foodborne. NTS is 
also estimated to be responsible for 155 thousand deaths each year86. Between 2004 and 
2013, a statistically significant decreasing trend of salmonellosis, probably linked to the 
implementation of control measures in the poultry industry, has been observed in the 
EU/EEA. However, the countries reporting an increase in the number of cases doubled since 
2012, although the trend seems to have stabilized in half of the Member States the past few 
years. This increase seems to be linked to an increase in the number of cases of S. enterica 
serovar Enteritidis, most specifically to an increase in the number of multi-country 
outbreaks caused by this serovar (Figure 1-2)85,87. In 2016, the most common cause of 
foodborne outbreaks was Salmonella, accounting for 22% of total cases85. The highest 
notification rate continued to be observed in children under 5 years old, and in Portugal it 
was even 34 times higher than in adults (25-44 years). The hospitalization rate was also 
very high in Portugal (74−88%), considering the low notification rates (<10 per 100,000)85. 
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Figure 1-2 - Trends of reported confirmed human cases of non-typhoidal salmonellosis 
versus trend of reported Salmonella enterica serovar Enteritidis cases, in the EU/EEA, 2008–2016. 
Adapted from (88). 
While more than 2600 serovars of S. enterica have been described to date, S. enterica 
serovar Enteritidis and S. enterica serovar Typhimurium remain the most common serovars 
that cause human disease, accounting for 80% of total cases of salmonelosis87. According to 
the “European Union summary report on zoonoses, zoonotic agents and food-borne 
outbreaks 2016”, the most commonly reported serovars in 2016 were: S. enterica serovar 
Enteritidis, S. enterica serovar Typhimurium, monophasic S. enterica serovar Typhimurium 
(S. 4,[5],12:i:-), S. enterica serovar Infantis, and S. enterica serovar Derby87. In the European 
Union (EU), laying hens, broilers and broiler meat remain the main sources of S. enterica 
serovar Enteritidis infections in humans. S. enterica serovar Typhimurium is manly 
associated with cattle, and their meat, and to a lesser extent with pigs, poultry and their 
meat. Contact with pigs and consumption of pig meat are the most frequent reported 
sources of monophasic S. enterica serovar Typhimurium, while S. enterica serovar Infantis 
is mostly associated with broiler and turkey chains. Finally, S. enterica serovar Derby was 
mostly reported in pigs and pig meat, and to a lesser extent in poultry and cattle (Figure 1-
3)87.  
S. enterica serovar Enteritidis 
Non-typhoidal Salmonella 
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Figure 1-3 - Distribution of the 2016 EU top-five Salmonella serovars in human salmonellosis 
acquired in the Member States, across different food, animal and meat sectors (broiler, cattle, pig and 
turkey). Adapted from (88). 
Enteric fever is very frequent in underdeveloped countries, where poor water 
supply and sanitation is very common. South/South-East Asia, sub-Saharan Africa, and 
Oceania islands are the most affected areas, presenting the highest mortality rates, 
especially among children81. In 2017, 14.3 million cases of enteric fever occurred globally, 
with 76.3% of cases caused by S. enterica serovar Typhi and 135.9 thousand deaths81. 
Enteric fever is a rare disease in the EU/EEA, mainly acquired while travelling to endemic 
countries, specially India and Pakistan. In 2016, 22 EU/EEA countries reported 1161 
confirmed cases of typhoid/paratyphoid fever, representing an increase comparing to 
previous years, probably related to higher notification rates and an increase in travels to 
countries outside the EU89. S. enterica serovar Typhi was the most frequent cause of enteric 
fever in EU/EEA, accounting for 60% of cases, followed by S. enterica serovar Paratyphi A89. 
When traveling to endemic countries, WHO recommends vaccination with one of the 3 
available vaccines82. 
 Pathogenesis 
After ingestion, Salmonella has to overcome numerous host defence mechanisms, 
such as gastric acidity, proteases, defensins and aggressins, in order to succeed and cause 
infection90,91. When Salmonella enters the small intestine, the bacteria adheres to intestinal 
epithelial cells, preferably M cells of Peyer’s patches (Figure 1-4), and disrupts the epithelial 
structure causing diarrhoeal symptoms90. Salmonella then invades enterocytes, via a type 
III secretion system encoded by SPI-1, T3SS-1, or dendritic cells, in order to reach follicles 
and mesenteric lymph nodes78. Inside the enterocytes, the bacteria resides in Salmonella-
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containing vacuoles (SCV) where it disrupts the cell’s cytoskeleton, alters membrane 
transport, signal transduction, and cytokine expression, by secreting SPI-2 encoded effector 
proteins via another type III secretion system, T3SS-278,90–92. This allows Salmonella to 
survive and replicate inside host cells. The SCVs are eventually transported to the 
basolateral membrane and Salmonella is released to the submucosa to either (i) colonize 
adjacent enterocytes, to repeat the intracellular cycle again, (ii) be phagocytosed by 
neutrophils, inflammatory monocytes, or dendritic cells, and then spread systemically upon 
phagocyte migration, (iii) or even to spread directly to the lymph nodes90–92. Some serovars, 
such is the case of S. enterica serovar Typhi and S. enterica serovar Typhimurium, have yet 
the ability to form biofilms on the gallbladder stones, prolonging their longevity inside the 
host91. 
Figure 1-4 – Pathogenesis of Salmonella, adapted from (92). a. Salmonella adheres to 
intestinal epithelium and M cells. b, c. Effector proteins cause changes to the cytoskeleton. d. 
Alternatively, Salmonella is directly engulfed by dendritic cells from the submucosa. e. Inside the 
enterocytes, Salmonella replicates inside Salmonella-containing vacuoles. f. Salmonella is released to 
the submucosa. g. Finally, bacteria is phagocytosed and contained in SCVs. 
 Diagnosis, antimicrobial therapy and antimicrobial resistance 
1.7.1. Diagnosis 
Salmonellosis diagnosis, whether if it is gastrointestinal disease or enteric fever, 
requires isolation of Salmonella from a clinical sample, which may be faeces, blood, bone 
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marrow, urine, among others. The culture medium used depends on the type of sample 
collected. Isolation of Salmonella in faeces usually requires an enrichment step in Selenite F 
(Salmonella enrichment and inhibition of other bacteria) or GN broth (Salmonella and 
Shigella enrichment and inhibition of other bacteria) for 6 to 12h prior to culture in selective 
media, such as Hektoen agar (selective and differential for Salmonella and Shigella), SS agar 
(selective and differential for Salmonella and Shigella), or XLD agar (selective for Salmonella 
and Shigella). Blood cultures require incubation in proper culture bottles followed by 
subculture in differential media. Urine samples are firstly cultured in CLED agar for 
inhibition of Proteus swarming and colony counting, and also subcultured in differential 
media. All the obtained cultures are then identified either by their biochemical 
characteristics using automated systems or more prosaic testing, or by MALDI-TOF MS.  
The serological Widal test is still used in several countries as the main diagnostic 
method for enteric fever given its low cost and straightforward operation. It consists in an 
agglutination reaction between O and H antigens with the antibodies present in serum of a 
patient. Given that an individual may present background antibodies due to previous or 
repeated infections, vaccination, or even for living in an endemic area, this test has low 
sensitivity and is very inaccurate. Moreover, this test also lacks specificity due to antigens 
cross reactivity. Rapid serologic tests, represent a slightly improvement from Widal test, but 
still lack sensitivity and specificity. When culture is not possible or successful, molecular 
testing by conventional or real-time PCR come as an alternative93,94. 
1.7.2. Antimicrobial therapy 
In the majority of cases, salmonellosis caused by NTS does not require 
hospitalization. Treatment usually involves replacement of fluids and electrolytes to control 
dehydration. Empirical antibiotic therapy is to be avoided in mild to moderate cases in 
otherwise healthy individuals, since it gives rise to antimicrobial resistance and may even 
contribute to prolongation of faecal shedding10,95. Nevertheless, antibiotics may be required 
to cure severe disease, invasive NTS (iNTS) infection and enteric fever, after appropriate 
testing96. Additionally, neonates and young children should always be treated to avoid 
bacteremia97. Treatment of chronic shedding involves long-term oral antibiotic therapy and 
possible removal of the gallbladder 95.  
For several years, the first-line of treatment of enteric fever and NTS severe 
infections was either ampicillin, chloramphenicol or trimethoprim–sulfamethoxazole96. 
With the emergence of multidrug resistant (MDR) strains, that is, strains presenting 
resistance phenotypes to at least three different drug classes, the fluoroquinolone 
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ciprofloxacin and later the third-generation cephalosporin ceftriaxone, have been used as 
empirical therapy, and azithromycin as the last line of treatment98. But eventually, 
resistance phenotypes to these antibiotics started to emerge and the nephrotoxic colistin 
was recently re-introduced has the last resort treatment of severe infections caused by MDR 
pathogens, including Salmonella99–102. Salmonellosis caused by MDR strains are more 
invasive, require more hospitalizations and are associated with higher mortality rates103. 
Recently a major concern is threatening the advances of modern medicine, with the 
identification of plasmids that confer resistance to colistin (mcr family), which will probably 
set us back to a post-antibiotic era, where patients will unfortunately succumb to common 
infections and minor injuries104–111.  
1.7.3. Antimicrobial resistance 
Antibiotics have been one of the major findings of the modern era. The introduction 
of penicillin for public use in the 1940s revolutionized Medicine, having countless lives been 
saved since then112. However, even at the time of its discovery, Alexander Fleming gave 
warning of the possibility of occurrence of penicillin resistant strains and in fact, the 
development and generalized misuse of new antibiotics has always been shortly 
accompanied with the arise of resistant strains (Figure 1-5)113. 
Figure 1-5. – Antibiotics timeline depicting the year of introduction and the year when the first 
resistant strain was identified, adapted from (114), (112), (115), (102), 
https://www.ukri.org/ukri/assets/Image/SiteImages/xorg/amrinfographicfull.jpg, and 
https://www.cdc.gov/drugresistance/about.html. *The use of colistin was abandoned in the 1980s 
due to nephrotoxicity effects and was later re-introduced to treat multidrug resistant infections. 
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The emergence of MDR strains is mainly promoted by the indiscriminate misuse of 
antibiotics in human and veterinary treatment, and as growth factors in animals for food 
production112. Antibiotic resistance may be intrinsic, when microorganisms exhibit 
inherent characteristics that confer resistance to certain drugs, or acquired, when 
resistance genes are acquired from other bacteria (same or different species), or when new 
mutations in chromosomal genes occur and induce expression of innate resistance 
mechanisms116. Foreign DNA may be acquired through intake of insertion sequences (IS), 
transposons, plasmids and bacteriophages117. In order to avoid an antibiotic apocalypse has 
preconized by World Health Organization (WHO), we are called for action specifically in 
respect of harmonization of surveillance in humans and food-producing animals, in a “One 
Health” approach. 
1.7.3.1. β-lactams 
β-lactams incorporate three major groups of antibiotics: penicillins, cephalosporins 
(1st to 4th generation) and carbapenems. They interfere with cell wall formation by 
inhibiting Penicillin Binding Proteins (PBPs), impeding synthesis of peptydoglican118. The 
most common mechanism of resistance to β-lactams in Salmonella is the secretion of β-
lactamases, enzymes that hydrolyse the β-lactam ring rendering these antibiotics 
inactive118. These hydrolytic enzymes can either be inherent to some bacteria being carried 
on chromosomes, or in plasmids with potential to disseminate to other microorganisms (bla 
genes)119. There are several classes of β-lactamases that comprise more than one thousand 
enzymes but the most commonly associated with Salmonella resistance are class A β-
lactamases, specially the extended-spectrum β-lactamases (ESBLs) gene family TEM114,118. 
Other genes commonly associated with Salmonella include class A blaPSE-1, blaCARB-2, blaKPC-2, 
and blaCTX-M, and class C blaampC, and blaCMY-2118. ESBLs became a major public health concern 
not only because they have the ability to hydrolyse cephalosporins (cefotaxime, ceftriaxone, 
ceftazidime, or cefepime) and monobactams (aztreonam), but also because they are widely 
disseminated worldwide114,120. 
1.7.3.2. Aminoglycosides 
Aminoglycosides (streptomycin, neomycin, amikacin, gentamicin, spectinomycin, 
kanamycin, tobramycin, among others) act by inhibiting protein synthesis by binding to the 
16S rRNA of the 30S ribosomal subunit, leading to codon misreading and inhibition of 
translation118,121. The mechanism of resistance to this group of antibiotics in Salmonella is 
usually the modification of the drug although other resistance mechanisms such as 
reduction of uptake, target alteration and increased efflux exist in other bacteria118,121. 
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There are several types of modifying enzymes that confer resistance to aminoglycosides. 
Aminoglycoside acetyltransferases confer resistance to gentamicin, tobramycin, and 
kanamycin by modifying their amino groups. They are coded by genes aac found in 
Salmonella genomic islands, integrons, and plasmids. Aminoglycoside phosphotransferases, 
coded by plasmid genes aph (aph(3’) and aph(6)-Id, also known as strA and strB, 
respectively), catalyse ATP-dependent phosphorylation of hydroxyl groups of 
streptomycin, kanamycin, and neomycin. Finally, nucleotidyltranferases encoded by genes 
aad, some also designated ant genes, also target hydroxyl groups by adding AMP from an 
ATP donor. The aadA gene, also known as ant(3’), confers streptomycin resistance in 
Salmonella, while aadB, or ant(2’)-Ia, provides resistance to gentamicin and 
tobramycin118,121.  
1.7.3.3. Quinolones 
All quinolones (nalidixic acid, ciprofloxacin, pefloxacin, levofloxacin, etc.) exhibit the 
same mechanism of action, typically targeting DNA gyrase and DNA topoisomerase IV, 
disrupting DNA replication and leading to cell death122,123. Consequently, the mechanism of 
resistance conferring resistance to one quinolone, confers resistance to all quinolones, 
although some mechanisms only decrease quinolone susceptibility and require the 
presence of additional alterations to confer full resistance124. Several mechanisms of 
resistance to quinolones have been described: (i) mutations in the genes that encode the 
two topoisomerases, gyrA, gyrB, parC and parE, lower the affinity of quinolones to the 
topoisomerases; (ii) the presence of plasmid-mediated quinolone resistance genes (PMQR), 
qnrA, qnrB, qnrS, qnrC, and qnrD, encoding topoisomerase-binding proteins that prevent 
quinolone binding to the enzymes; (iii) the presence of the aac(6’)lb-cr gene, encoding a 
modifying enzyme that decreases quinolone activity; (iv) efflux pumps encoded by oqxAB 
and qepA; (v) and finally, the regulation of multidrug efflux pumps AcrAB-TolC, which lower 
the concentration of quinolones in the cell122. 
1.7.3.4. Macrolides 
Macrolides act by binding to the large subunit of 23S rRNA, inhibiting protein 
synthesis, causing premature dissociation of the tRNA125. Macrolide resistance in general is 
either conferred by (i) ribosomal binding site modification by methylases encoded by erm 
genes; (ii) by antibiotic modifying enzymes esterases (ereA and ereB) and 
phosphotranferases (mphA, mphB, and mphD); (iii) by active efflux of the antibiotic (mefA 
and msrA); or (iv) by the presence of mutations in the genes rrl and rpl, encoding the 50S 
ribosomal proteins L4, and L22 and in 23S rRNA126.  
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1.7.3.5. Other antibiotics 
Resistance mechanisms to additional clinically relevant antibiotics have been 
identified in Salmonella. Chloramphenicol acts by binding to the 50S ribosomal unit, 
preventing the formation of new peptide bonds. Resistance to chloramphenicol is conferred 
by enzymatic inactivation of the antibiotic (cat1 and cat2) or by the presence of efflux 
pumps (cmlA and floR)118. 
Tetracyclines also act by inhibiting protein synthesis, by preventing binding of tRNA 
to the 30S ribosomal subunit. Resistance to tetracyclines in Salmonella depends on the 
presence of efflux pumps encoded by tet(A), tet(B), tet(C), tet(D), tet(G), and tet(H)118. 
Sulphonamides and trimethoprim have been used in combination for a few decades. 
These antimicrobials have a similar mode of action, inhibiting enzymes involved in the 
synthesis of tetrahydrofolic acid (co-factor in synthesis of amino acids and nucleic acids). 
The mechanism of resistance to both antibiotics is also similar. Genes sul1, sul2, and sul3, 
and dhfr1, dfrA1, and dhfr12 express enzymes insensitive to sulphonamides and 
trimethoprim respectively118.  
Finally, and in brief, colistin, also known as polymyxin E, binds in a disruptive way 
to lipopolysaccharides (LPS) of the outer membrane of Gram-negative bacteria, leading to 
an increase of permeability of the cell and ultimately to cell death. Colistin resistance is quite 
complex and involves several mechanisms. For the most part, mechanisms leading to 
colistin resistance are linked to chromosomal mutations, except for the plasmid mediated 
mcr gene family. In general, in Salmonella, they involve mutations that lead to modifications 
of the outer membrane (pmrA/pmrB, phoP/phoQ, arnBCADTEF, and mcr1-5)127. 
 Heavy metals tolerance 
Metals occur naturally in nature and act as important co-factors for several 
enzymatic processes. In fact, bacterial growth requires the presence of metals, but these 
compounds become toxic at higher concentrations128. In 2006, EU banned the use of 
antimicrobials in animal feed, which lead to the use of heavy metals such as copper, cobalt, 
and zinc, as alternative growth promoters or preservatives129,130. Additionally, arsenic, 
copper, mercury, silver and zinc have been used as biocidal agents to treat human and 
animal infections for several decades. Mercury and silver are also recognized by their 
disinfectant properties128. Meanwhile, heavy metal tolerance has been detected in 
association with antibiotic resistance genes in several bacteria, including Salmonella130–132. 
These genes are usually located in plasmids, transposons, or integrons, therefore, the use of 
heavy metals has been suggested to promote the spread of antibiotic resistance130–135. The 
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mechanisms that lead to heavy metal tolerance include efflux systems to reduce copper 
concentration in the cell (pcoABCDRSE and tcrYAZB), silver (silCFBAPRSE) or arsenic 
(arsRBC), detoxification of mercury by enzymatic reduction (mer operon), and tellurite 
resistance system (terZABCDEF)132,136. 
 Aims and research plan 
The main objective of this PhD dissertation was to contribute to the determination 
of the genomic structure and antibiotic resistance phenotype of particular Salmonella 
enterica serovars identified in Portugal, through WGS of several isolates with different 
phenotypes and genotypes. This main objective is divided in several specific aims: 
i) to evaluate the main serovars causing salmonellosis in Portugal and to 
identify serovars of interest for our study (Chapter 1); 
ii) to identify clusters of potential epidemiological interest and compare 
several typing methods with WGS (Chapter 2, 3, and 4); 
iii) to study the genomic structure of isolates of the same serovar (Chapter 2, 3, 
and 4); 
iv) to identify resistance markers and mobile genetic elements responsible for 
the phenotype expressed by the isolates in study (Chapter 2, 3, and 4). 
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LS performed most of the experimental work from 2014 to 2019 and interpreted all the data 
analysed for this chapter. 
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2. Salmonella spp. surveillance in Portugal  
 Global trends 
In 1899, in order to structure and develop a public health system, by offering 
technical and professional qualification to the sanitary practise, and most specifically, as a 
means to overcome a large bubonic plague outbreak in Porto, Doctor Ricardo Jorge, a 
renowned Portuguese doctor and researcher, founded “Instituto Central de Higiene” 
(Central Institute of Health), renamed “Instituto Nacional de Saúde Doutor Ricardo Jorge” 
(National Institute of Health Doctor Ricardo Jorge) (INSA) in 1971 in his honour. 
Throughout the years, INSA has always been working towards public health improvement 
in several fields of action, including Salmonella spp. surveillance137.  
In this regard, since 1950, Salmonella serotyping has been performed at INSA, and 
the National Reference Laboratory (NRL) of Gastrointestinal Infections, formally created in 
1991, has carried on the work of its predecessors to these days. In 1972, Professor Adriana 
Figueiredo published the results of 21 years of serotyping of Salmonella spp. isolated in 
Portugal. Between 1950 and 1971, the 10 most common serovars in Portugal, in decreasing 
order, were S. enterica serovar Typhi, S. enterica serovar Typhimurium, S. enterica serovar 
Enteritidis, S. enterica serovar Paratyphi B, S. enterica serovar Newport, S.enterica serovar 
Bredeney, S. enterica serovar Infantis, S. enterica serovar Thompson, S.enterica serovar 
Blockley, and S. enterica serovar Anatum. Naturally, typhoid and paratyphoid fever cases 
decreased significantly through the years, while new serovars appeared and increased in 
numbers138. Figure 2-1 incorporates the data available, from 1950 to July 2019, regarding 
the number of Salmonella spp. isolates serotyped. In total, 21,362 Portuguese isolates were 
analysed, the most part (approximately 84%) isolated from human clinical samples (Figure 
2-2). Between 2003 and 2007 the number of isolates identified peaked, decreasing 
subsequently until 2011. The introduction of Salmonella control measures at the primary 
production level, established in Regulation (EC) No 2160/2003, and following amendments, 
are the most likely cause for the Salmonella decreasing trend in Europe and also in Portugal. 
On the contrary, an increase in the number of outbreaks, was a likely cause for the increase 
in the number of isolates serotyped and in the number of S. enterica serovar Enteritidis from 
2014 to 2017, which was also observed in most EU/EEA member states87,139,140. 
Interestingly, the trends of the total number of Salmonella spp. accompany perfectly the 
trends of S. enterica serovar Enteritidis, since it has been one of the main causes of human 
infection for several years (Figure 2-3).
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Figure 2-1– Origin of the Salmonella spp. isolates received at 
National Institute of Health Doctor Ricardo Jorge for serotyping, 
from January 1998 to July 2019. 
Figure 2-2 – Total of Salmonella spp. serovars identified from 1950 to July 
2019 in the National Institute of Health Doctor Ricardo Jorge. No data 
available from 1972 to 1979. The restriction of access to INSA between 
November 1997 and July 1998, as a result of a contamination hazard, led 
to a decrease in the number of isolates received at the NRL in both years. 
Adapted from (138). 
 
 
 
Figure 2-3 – Trends of total Salmonella spp. serovars identified versus number 
of Salmonella enterica serovar Enteritidis, from 1950 to July 2019 in the 
National Institute of Health Doctor Ricardo Jorge. 
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Regarding the human clinical cases, typhoid and paratyphoid fevers have been 
compulsorily notifiable diseases in Portugal since 1950, while for salmonellosis, this 
occurred only after 1987. While comparing the number of notifications of typhoid and 
paratyphoid fever and the number of cases confirmed by the NRL (Figure 2-4), it can be 
observed that the discrepancies that once existed gradually diminished. This paralleled the 
decreasing use of Widal tests in Portuguese hospitals, along with a tighter validation process 
by the Health Directorate of the cases notified, avoiding an over notification that likely 
existed in the first years. As far as it is known, the majority of cases of typhoid and 
paratyphoid fevers in Portugal are acquired while travelling. As for salmonellosis (Figure 2-
5), variation between notifications and confirmed cases still remains. Salmonellosis is one 
of the most commonly notified diseases in Portugal141–145. 
Analysing the data from the isolates received in the NRL, the age-specific confirmed 
case rate was always highest in the 0-4 age group (in average 24.64 per 100,000 
inhabitants) (Figure 2-6), and was 11 to 53 times higher than the 15-24 age group, which 
was the group with less cases overall. For the most part the male to female ratio was 1:1. 
Overall, most clinical samples were faeces, followed by blood and urine. It should be taken 
into account that NTS was responsible for 92.85% of systemic infections. Salmonella cases 
follow a seasonal trend, with most cases occurring during the summer months, mainly July 
and August, and a smaller peak in December, probably due to overconsumption of egg-
based desserts during the holyday season (Figure 2-7). As expected, due to the high 
population density, most patients reside in Lisboa and Porto, and several districts have few 
confirmed cases (Figure 2-8). Of note, the detection of 214 outbreaks, between January 
1998 and July 2019, with 18.69% being identified in the last 5 years.  
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Figure 2-4 – Number of notifications of typhoid/paratyphoid fever from January 1998 to 
December 2016 and number of laboratory confirmed cases from January 1998 to July 
2019, in Portugal. Adapted from (141–145). The scale of the y-axis is broken for simplification 
purposes. 
Figure 2-5 – Number of notifications of salmonellosis from January 1998 to December 2016 
and number of laboratory confirmed cases from January 1998 to July 2019, in Portugal. 
Adapted from (141–145).  
339
412
309
522
328
602
544
513
415
461
347
222
207
174 190 171
250
332
442
95
204
373
590 568
751
679
798
614
676
502
335
200
127
158 144 157
246
323
405
269
177
0
100
200
300
400
500
600
700
800
900
1
9
9
8
1
9
9
9
2
0
0
0
2
0
0
1
2
0
0
2
2
0
0
3
2
0
0
4
2
0
0
5
2
0
0
6
2
0
0
7
2
0
0
8
2
0
0
9
2
0
1
0
2
0
1
1
2
0
1
2
2
0
1
3
2
0
1
4
2
0
1
5
2
0
1
6
2
0
1
7
2
0
1
8
2
0
1
9
N
U
M
B
ER
 O
F 
C
A
SE
S
YEAR
Salmonellosis Confirmed cases
43
23
36
16
14 14 13
19
9 10
2
4 3
12
2
4 3 3 2 6 4
2 3 2 3
6
97
17
5
0
10
20
30
40
50
1
9
9
8
1
9
9
9
2
0
0
0
2
0
0
1
2
0
0
2
2
0
0
3
2
0
0
4
2
0
0
5
2
0
0
6
2
0
0
7
2
0
0
8
2
0
0
9
2
0
1
0
2
0
1
1
2
0
1
2
2
0
1
3
2
0
1
4
2
0
1
5
2
0
1
6
2
0
1
7
2
0
1
8
2
0
1
9
N
U
M
B
ER
 O
F 
C
A
SE
S
YEAR
Typhoid and paratyphoid fever Confirmed cases
304
202
140
172
97 76 78 92 52
50
250
450
N
U
M
B
ER
 O
F 
C
A
SE
S
 27 
Figure 2-6 – Rates of cases by age group, sent to the Portuguese National Reference Laboratory for serotyping, from January 1998 to December 2018. 
 
Figure 2-7 – Seasonality of Salmonella 
spp. in Portugal. The graph displays the 
max, min and mean values obtained for 
each month in the period between 1998 
and 2019.
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Figure 2-8 – Place of residence of patients with salmonellosis between January 1998 and July 2019. 
 Serotyping: trends from January 1998 to July 2019  
In Portugal, between January 1998 and July 2019, the most commonly isolated 
serovars were S. enterica serovar Enteritidis, S. enterica serovar Typhimurium, and S. 
enterica serovar 1,4,[5],12:i:- (Figure 2-9). As shown in Figure 2-10, S. enterica serovar 
Enteritidis was unequivocally the most common serovar until 2010, whereas this trend is 
not seen since then. Given that this serovar was mainly found in poultry, the European 
Commission enforced a framework of legislation targeting S. enterica serovar Enteritidis 
and S. enterica serovar Typhimurium in broilers, breeders and turkeys. The turning point 
was most likely the introduction of Regulation (EC) No 2160/2003 that includes minimum 
requirements for testing and the elimination of breeding flocks positive for Salmonella, and 
the subsequent introduction of Regulation (EC) No 853/2004, and Regulation (EC) No 
854/2004 that includes rules for food safety measures, and rules for the implementation of 
mandatory official checks, respectively. These regulations contributed for the decrease of 
cases caused by this serovar, however, in 2017 several S. enterica serovar Enteritidis 
outbreaks, still unexplainable, occurred and this serovar became once again the most 
prevalent in that year.  
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In 1986-1987, the first monophasic S. enterica serovar Typhimurium, S. enterica 
serovar 1,4,[5],12:i:-, was isolated from poultry carcasses in Portugal146. Since then, this 
serovar has been identified more frequently in Portugal, even surpassing S. enterica serovar 
Enteritidis in 2012, 2014-2016, 2018, and in the first semester of 2019. Regarding other 
serovars with less representation but also of clinical interest, S. enterica serovar Typhi, for 
example, slightly increased in 2002, 2016 and 2018. Additionally, an increase in the number 
of isolates of S. enterica serovar Rissen in 2015, prompted a study, detailed in Chapter 4 of 
this dissertation, on the diversity of this serovar in Portugal. In July and August 2019, a 
sudden increase of S. enterica serovar Newport, prompted a still ongoing outbreak 
investigation, which also involves the Portuguese Health Authorities. In order to establish 
possible links, epidemiological inquiries are taking place and in WGS of a set of isolates was 
already carried out (Chapter 3).  
Figure 2-9 – Percentage of Salmonella spp. serovars isolated from patients between January 1998 
and July 2019, in Portugal. 
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Figure 2-10 – Trends of 10 serovars of interest isolated between January 1998 and July 2019 from 
Portuguese patients. Due to the major differences in number between the top 3 most common serovars, 
represented on the top panel, and the next seven, represented on the bottom panel, two different vertical 
axis had to be included in the graph. Additionally, the y-axis is broken for simplification purposes. 
 Multidrug resistance in Portugal 
Since 2015, the NRL has been following the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) guidelines for antimicrobial surveillance of all Salmonella 
isolates received, on a panel of 17 antimicrobials of 10 groups (penicillins, tetracyclines, 
cephalosporins, aminoglycosides, chloramphenicol, macrolides, fluoroquinolones, 
trimethoprim, sulfamethoxazole, and carbapenems). Previously, antimicrobial testing was 
rarely performed, usually upon request. Of over 1500 susceptibility tests performed, 
38.33% of isolates tested were MDR. Most part of the MDR isolates were S. enterica serovar 
1,4,[5],12:i:-, followed by S. enterica serovar Typhimurium (Figure 2-11). Approximately 
47% of MDR isolates presented a profile of resistance to penicillins, tetracyclines, and 
sulfamethoxazole. Overall, resistance to sulfamethoxazole was the most frequent, followed 
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by penicillins, and tetracycline (Figure 2-12). Fortunately, resistance to carbapenems was 
not detected and resistance to macrolides remains sporadic. 
 
Figure 2-11 – Most relevant multidrug resistant serovars from January 2015 to June 
2019. 
 
Figure 2-12 – Percentage of isolates resistant to each antibiotic group tested, from January 2015 to 
June 2019 (isolates from the end of June and July 2019 have not been tested to this date). 
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CHAPTER 3 
The new era of surveillance of Salmonella 
 
 
 
 
 
 
 
 
 
 
LS implemented MLVA at the National Reference Laboratory, contributed in the transition 
of surveillance of Salmonella to whole-genome sequencing, performed part of the 
experimental work and part of the bioinformatics analyses, interpreted data in this chapter, 
and is preparing the manuscript. 
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3. The new era of surveillance of Salmonella 
The first Salmonella outbreak study enrolling WGS was published by Baker et al in 
2011, and described a SNP based approach to discriminate outbreak related cases and non-
related cases in a group of S. enterica serovar Montevideo isolates previously characterized 
by PFGE with a single pattern147. Other relevant outbreak studies followed, attesting the 
discriminatory power of WGS for outbreak resolution29,55,148–150. In the Portuguese NRL, the 
transitioning process from Salmonella classical typing methods to WGS began in 2014, in 
the context of a Master Thesis 151, where 16 isolates of Salmonella enterica were sequenced. 
The results demonstrated high levels of concordance between data previously obtained 
through classical typing methods, and in silico predictions. Moreover, even though the 
dataset was small, the incomparable high discriminatory power of WGS was demonstrated. 
Another project that helped prompt the application of WGS in the Portuguese NRL was 
INNUENDO45, developed in collaboration with INSA and other European Reference 
Laboratories. In this context, 22 S. enterica serovar Enteritidis isolated in Portugal were part 
of the large pool provided by the project partners, and were sequenced and subjected to the 
INNUca pipeline, a platform for bacterial genome assembly, developed in the context of the 
project, and used throughout the analysis of the isolates in this PhD dissertation. Also, as an 
output of INNUENDO, a dynamic gene-by-gene scheme was proposed, allowing long-term 
surveillance and outbreak investigations in simultaneous. This was the approach chosen to 
analyse the isolates that are the focus of Chapters 3, 4, and 5. 
Overall, on behalf of the role of INSA as a reference laboratory for human 
salmonellosis aiming at transiting from traditional typing methodologies to WGS-based 
approaches, in the last four years, 315 Salmonella spp isolates were sequenced in several 
contexts described below, excluding some isolates that were purposefully sequenced for the 
Master thesis already mentioned: 
i) 9 isolates with undetermined serovar by the classical serotyping method for 
confirmation of serovar in silico; 
ii) 6 isolates with azithromycin resistant phenotype to check if the underlying 
resistance mechanism was the same in the different serovars; 
iii) 29 isolates for confirmation of 12 Urgent Inquiries; 
iv) 47 isolates of monophasic Salmonella enterica serovar Typhimurium, for a 
surveillance study which is still ongoing;  
v) 20 Salmonella enterica serovar Typhi to evaluate the genomic structure of 
the isolates from Portugal and integrate them with isolates from other 
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countries, especially endemic countries where this serovar is very frequent, 
to hopefully identify their origin (ongoing study); 
vi) 78 Salmonella enterica serovar Enteritidis for the study described in detail 
in this chapter (not all isolates included for confidentiality reasons); 
vii) 9 Salmonella enterica serovar Newport of an ongoing outbreak, and that will 
also be described in this chapter; 
viii) 70 Salmonella enterica serovar Rissen for the study described in detail in 
Chapter 4 (not all isolates were included in the study due to quality issues); 
ix) And finally, 36 Salmonella isolated from imported fresh poultry meat, for the 
study detailed in Chapter 5. 
WGS has already proven to be a valuable tool for the Portuguese NRL, with 
particular relevance when classical serotyping proves inconclusive. All the isolates 
subjected to in silico serotyping had their serovars confirmed. Additionally, in silico 
serotyping also confirmed the serovars of all the isolates sequenced for other purposes, 
proving to be a reliable replacement of the labour intensive and expensive classical method. 
Genome sequencing has also been invaluable to investigate suspected outbreaks allowing 
the Portuguese NRL to start responding to Urgent Inquiries launched on the Epidemic 
Intelligence Information System for food- and waterborne diseases (EPIS-FWD), managed 
by the European Centre for Disease Prevention and Control (ECDC). As described in the 
points above, four major topics will be discussed in the following chapters. Chapter 4 
consists in a study of the genetic diversity of Salmonella enterica serovar Rissen isolated in 
Portugal and its, contextualization among isolates from several countries. Chapter 5 also 
entails a study of genetic diversity of certain Salmonella enterica serovars, in this case 
serovars Heidelberg and Minnesota, isolated from fresh poultry meat imported to Portugal. 
In the present chapter, two examples of rather simple situations in which WGS was also 
applied will be described. First, an example of the transition from a traditional molecular 
typing technique, MLVA, to WGS for S. enterica serovar Enteritidis will follow. Secondly, a 
practical example, of an ongoing outbreak of S. enterica serovar Newport, in which WGS is 
playing an important role. The decision to present these two subjects in a single chapter 
with an unconventional format, is mainly due to the methodology being essentially the same 
when it comes to WGS, and the fact that, contrarily to chapters 4 and 5, both studies are 
ongoing and are not in a submitted manuscript format. All these topics share most part of 
the methodology, a WGS-based gene-by-gene analysis. Since chapters 4 and 5 are based on 
submitted manuscripts, the “Materials and Methods” section may seem repetitive (due to 
the unavoidable highly specific bioinformatics-based descriptions common to these 
studies), although minor changes were made to each manuscript to avoid such situation. 
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Likewise, to avoid excessive repetition, this chapter will include a general “Materials and 
Methods” section where the methodology common to both topics will be described. 
 Materials and Methods 
The following WGS methodology was applied to the studies i) Retrospective study 
of the genetic diversity of Salmonella enterica serovar Enteritidis in Portugal; and ii) 
Ongoing outbreak of Salmonella enterica serovar Newport, 2019. 
3.1.1.1. Whole Genome Sequencing (WGS)  
For each isolate, WGS and bacterial de novo assembly were performed as previously 
described 152. Total DNA was extracted from fresh cultures on the NucliSens easyMAG 
platform (Biomerieux), according to the manufacturer’s instructions. Quantification and 
quality assessment of the purified DNA was performed using Qubit Fluorometer with 
hsDNA Assay Kit (Thermo Fisher Scientific) and agarose gel electrophoresis (0,8%), 
respectively. High-quality DNA samples were then used to prepare dual-indexed Nextera 
XT Illumina libraries (Illumina, USA) that were subsequently subjected to cluster generation 
and paired-end sequencing (2×250bp or 2x150bp) on either a MiSeq or a NextSeq 550 
instrument (Illumina, USA) available at the Portuguese NIH, according to the 
manufacturer’s instructions. All genomes were de novo assembled using the INNUca v3.1 
pipeline (https://github.com/B-UMMI/INNUca), which consists of integrated modules for 
reads QA/QC, de novo assembly and post-assembly optimization steps. After reads’ quality 
analysis using FastQC v0.11.5 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and cleaning with 
Trimmomatic v0.36 153, genomes were assembled with SPAdes 3.11 154 and subsequently 
improved using Pilon v1.18 155.  
3.1.1.2. Gene-by-gene analysis 
Gene-by-gene analysis was performed by taking advantage of a publicly available 
panel of 8558 loci 156 derived from the EnteroBase Salmonella wgMLST schema 63, curated 
and prepared using the chewBBACA free software (https://github.com/B-
UMMI/chewBBACA)157, downloaded on August 2018 
(http://doi.org/10.5281/zenodo.1323684). Allele calling was performed using 
chewBBACA v2.0.11 (https://github.com/B-UMMI/chewBBACA) with default parameters 
and a publicly available training file for S. enterica 
(https://github.com/mickaelsilva/prodigal_training_files). Exact and inferred matches 
were used to construct an allelic profile matrix, where other allelic classifications 
(https://github.com/B-UMMI/chewBBACA/wiki) were assumed as “missing” loci. 
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To evaluate the genetic relationship between strains, minimum spanning trees 
(MSTs) were constructed taking advantage of goeBURST algorithm158 implemented in the 
PHYLOViZ online web-based tool 61, based on 100% shared loci between the analyzed 
strains (i.e., shared-genome MLST) 159.  
3.1.2. Data availability 
All raw sequence reads used in the present study were deposited in the European 
Nucleotide Archive (ENA) under the study accession number PRJEB32515. 
 Retrospective study of the genetic diversity of Salmonella 
enterica serovar Enteritidis in Portugal 
3.2.1. Introduction 
Salmonellosis is one of the main causes of gastroenteritis in the world, causing huge 
global burden of morbidity and mortality 86. The genus Salmonella consists of two different 
species, S. enterica and S. bongori. S. enterica comprises six subspecies and more than 2600 
different serovars, while S. bongori includes only 22 serovars 15. However, human 
salmonellosis is mainly caused by S. enterica subspecies enterica, most frequently by S. 
enterica serovar Enteritidis 88. In Portugal, this serovar accounted for more than 50% of 
salmonellosis cases for several years (chapter 2)160. The main source of infection by this 
serovar is the consumption of contaminated poultry and poultry products, mainly eggs. The 
implementation of control programmes in the poultry industry, involving for example 
vaccination against S. enterica serovar Enteritidis, resulted in the decline of S. enterica rates 
of infection for the past twelve years. Nonetheless, salmonellosis remains the second most 
common zoonosis in humans in the EU/EEA, with 22.9 cases per 100,000 inhabitants 88. In 
fact, salmonellosis remains the most common cause of foodborne outbreaks, and since 2014 
an increase in the number of outbreaks caused by S. enterica serovar Enteritidis has been 
observed, accounting for 60.3% of all Salmonella outbreaks in the EU in 2015 161,162.  
Since 2016, a Multi Locus Variable-Number Tandem Repeat Analysis (MLVA) 
scheme has been available for molecular subtyping of S. enterica serovar Enteritidis 32. This 
typing technique, based on the measurement of the number of repeats in the variable 
number of tandem repeat regions (VNTRs) of the genome is a useful tool for outbreak 
detection and a strong contribution for rapid source detection 30. However, whole-genome 
sequencing (WGS) has already proven to be even more discriminatory while establishing 
outbreak links and attributing sources of infection 59,163–165. In this work, we evaluated the 
genetic diversity by MLVA of all S. enterica serovar Enteritidis isolates recovered from 
human clinical samples, from January 2012 to July 2019, sent to the NRL of Gastrointestinal 
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Infections at the Portuguese National Institute of Health (INSA) for serotyping. We then 
proceeded with WGS of 51 of those isolates to evaluate the clonality of two apparently 
endemic MLVA types that were the most frequent cause of salmonellosis in Portugal during 
the last few years. We also included in the WGS analysis, data of 15 isolates recovered in 
2001, 2002, and 2003 presenting the same endemic MLVA profiles, that were already 
sequenced during the INNUENDO project. 
3.2.2. Materials and Methods 
From January 2012 to July 2019, 528 S. enterica serovar Enteritidis isolates were 
serotyped using the White-Kauffman-Le Minor classification scheme 15. The isolates were 
sent to INSA for serotyping by several Portuguese hospitals and laboratories, covering 
several regions of the country. MLVA was performed using the 5-locus MLVA method 
published by Hopkins et al, 2011166. Isolates were grown overnight in non-selective medium 
at 37ºC. An aliquot of each isolate was prepared in 100 µl of sterile water and using a sterile 
1 µl loop to pick the colonies. The microtubes were placed in a water bath at 100ºC for 10 
minutes, followed by cooling in ice for 1 minute and centrifugation for 10 minutes at 10,000 
rpm. The supernatant was used in the amplification reaction. PCR products were diluted 
1:10 and subjected to capillary electrophoresis 32,166. In order to evaluate the genetic 
diversity of the two most frequent MLVA profiles in Portugal, 51 isolates recovered in 
several years were selected for WGS (methods previously described). Fifteen additional 
isolates, recovered in 2001 and 2002, previously sequenced and assembled following the 
same methodology described above, in the context of the INNUENDO project, were also 
included in the subsequent analysis (Table 3-1). The ResFinder 3.1 web server49 
(https://cge.cbs.dtu.dk/services/ResFinder/) was used to identify acquired antimicrobial 
resistance genes and/or chromosomal mutations, using the default threshold (Table 3-1). 
PlasmidFinder 2.050 was used to detect and characterize the plasmids present in these 
isolates (https://cge.cbs.dtu.dk/services/PlasmidFinder/), also using the default threshold 
(Table 3-1).
 40 
Table 3-1 – Sixty-six Salmonella enterica serovar Enteritidis sequenced isolates with MLVA profiles 3-10-5-4-1 and 3-11-5-4-1. Since genome assembly of isolate PT50 
failed, it was excluded from the subsequent analysis. 
ID Year MLVA 
profile 
Sample 
type 
Region Age Gender Genotype Plasmids 
PT1 2012 3-10-5-4-1 Faeces Setúbal 21 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT2 2012 3-10-5-4-1 Faeces Setúbal 7 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S), Col440I 
PT3 2012 3-10-5-4-1 Faeces Lisboa 7 M aac(6')-Iaa, gyrA p.S83F IncFIB(S), IncFII(S) 
PT4 2012 3-10-5-4-1 Faeces Lisboa 5 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT5 2012 3-10-5-4-1 Faeces Faro Unknown M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT6 2013 3-10-5-4-1 Faeces Porto 1 F aac(6')-Iaa, gyrA p.S83F IncFIB(S), IncFII(S) 
PT7 2013 3-10-5-4-1 Faeces Braga 4 M aac(6')-Iaa, gyrA p.S83F IncFIB(S), IncFII(S) 
PT8 2013 3-10-5-4-1 Faeces Beja 6 M aac(6')-Iaa, blaTEM-1B IncFIB(S), IncFII(S), IncX1 
PT9 2013 3-10-5-4-1 Faeces Lisboa 3 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT10 2013 3-10-5-4-1 Faeces Lisboa 10 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT11 2013 3-10-5-4-1 Unknown Ponta Delgada 13 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT12 2013 3-10-5-4-1 Faeces Beja 6 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT13 2014 3-10-5-4-1 Faeces Setúbal 3 M aac(6')-Iaa, gyrA p.S83F IncFIB(S), IncFII(S) 
PT14 2014 3-10-5-4-1 Faeces Beja 6 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT15 2014 3-10-5-4-1 Faeces Braga 1 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT16 2014 3-10-5-4-1 Faeces Lisboa 25 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT17 2014 3-10-5-4-1 Faeces Porto 6 F aac(6')-Iaa, blaTEM-1B IncFIB(S), IncFII(S), IncX1 
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ID Year MLVA 
profile 
Sample 
type 
Region Age Gender Genotype Plasmids 
PT18 2015 3-10-5-4-1 Unknown Unknown Unknown M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S), IncI1 
PT19 2015 3-10-5-4-1 Faeces Lisboa 4 M aac(6')-Iaa IncFIB(S), IncFII(S) 
PT20 2015 3-10-5-4-1 Blood Porto 67 M blaTEM-1B IncFIB(S), IncFII(S), IncX1 
PT21 2015 3-10-5-4-1 Faeces Castelo Branco 3 M aac(6')-Iaa IncFIB(S), IncFII(S) 
PT22 2016 3-10-5-4-1 Faeces Porto 57 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT23 2016 3-10-5-4-1 Faeces Porto 4 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT24 2016 3-10-5-4-1 Faeces Lisboa 9 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT25 2016 3-10-5-4-1 Faeces Porto 5 F aac(6')-Iaa IncFIB(S), IncFII(S) 
PT26 2016 3-10-5-4-1 Faeces Bragança 8 F aac(6')-Iaa IncFIB(S), IncFII(S) 
PT27 2016 3-10-5-4-1 Faeces Unknown 3 M aac(6')-Iaa IncFIB(S), IncFII(S) 
PT28 2016 3-10-5-4-1 Faeces Unknown 3 F aac(6')-Iaa IncFIB(S), IncFII(S) 
PT29 2017 3-10-5-4-1 Faeces Unknown 11 F aac(6')-Iaa, gyrA p.S83F IncFIB(S), IncFII(S) 
PT30 2017 3-10-5-4-1 Faeces Porto 5 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT31 2017 3-10-5-4-1 Faeces Unknown Unknown F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT32 2017 3-10-5-4-1 Faeces Ponta Delgada Unknown F aac(6')-Iaa IncFIB(S), IncFII(S) 
PT33 2017 3-10-5-4-1 Faeces Ponta Delgada Unknown M aac(6')-Iaa IncFIB(S), IncFII(S) 
PT34 2017 3-10-5-4-1 Faeces Vila Real 7 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT35 2017 3-10-5-4-1 Faeces Ponta Delgada Unknown M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
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ID Year MLVA 
profile 
Sample 
type 
Region Age Gender Genotype Plasmids 
PT36 2018 3-10-5-4-1 Faeces Lisboa 7 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT37 2018 3-10-5-4-1 Faeces Porto 7 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT38 2018 3-10-5-4-1 Faeces Bragança 8 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT39 2018 3-10-5-4-1 Faeces Unknown 5 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT40 2001 3-10-5-4-1 Faeces Lisboa 2 F aac(6')-Iaa IncFIB(S), IncFII(S) 
PT41 2001 3-10-5-4-1 Faeces Lisboa Unknown M aac(6')-Iaa IncFIB(S), IncFII(S) 
PT42 2001 3-10-5-4-1 Faeces Lisboa Unknown Unknown aac(6')-Iaa IncFIB(S), IncFII(S) 
PT43 2001 3-10-5-4-1 Faeces Lisboa 0 M aac(6')-Iaa IncFIB(S), IncFII(S) 
PT44 2002 3-10-5-4-1 Blood Lisboa 35 M blaTEM-1B, sul1, sul2, aac(6')-Iaa, aadA1, 
aph(3'')-Ib, aph(6)-Id, dfrA1 
IncFIB(S), IncFII(S), IncI1, 
IncQ1 
PT45 2002 3-10-5-4-1 Faeces Setúbal 11 M aac(6')-Iaa IncFIB(S), IncFII(S) 
PT46 2003 3-10-5-4-1 Faeces Lisboa 6 M aac(6')-Iaa IncFIB(S), IncFII(S) 
PT47 2001 3-10-5-4-1 Faeces Leiria 3 F aac(6')-Iaa IncFIB(S), IncFII(S) 
PT48 2002 3-10-5-4-1 Faeces Lisboa 35 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT49 2012 3-11-5-4-1 Faeces Setúbal 6 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT50 2015 3-11-5-4-1 Faeces Setúbal 5 F ND ND 
PT51 2016 3-11-5-4-1 Faeces Unknown 8 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT52 2016 3-11-5-4-1 Faeces Lisboa 8 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT53 2016 3-11-5-4-1 Faeces Lisboa 3 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
 43 
ID Year MLVA 
profile 
Sample 
type 
Region Age Gender Genotype Plasmids 
PT54 2016 3-11-5-4-1 Faeces Lisboa 5 M aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT55 2016 3-11-5-4-1 Faeces Lisboa 7 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT56 2016 3-11-5-4-1 Faeces Unknown Unknown Unknown aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT57 2016 3-11-5-4-1 Faeces Unknown Unknown Unknown aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT58 2016 3-11-5-4-1 Faeces Unknown Unknown Unknown aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT59 2016 3-11-5-4-1 Faeces Unknown Unknown Unknown aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT60 2018 3-11-5-4-1 Faeces Setúbal 60 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT61 2001 3-11-5-4-1 Faeces Porto 26 M aac(6')-Iaa IncFIB(S), IncFII(S), Col156 
PT62 2002 3-11-5-4-1 Faeces Setúbal 70 F aac(6')-Iaa IncFIB(S), IncFII(S) 
PT63 2002 3-11-5-4-1 Faeces Setúbal 10 M aac(6')-Iaa IncFIB(S), IncFII(S) 
PT64 2002 3-11-5-4-1 Faeces Lisboa 5 F aac(6')-Iaa IncFIB(S), IncFII(S) 
PT65 2003 3-11-5-4-1 Faeces Lisboa 6 F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
PT66 2002 3-11-5-4-1 Faeces Porto Unknown F aac(6')-Iaa, gyrA p.D87Y IncFIB(S), IncFII(S) 
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3.2.3. Results 
For several years the number of S. enterica serovar Enteritidis had been decreasing 
in Portugal (chapter 2), until in 2015 the trend inverted reaching a new peak in 2017 (Figure 
3-1). Among the 528 isolates analyzed, MLVA revealed a total of 56 different profiles (Figure 
3-2). Between January 2012 and July 2019, the three most common profiles were 3-10-5-4-
1, 3-11-5-4-1, and 2-10-7-3-2, corresponding to almost 46% of all cases (Figure 3-3). 
Remarkably, profiles 3-10-5-4-1, 3-11-5-4-1, and 3-9-5-4-1, seem to be endemic in Portugal, 
consistently appearing throughout the entire period of study (Figure 3-4). Moreover, 
profiles 3-10-5-4-1 and 3-11-5-4-1, increased quite significantly in 2013 and 2016 
respectively, probably related with undetected national outbreaks. Interestingly, the most 
frequent profiles in 2017 were 2-10-7-3-2, 2-9-7-3-2, and 2-11-7-3-2, profiles previously 
infrequent or undetected. No relevant relation between a specific profile and demographic 
data was found. 
 
Figure 3-1 – Trend of Salmonella enterica serovar Enteritidis received at the National Institute of 
Health in Portugal. 
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Figure 3-2 – Minimum spanning tree of the 56 different MLVA profiles detected among the 528 isolates 
analysed (2012-2019). For simplification purposes, rare profiles are in the same colour. 
 
Figure 3-3 – Percentage of the most common MLVA profiles in Portugal, 
between 2012 and July 2019.
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Figure 3-4 – Number of cases of the 10 most frequent profiles per year. 
In silico MLST analysis of the 65 sequenced isolates revealed that all enrolled isolates 
belonged to ST11. In order to assess their genomic diversity and phylogenetic relationships, 
using a gene-by-gene approach, a MST based on 3103 shared loci between all 65 isolates 
was generated. The MST revealed an overall genetic relatedness between the two MLVA 
profiles (Figure 5-5). In fact, some isolates of profile 3-11-5-4-1 were closer to isolates of 
profile 3-10-5-4-1 than to isolates of the same profile. Interestingly, profile 3-11-5-4-1 
reveals a considerably higher degree of diversity than profile 3-10-5-4-1. This profile 
included two isolates (PT66 and PT62) very distant from the others, both recovered in 
2002. When comparing the other isolates with PT66, we found 111 exclusive loci that will 
require further analysis. Additionally, nine isolates were closely related, confirming a 
suspected outbreak that occurred in 2016. In parallel, two additional outbreaks involving 
isolates of profile 3-10-5-4-1, seem to have occurred. 
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Figure 3-5 – Global phylogeny of S. enterica serovar Enteritidis isolates with MLVA profiles 3-10-5-
4-1 and 3-11-5-4-1, based on a dynamic gene-by-gene approach using a wgMLST schema with 8558 
loci. A Plot depicting the distribution of the number of allelic differences between all 65 isolates 
(PT50 assembly failed) and between isolates of the same MLVA profile. B The minimum spanning 
tree enrolling 65 isolates retrieved in Portugal, was constructed based on the allelic diversity of 3103 
shared loci, using the goeBURST algorithm implemented in the PHYLOViZ online platform. Filled 
circles (nodes) represent unique allelic profiles, and are colored according to the MLVA profile. The 
allele differences between isolates are represented by a number next to each line. Circled in red, a 
confirmed outbreak that occurred in 2016, and in green two potential clusters not previously 
detected. 
3.2.4. Discussion 
S. enterica serovar Enteritidis is one of the most common serovars in Portugal. It is 
also the serovar most frequently associated with outbreaks in the EU85,162. MLVA usefulness 
to the confirmation of outbreaks of S. enterica serovar Typhimurium and S. enterica serovar 
Enteritidis is well established164,167. In this work, we characterized 528 S. enterica serovar 
Enteritidis isolates recovered from January 2012 to July 2019, in Portugal. We identified 56 
different MLVA profiles, although 46% of all cases belonged to only three profiles, 3-10-5-
4-1, 3-11-5-4-1, and 2-10-7-3-2, that constantly appear throughout the period of study This 
fact points to the possibility that these three profiles are endemic in Portugal. Also, the huge 
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variability of profiles among sporadic cases may reveal a great multitude of sources, maybe 
including importation of isolates, but additional studies would be required to support this 
hypothesis. 
Given the representativity of MLVA profiles 3-10-5-4-1 or 3-11-5-4-1 in Portugal, 
we performed WGS on several isolates to access their genomic diversity and conclude about 
the potential bias associated with the use of the MLVA for molecular epidemiology studies. 
A gene-by-gene analysis of 65 isolates revealed, as expected, that multiple isolates within 
and between these two MLVA profiles are very closely related considering the low number 
of allelic differences between them. Even so, WGS undoubtedly has higher discriminatory 
power than MLVA, as 63 nodes were detected among the 65 isolates, although these were 
clustered in only two distinct MLVA profiles. This is easily explained by the fact that while 
MLVA typing evaluates the number of tandem repeats present in five alleles, the WGS 
schema, upon which all the analysis of this dissertation is based, enrols the allelic diversity 
among >3000 shared loci (from a total of 8558 loci in the wgMLST schema). Interestingly, 
profile 3-11-5-4-1 presents higher genomic diversity than profile 3-10-5-4-1, and some 
isolates of profile 3-11-5-4-1 are closer to isolates of profile 3-10-5-4-1, although the later 
observation is not very surprising as these two profiles differ by only one repetition in one 
of the five loci analysed. 
In 2016, MLVA proved to be an efficient and timely tool to clarify a suspected 
outbreak, involving 11 isolates, nine belonging to profile 3-11-5-4-1, and two to profile 2-
10-9-2-2. WGS confirmed the extremely high genetic relatedness of the nine isolates sharing 
the same MLVA profile (Figure 3-5). In retrospective, WGS also revealed other potential 
clusters that were not signalized by the Public Health Authorities. That may be the case of 
the two clusters signalled in Figure 3-5, each comprising eight isolates, that differ in no more 
than five or six alleles within the 3103 shared loci. Both these clusters correspond to cases 
in children under 8 years old, from several regions of the country. The resistance genotypes 
and plasmids present in the isolates of these clusters are identical in both cases (Table 3-1). 
Eventually, surveillance of S. enterica serovar Enteritidis through WGS, in real time, will now 
enable the NRL to inform the Public Health Authorities of possible outbreaks that require 
investigation.  
In summary, S. enterica serovar Enteritidis, once thought to be a highly clonal 
population, appears to have a higher heterogenicity, revealed by WGS. This methodology 
already presents higher discriminatory power than molecular methods once considered 
gold standard, even allowing the detection of previously undetectable outbreaks.  
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 Ongoing outbreak of Salmonella enterica serovar Newport, 
2019 
3.3.1. Introduction 
Although Salmonella enterica serovar Newport is rarely reported in Portugal 
(chapter 2), it was the 5th most reported serovar causing salmonellosis in 2016 in the EU. 
Nevertheless, more than one third of the cases were associated with travel outside the EU87. 
In the United States of America (USA), this serovar was the third most common cause of 
salmonellosis in 2013168. Furthermore, several outbreaks of S. enterica serovar Newport 
have been detected through the years, and the type of food implicated, is quite diverse. 
Susceptible isolates are usually associated with produce, and resistant isolates with 
products of animal origin, such as, ground beef, unpasteurized cheese, and poultry and their 
products168. In 2019, a sudden increase of the number of cases of S. enterica serovar 
Newport identified in the Portuguese NRL, gave rise to the suspicion of an outbreak. 
Therefore, nine isolates from different regions of the country and recovered from different 
sample types (faeces, blood, urine and ascitic fluid) were selected for WGS to confirm the 
suspected outbreak. 
3.3.2. Epidemiological information 
In July of 2019 (Figure 3-6; week 27 to week 30), 15 S. enterica serovar Newport 
were detected in the NRL. In total, until week 34 (August), 30 cases were identified. This 
fact prompted the suspicion of the existence of an outbreak since only 44 cases had been 
identified, for the past 10 years (Figure 3-7). 
 
Figure 3-6 – Distribution of suspected outbreak cases by 
month, July to August 2019 (n=30). 
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Figure 3-7 – Trend of Salmonella enterica serovar Newport identified in the Portuguese National 
Reference Laboratory, 1998-2019. 
Patients ages ranged from 0 to 91 years old with most of the cases affecting patients 
over 65 years old. Most part of the cases were from Lisboa, but there were also cases from 
other regions of the country (Figure 3-8). All isolates were pan-susceptible (susceptible to 
all antimicrobials tested). The isolates selected for WGS were from Lisboa (n=5), Leiria 
(n=1), Funchal (n=1), Évora (n=1) e Porto (n=1).  
Figure 3-8 – Cases’ distribution in the Portuguese continent, and Madeira 
and Açores archipelagos. 
0
2
4
6
8
10
12
14
16
18
20
22
24
26
28
30
32
1
9
9
8
1
9
9
9
2
0
0
0
2
0
0
1
2
0
0
2
2
0
0
3
2
0
0
4
2
0
0
5
2
0
0
6
2
0
0
7
2
0
0
8
2
0
0
9
2
0
1
0
2
0
1
1
2
0
1
2
2
0
1
3
2
0
1
4
2
0
1
5
2
0
1
6
2
0
1
7
2
0
1
8
2
0
1
9
N
U
M
B
ER
 O
F 
C
A
SE
S
YEAR
CHAPTER 3. THE NEW ERA OF SURVEILLANCE OF SALMONELLA 
 
51 
3.3.3. WGS-based analysis 
In silico MLST revealed that one of the nine isolates selected for WGS analysis 
belonged to ST2368, while the other eight isolates belonged to ST118. The gene-by-gene 
analysis revealed ST118 isolates shared 3728 loci. In fact, 4 isolates shared the same 
genomic background and only presented 1 to 8 Allele Differences (AD) from the other 
isolates. The isolate with a different ST presented 425 AD from the closest isolate (Figure 3-
9).  
 
Figure 3-9 – Allelic diversity analysis of Salmonella enterica serovar Newport ST118 and ST2368 
based on a gene-by-gene approach. 
3.3.4. Conclusions 
Given the epidemiological data available, and the WGS data obtained, there is a 
strong possibility that all the cases of S. enterica serovar Newport ST118 that occurred in 
the 8 weeks of study are closely related. ST118 belongs to lineage Newport-III that mostly 
encloses pan-susceptible isolates169. In fact, all S. enterica serovar Newport isolates 
recovered in the period of the study were pan-susceptible. Infection caused by susceptible 
isolates is usually less severe, and tends to affect young children, the elderly, and 
immunocompromised patients. In this case, the most affected age group was ≥65 years old. 
This information was shared with Portuguese Public Health Authorities that will conduct a 
proper investigation of each case. Although this work is still ongoing, as other isolates will 
soon be sequenced, it constitutes a very practical example of what WGS brought to the NRL, 
namely the capacity to establish genetic links that allow the Epidemiologists to conduct 
targeted inquires when suspecting of outbreaks, and propose measures to identify the 
infectious sources and stop the transmission chains.
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4. Multidrug resistant Salmonella enterica serovar Rissen clusters 
detected in Azores archipelago, Portugal  
 Abstract 
Gastrointestinal infections caused by Nontyphoidal Salmonella (NTS) remain one of 
the main causes of foodborne illness worldwide. Within the multiple existing Salmonella 
enterica serovars, the serovar Rissen is rarely reported, particularly as a cause of human 
salmonellosis. Between 2015 and 2017, the Portuguese National Reference Laboratory of 
Gastrointestinal Infections observed an increase in the number of clinical cases caused by 
multidrug resistant (MDR) S. enterica serovar Rissen, particularly from the Azores 
archipelago. In the present study, we analysed by whole genome sequencing (WGS) all 
clinical, animal, food and environmental isolates received up to 2017 in the Portuguese 
Reference Laboratories. As such, through a gene-by-gene analysis, we aimed to identify 
potential epidemiological clusters linking clinical and samples from multiple sources, while 
gaining insight into the genetic diversity of S. enterica serovar Rissen. We also investigated 
the genetic basis driving the observed multidrug resistance. By integrating 60 novel 
genomes with all publicly available serovar Rissen genomes, we observed a low degree of 
genetic diversity within this serovar. Nevertheless, the majority of Portuguese isolates 
showed high degree of genetic relatedness and a potential link to pork production. An in-
depth analysis of these isolates revealed the existence of two major clusters from the Azores 
archipelago composed of MDR isolates, most of which were resistant to at least five 
antimicrobials. Considering the well-known spread of MDR between gastrointestinal 
bacteria, the identification of MDR circulating clones should constitute an alert to public 
health authorities. Finally, this study constitutes the starting point for the implementation 
of the “One Health” approach for Salmonella surveillance in Portugal. 
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 Introduction 
Nontyphoidal Salmonella (NTS) are zoonotic pathogens that remain one of the main 
causes of gastrointestinal infection and one of the most important causes of foodborne 
illness around the world. Annually, an estimated 93.8 million cases of gastroenteritis are 
caused by NTS worldwide, of which 80.3 million are considered foodborne 86. Salmonellosis 
is also estimated to be responsible for 155,000 deaths each year 86. In 2015, over 95,000 
cases of salmonellosis were reported in the European Union (EU) 162. Although more than 
2600 Salmonella enterica serovars have been identified to date, most of the cases in 
developed countries are caused by S. enterica serovar Enteritidis or S. enterica serovar 
Typhimurium, accounting for 63% of all reported cases in the EU in 2012 170,171. In contrast, 
S. enterica serovar Rissen is rarely reported as a cause of human salmonellosis in Europe, 
but is frequently reported in the United States of America and particularly in Asia 172–174. As 
a matter of fact, between 2014 and 2016, this serovar was not even among the 20 most 
frequently reported serovars responsible for human salmonellosis in the EU/EEA 87. In 
Portugal, only 31 cases of human salmonellosis caused by S. enterica serovar Rissen were 
identified is a 12 year period (2000-2012) 175. However, this is one of the most commonly 
reported serovars in pigs and pork, in several European and Asian countries 176–183. This 
serovar has also been isolated less frequently from other sources, namely beef, chicken and 
seafood 180,181,184,185. In Portugal, it has been identified in several studies, not only in pig and 
pork, but also in beef, chicken and wild animals 177,186–188.  
Salmonella serotyping has been the gold standard for Salmonella surveillance for 
years, allowing monitoring of shifts in prevalence of certain serovars in specific regions, 
which are strong indicatives of existing clusters 54,163. Until recently, Salmonella outbreak 
investigations have been conducted using different molecular typing methods, such as 
phage typing, MLVA or PFGE 164,189,190. With the development of next generation sequencing 
technologies, those classical typing methods are being used to a lesser extent and genomic 
approaches based on single nucleotide polymorphisms and gene-by-gene analysis are 
progressing as frontline tools for high-resolution isolate characterization and outbreak 
detection 64,191,192.  
Between 2015 and 2017, an increase in the number of S. enterica serovar Rissen 
isolated from clinical samples, especially multidrug resistant (MDR) isolates from the 
Azores archipelago, was observed. We used whole-genome sequencing (WGS) to analyse all 
clinical isolates received up to 2017 at the National Reference Laboratory (NRL) of 
Gastrointestinal Infections at the Portuguese National Institute of Health (INSA), in order to 
gain insight into the genetic diversity of S. enterica serovar Rissen Portuguese (PT) isolates 
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and eventually identify suspected outbreaks. All animal, food and environmental S. enterica 
serovar Rissen isolates received at the NRL from the National Institute of Agrarian and 
Veterinary Research (INIAV), between 2014 and 2017, were also included in this work to 
investigate potential sources of infection. 
 Materials and Methods 
4.3.1. Bacterial isolate typing and antimicrobial susceptibility testing 
S. enterica isolates included in the present study were obtained from the INSA and 
INIAV culture collections. The isolates were serotyped by the slide agglutination method, 
according to the Kauffman-White-Le Minor scheme 15. In total, 60 S. enterica serovar Rissen 
isolates, collected from 2014 to 2017 in Portugal, were selected for WGS (Supplementary 
Table 4-1). Twenty-two were isolated from human clinical samples, 14 from animals, mostly 
pigs (N=9) but also bovine (N=4), and chicken (N=1), 22 from food products of animal 
origin, and 2 from environmental samples. 
Antimicrobial Susceptibility Testing was performed by disc diffusion, following the 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) 193 
recommendations, on a panel of 17 antimicrobials: ampicillin, amoxicillin-clavulanic acid, 
cefoxitin, cefotaxime, ceftazidime, ceftriaxone, cefepime, meropenem, pefloxacin, nalidixic 
acid, gentamicin, azithromycin, tetracycline, tigecycline, chloramphenicol, 
sulfamethoxazole, and trimethoprim. Results were interpreted using current EUCAST 
breakpoints and Epidemiological cut-off values 193–197. 
4.3.2. Whole Genome Sequencing and genome characterization 
DNA was extracted from each PT isolate using the NucliSens easyMAG platform 
(bioMérieux, France) for total nucleic acid extraction according to the manufacturer’s 
instructions. DNA was then subjected to the NexteraXT library preparation protocol 
(Illumina, USA) prior to paired-end sequencing (2x250 bp or 2x150 bp) on either a MiSeq 
or a NextSeq 550 instrument (Illumina, USA) according to the manufacturer’s instructions 
(detailed in Supplementary Table 4-1). 
All genome sequences were assembled using the INNUca v3.1 pipeline 
(https://github.com/B-UMMI/INNUca) an integrative bioinformatics pipeline for read 
quality analysis and de novo genome assembly. Read quality analysis and improvement is 
performed respectively using FastQC v0.11.5 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and Trimmomatic v0.36 153 
(with sample-specific read trimming criteria determined automatically based on FasQC 
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report). Genomes are assembled with SPAdes v3.10 (Bankevich et al., 2012) and 
subsequently polished using Pilon v1.18155, with QA/QC statistics (such as depth of 
coverage and number of contigs) being monitored and reported throughout the analysis. In 
silico MLST prediction is performed using the mlst v2.4 software 
(https://github.com/tseemann/mlst). The full characterization of isolates, including 
specimen type and source, sampling date, sequence type (ST), final genome assembly sizes 
and depth of coverage values are reported in Supplementary Table 4-1. 
For all isolates, the serovar was predicted in silico using SeqSero software 48. As a 
means to potentiate strain discrimination, assemblies were also analysed using PHASTER 
52 as to determine the presence of phages. The ResFinder 3.1 web server 49 
(https://cge.cbs.dtu.dk/services/ResFinder/) was used to identify acquired antimicrobial 
resistance genes and/or chromosomal mutations, using a threshold of 80% identity. The 
predicted results from both platforms were then compared with antimicrobial 
susceptibility testing results. After genome annotation using Prokka v1.13 198, metal 
tolerance was accessed by inspecting the presence of several genes from different metal 
export systems, such as the copper tolerance genes pcoABCDRSE, silver tolerance genes 
silCFBAPRSE, arsenite transmembrane pump genes arsABCR, mercury tolerance genes 
merACDE, and tellurite resistance gene tehAB 132. 
4.3.3. Gene-by-gene analysis 
Gene-by-gene analysis was performed by taking advantage of a publicly available 
panel of 8558 loci 156 derived from the EnteroBase Salmonella wgMLST schema 63, curated 
and prepared using chewBBACA 157, downloaded on August 2018 
(http://doi.org/10.5281/zenodo.1323684). Allele calling was performed on all genomes 
using chewBBACA v2.0.11 157 with default parameters and a publicly available training file 
for S. enterica (https://github.com/mickaelsilva/prodigal_training_files). Exact and 
inferred matches were used to construct an allelic profile matrix, where other allelic 
classifications (see https://github.com/B-UMMI/chewBBACA/wiki) were assumed as 
“missing” loci. Minimum spanning trees (MSTs) were constructed using the goeBURST 
algorithm 158 implemented in the PHYLOViZ online web-based tool 61, based on 100% 
shared loci between all isolates (i.e., shared-genome MLST) 159.  
For comparative purposes, all S. enterica genomes from serovar Rissen identified in 
the EnteroBase database were downloaded (on November 2018) from the European 
Nucleotide Archive (ENA) and were assembled as described above using the INNUca 
pipeline. After post-assembly inspection and confirmation of serovar using SeqSero, a total 
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of 270 genomes from strains isolated worldwide, described in Supplementary Table 4-2, 
were used to construct an initial MST enrolling all genomes (i.e. 60 PT plus 270 retrieved 
from ENA) to integrate all these novel PT genomes within the known S. enterica serovar 
Rissen diversity. Additionally, in order to perform WGS-based epidemiological cluster 
analysis a second MST was constructed enrolling only the 60 novel PT genomes. To increase 
the resolution power for cluster analysis of the PT isolates for both initial MSTs, we took 
advantage of PHYLOViZ online 2.0 Beta version (http://online2.phyloviz.net/). This 
platform allows maximization of the shared genome in a dynamic manner, i.e., for each sub-
set of isolates under comparison, the maximum number of shared loci (at 100%) between 
them is automatically used for sub-tree construction. All allelic distance thresholds used 
during cluster investigation were expressed as percentages of allele differences (AD) (i.e., 
the number of observed allelic differences divided by the total number of shared loci under 
comparison). Thus, to explore isolates sub-sets, a conservative step-by-step approach was 
performed by applying three allelic distance cut-offs of 1, 0.5 and 0.25% to both initial MSTs, 
based on previously described data for cluster investigation in gene-by-gene based 
surveillance 45.  
 Results 
4.4.1. Antimicrobial susceptibility and heavy metal tolerance 
All antimicrobial resistance phenotype and genotype data are presented in 
Supplementary Table 4-1. Although none of the 60 PT isolates are resistant to either 
meropenem, cefoxitin, cefotaxime, ceftazidime, ceftriaxone, cefepime or tigecycline, most 
are resistant to at least one of the remaining antimicrobials tested. Moreover, resistance to 
more than one antimicrobial was verified in 88.3% of the isolates and 83.3% are MDR. Only 
one isolate (PT11) is fully susceptible to the antimicrobials tested (1.7%). Sulfamethoxazole 
resistance is the most common (83.3%), followed by tetracycline (81.7%), trimethoprim 
(80.0%), ampicillin (73.3%), chloramphenicol (53.3%), and azithromycin (50.0%) 
resistance. Of note, two distinct food-associated isolates exhibit resistance to quinolones, 
with PT60 being resistant to both pefloxacin and nalidixic acid while PT44 only to nalidixic 
acid. Additionally, only one isolate (PT03) reveals intermediate susceptibility to gentamicin 
(1.7%). None of the isolates presents the genes that confer resistance to colistin (i.e., the 
mcr genes). 
Metal resistance-associated genes for copper (pcoABCDRSE), arsenic (arsABCR) and 
tellurite (tehAB) were observed in all PT isolates analysed (Supplementary Table 4-1). 
Thirteen isolates (21.7%) presented the mercury resistance-associated genes merACDE, 
which was always collocated with the ampicillin and sulphonamide resistance genes  bla-
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TEM-1B and sul1, respectively. All these isolates also presented cmlA1, conferring resistance 
to chloramphenicol, and dfrA1, conferring resistance to trimethoprim. Fifty-three isolates 
(88.3%) also present the complete silver tolerance cassette silCFBAPRSE, which was located 
contiguously with the pco gene cluster. 
4.4.2. Global genetic diversity of S. enterica serovar Rissen 
All novel PT isolates were firstly integrated with all publicly available S. enterica 
serovar Rissen genomes (N=270), using a gene-by-gene approach, in order to assess their 
genomic diversity and phylogenetic relationships within the worldwide circulating 
population. In silico MLST analysis revealed that all enrolled isolates belonged to ST469. The 
initial MST (Figure 4-1 A), based on 2305 shared loci between all 330 isolates, reveals low 
genetic diversity between all isolates, with an overall mean pairwise AD of 35 ± 9, and that 
most PT isolates from the present study are closely related. While an initial conservative 
threshold of 1% (i.e., an AD of 24) still maintains all PT isolates phylogenetically linked, 
when applying a cut-off of 0.5% to the MST (due to the overall low genetic diversity 
observed), 10 out of the 60 isolates showed up as unlinked (with two pairs and six single 
isolates segregating independently) (Figure 4-1 A), potentially indicating that they are 
epidemiologically unrelated. In order to further analyse the cluster containing most PT 
isolates (at a 0.5% threshold), a sub-MST of this cluster was generated (Figure 4-1 B) which 
increased the number of shared loci to 3162 and an overall mean pairwise AD of 29 ± 10 
was observed. This sub-set of 97 isolates comprises, not only most PT isolates, but also 
isolates from the United States of America, the United Kingdom, Spain, Denmark and 
Vietnam. Applying a cut-off of 0.5% to this sub-set, corresponding to an AD of 16, two main 
clusters containing PT isolates remain and one isolate segregates independently (PT10). 
Nevertheless, when a more restrict cut-off is applied (0.25%; 8 AD), more consistent with 
outbreak clustering investigation 45, all the PT isolates separate from strains of other 
countries (with the exception of an isolate from the United Kingdom, ENA accession # 
SAMN09298461) and two main clusters containing most of the PT isolates are observed, 
suggesting two main circulating clones. 
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Figure 4-1 – Phylogenetic analysis of S. enterica serovar Rissen, based on a gene-by-gene approach using a wgMLST schema with 8558 loci. (a) – Minimum spanning 
tree (MST) enrolling 270 publicly available genomes and the 60 novel “Portuguese” (PT), constructed based on the allelic diversity of 2305 shared loci. The numbers 
in red on the connecting lines represent the AD between isolates. Nodes linked with allelic distances (AD) equal to or below 0.5% (i.e., 12 AD) have been collapsed for 
visualization purposes. Node sizes are proportional to the number of isolates they represent. Nodes are coloured according to the country of origin. (b) – Sub-MST 
constructed based on the maximum number of shared loci (3162 loci) between the sub-set of isolates linked at an allelic distance of 0.5% and containing most PT 
isolates. Two major clusters containing mostly PT isolates linked with AD ≤ 0.25% are highlighted in grey.
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4.4.3. WGS-based epidemiological analysis of the PT isolates 
We then proceeded with the same gene-by-gene approach, strictly for the 60 PT S. 
enterica serovar Rissen isolates, to assess their potential epidemiological relatedness 
(Figure 4-2). The initial MST reveals that the isolates share 3465 loci, with a mean pairwise 
AD of 35 ± 17 (ranging from 0 up to 47). As such, we observed that, while the number of 
shared loci between the PT isolates was increased by more than 1100 loci, in comparison 
with the initial analysis, the overall genetic diversity is still low. As a means to exclude 
potential epidemiologically unrelated cases of S. enterica serovar Rissen within this set of 
isolates, an initial conservative threshold of 1% (i.e., 35 AD) reveals that at least 3 isolates 
(PT60, PT40 and PT17) segregate independently. As two of these isolates are linked (cluster 
E), we performed a sub-MST analysis that sustains their close genetic relatedness as the 
increase in the number of shared loci to 3801 only increments their AD by 3. Nevertheless, 
an epidemiological link between these isolates could not be traced. 
In order to generate potential clusters to be subjected to the dynamic MST analysis, 
we then applied a lower threshold of 0.5% (i.e., 17 AD) which reveals four additional 
clusters and even more potential isolated cases (PT01, PT10, PT11, PT12, PT16, PT18, PT19, 
PT50, and PT56). One of these clusters (Cluster D) contains two food isolates (Figure 4-2 C) 
retrieved from chicken meat in 2016 (Figure 4-2 B), one from the Lisbon Metropolitan area 
(PT45) and the other from Spain (PT44) (Figure 4-2 A). After increasing the number of 
shared loci under analysis to 3828, the sub-MST shows that these isolates are 
distinguishable by only 7 AD. This suggests the existence of either a S. enterica serovar 
Rissen strain already circulating within the Iberian Peninsula, though more isolates are 
required for confirmation, or a discrete phenomenon as only two cases were detected. 
Nevertheless, these isolates present the resistance genes sul1 (Supplementary Table 4-1), 
dfrA12 (Supplementary Table 4-1), and aadA2 (Supplementary Table 4-1), as reported by a 
previous study on this area 183. We also observed a more heterogeneous cluster (Cluster C) 
where the epidemiological linkage between the four isolates is unclear, due to the 
differences in geographical location (Figure 4-2 A), isolation date (Figure 4-2 B), source 
(Figure 4-2 C) and antibiotic resistance profile (Figure 4-2 D). Still, the sub-MST for this 
cluster (which is based on 3805 loci) suggests that these isolates are genetically related, as 
they present a mean pairwise AD of 14 ± 3. Regarding Cluster B, sub-MST analysis now 
enrolling 3686 shared loci shows that isolates are still linked at the 0.5% threshold, with a 
mean pairwise AD of 14 ± 6. Although this cluster is comprised by isolates from animal, food 
and clinical samples (Figure 4-2 C), it is hard to suggest a direct transmission link from these 
sources to human, with the clinical cases all detected prior to 2016, contrarily to all but one 
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non-human sample (PT24) (Figure 4-2 B). However, all isolates from this cluster are MDR 
(Figure 4-2 D). In addition, 12 out of the 13 isolates from this cluster possess the mercury 
tolerance genes merACDE, in association with the chloramphenicol resistance gene, cmlA1, 
and trimethoprim resistance gene dfrA1 which further distinguishes this cluster from all 
others where these genes are absent. The only other isolate possessing these genes in the 
entire dataset is PT50, which is very closely related to this cluster at an AD of 18, suggesting 
its genetic close relatedness but lacking epidemiological relationship. Moreover, the 
absence of the silver tolerance-associated genes (silCFBAPRSE) was only observed in 
isolates from this cluster (7 out of the 13, including the five isolates from pork skewers). Of 
note, the five 2016 isolates from pork skewers with an undisclosed origin (PT29, PT30, 
PT31, PT32, PT33) are very likely meat products from the same pig holding facility, as 
within 3831 shared loci they only exhibit up to 6 AD between them and share the same 
resistance profile. These isolates share the same year of isolation and resistance profile, to 
both antibiotics and heavy metals, with a pork isolate from the Azores archipelago (PT35) 
with a maximum AD of 8, all indications of the existence of a possible cluster in Azores. 
Finally, the largest cluster (Cluster A) is mostly comprised by isolates from the 
Azores archipelago (n =21) but also includes two isolates from Lisbon Metropolitan area, 
two from Centre region and one from North region (Figure 4-2 A). Analysis of this cluster 
reveals that the isolates share a maximum of 3639 loci with a mean pairwise AD of 12 ± 4, 
with all isolates still linked after sub-MST construction. This cluster presents distinct 
sources (Figure 4-2 C), with the majority of isolates (14 out of 29) originating from pigs 
(Supplementary Table 4-1) or being human clinical cases (11 out of 29), suggesting that this 
epidemiological clone may originate from pig holding facilities. Of note, we observed that a 
clinical isolate (PT20) and a food isolate (PT13), collected two months apart in Azores, are 
only distinguishable by 1 AD in 3866 loci, strongly indicating an epidemiological link 
between them. Moreover, with the exception of PT48 and PT49, all isolates from this cluster 
are MDR, presenting 4 to 7 resistance determinants (Figure 4-2 D). The two non-MDR 
isolates are likely epidemiologically linked (1 AD over 3866 shared loci between the two) 
and present the same resistance profile, being resistant to ampicillin, amoxicillin-clavulanic 
acid and chloramphenicol. Most isolates are resistant to azithromycin, with the exception of 
PT02, PT48, and PT49. In addition, four sets of isolates present the same resistance profiles 
between them (Supplementary Table 4-1): i) PT26, PT28, and PT46; ii) PT37, PT51, and 
PT55; iii) PT25, PT38, PT39 and PT52; iv) PT06, PT13, PT14 PT15, PT20, PT34 PT41, PT43, 
PT57 and PT58. Phage presence analysis for all 60 isolates also reveals that all isolates from 
Cluster A (except PT42) and Cluster C possess an Entero P88 Phage-like structure, which 
further distinguishes them from isolates of Cluster B. In fact, only PT09 from Cluster B 
CHAPTER 4. MDR SALMONELLA ENTERICA SEROVAR RISSEN CLUSTERS 
 
64 
contains a similar phage but its nucleotide sequence is different from the ones detected in 
Cluster A and C. In summary, the described data points to the simultaneous existence of at 
least two multidrug resistant epidemic S. enterica serovar Rissen clones circulating in the 
Azores archipelago at least since 2014, which were already introduced throughout the 
Portuguese continent.  
 65 
Figure 4-2 – Allelic diversity analysis of the “Portuguese” (PT) S. enterica serovar Rissen, using a wgMLST-based gene-by-gene approach. Minimum spanning tree 
enrols a total of 3465 shared loci. Nodes are coloured by (a) region of isolation, (b) year of isolation, (c) sample type and (d) antibiotic resistance profile. The numbers 
in red on the connecting lines represent the allelic distance between isolates. MDR – Multidrug resistant. 
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 Discussion  
WGS is quickly supplanting traditional procedures for Salmonella surveillance and 
outbreak detection in Reference Laboratories. In this regard, food- and water-borne 
outbreaks are detected either when a common source is determined through 
epidemiological inquiries, followed by the characterization of all the isolates, or when a 
group of similar isolates is identified, followed by the common source by epidemiological 
investigation 191. The current study aimed for the identification of S. enterica serovar Rissen 
genetic clusters circulating in Portugal, and the detection of potential sources of infection, 
as a follow-up of an unusual increment in the number of isolates that arrived at the NRLs 
since 2015. 
Even though S. enterica serovar Rissen is rarely reported worldwide as a cause of 
human salmonellosis, it has previously been identified in Portugal associated with pig, pork, 
beef, chicken and wild animals 177,186–188,199, which was also observed in this work. Using a 
dynamic shared-genome based approach, by progressively maximizing the number of 
shared loci between isolates, we detected five potential clusters of closely related clinical, 
animal, food, and environmental S. enterica serovar Rissen ST469 isolates 45, with the two 
largest clusters containing all the isolates from the Azores archipelago (Cluster A and 
Cluster B) (Figure 4-2 A). This approach revealed a high degree of similarity among the S. 
enterica serovar Rissen population, contrary to what was previously described through 
PFGE 178. In fact, among the 330 studied isolates, we found a mean genetic distance of about 
35 AD (with a maximum AD of 81) within the shared 2305 loci. Apart from a few isolates 
that segregate independently, a great number of the PT isolates formed very closely related 
clusters. Increasing the resolution of the initial shared wgMLST approach by increasing the 
number of loci analysed, reinforced the relatedness of the Portuguese clusters, most 
specifically the clusters containing MDR isolates from the Azores archipelago (Cluster A and 
Cluster B). Even though this genomic approach seems to be highly discriminatory, there is 
no universal cut-off defined for identification of outbreaks, therefore epidemiological 
investigation should be carried out to facilitate the interpretation of WGS data. Given the 
high degree of genetic similarity within this serovar revealed in this study, several isolates 
that seem very closely related may in fact be epidemiologically unlinked. Nonetheless, the 
genomic analysis together with the scarce epidemiological information points to the 
existence of two non-related MDR S. enterica serovar Rissen clones circulating in the Azores 
archipelago for the past years. Additionally, the identification of clinical isolates as well as 
isolates from animals and food in the Portuguese continent that show a perfect clustering 
with the isolates from Azores strongly suggests the spread of the circulating clones 
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throughout the Portuguese territory, with a putative origin in Azores. The fact that the 
Azores archipelago is composed by nine small islands with livestock as one of the major 
economic resources reinforces this possibility. Another detected cluster containing a PT 
isolate and a Spanish isolate seems to concern an already described successful clone 
circulating in the Iberian Peninsula, as a result of intensive trade of live pigs and pork 
between Portugal and Spain 183. 
Increased antimicrobial resistance in pig-associated S. enterica serovars has become 
a reality for the past decades, including the successful clone S. enterica serovar Rissen ST469 
131,183,200. MDR bacteria emerge as a direct consequence of selective pressure derived from 
overall antibiotic misuse. The use of antibiotics in food-producing animals has been 
associated with the emergence of certain MDR clones 104. Additionally, the acquisition of 
novel properties, such as antibiotic resistance and metal tolerance may occur by horizontal 
gene transfer between different bacteria and even between bacterial species 201. In the 
present study, 88.3% of the isolates were resistant to more than one antimicrobial and 
83.3% were MDR (Supplementary Table 4-1 and Figure 4-2 D). A high level of resistance to 
several antibiotics was observed, although resistance to carbapenems, cephalosporins and 
colistin was not detected. Moreover, 50% of the isolates, mainly isolates from Cluster A, 
were resistant to azithromycin, which is widely used for the treatment of invasive 
Salmonella infections. According to the genomic analysis of these isolates, azithromycin 
resistance is likely mediated by the macrolide inactivation gene mphA, while blaTEM-1B_1 
seems to be responsible for ampicillin resistance. Also, tet(A) appears in all the tetracycline 
resistant isolates of this serovar, confirming that tet(A) is most likely the gene responsible 
for tetracycline resistance in S. enterica serovar Rissen 183. We also accessed the presence of 
metal tolerance genes in these isolates as heavy metals are widely used in biocidal products, 
feed additives and soil fertilizers, leading to bioaccumulation processes 131. The acquisition 
of copper and silver resistance genes by Salmonella seems to be related to the emergence 
and widespread of certain MDR clones, as a means of survival in metal contaminated 
environments 131. In this study, 53 PT isolates presented the pcoABCDRSE and silCFBAPRSE 
cassettes in the same genetic structure, suggestive of tolerance to those heavy metals. This 
fact reinforces the association of pco and sil cassettes with successful MDR clones in pig 
production, most specifically the ST469 S. enterica serovar Rissen clone, as described 
previously 109,131. 
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 Conclusions 
In summary, we identified at least two MDR S. enterica serovar Rissen clones in the 
Azores archipelago, already circulating in the continent. The presence of MDR isolates with 
zoonotic potential in food-producing animals is a growing public health concern, having not 
only a severe burden to human health, but also great economic impact. Patients infected by 
MDR bacteria have an increased risk of developing severe infections with high mortality and 
morbidity rates, and represent an increased healthcare cost 103. International trade of food-
producing animals and their products contributes greatly to the global spread of MDR 
Salmonella clones, which calls for continuous monitoring, especially in pig-production. 
Although WGS has great potential in supporting epidemiological investigations, the 
availability of epidemiological data is critical for timely and efficient source detection and 
outbreak control. This WGS-based S. enterica serovar Rissen surveillance study in Portugal 
results from the collaboration between the Portuguese Salmonella NRLs of human and 
animal health. Hopefully, this stands as the starting point for the implementation of the “One 
Health” approach for Salmonella surveillance in Portugal. 
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5. Characterization of multidrug-resistant isolates of Salmonella 
enterica serovars Heidelberg and Minnesota from imported 
poultry meat in Portugal 
 Abstract 
Multidrug resistant bacteria are a major public health problem, mainly linked to 
antimicrobials misuse in human and veterinary medicine, as well as in animal production. 
Salmonella enterica serovar Heidelberg and Salmonella enterica serovar Minnesota are a 
frequent cause of foodborne infection in North and South America, but are rarely reported 
in Europe. Their frequent multidrug resistance (MDR) character make them potential 
spreaders of antibiotic resistance genes. In this work, we determined the antibiotic 
resistance profile and performed whole-genome sequencing (WGS) on a set of S. enterica 
serovar Heidelberg and S. enterica serovar Minnesota isolates recovered from samples of 
fresh poultry meat, collected in 2012-2019 within the Portuguese Official Inspection Plan 
for imported foodstuffs, and integrated these results with data already reported in the 
literature. Several isolates of both serovars showed extremely high genetic relatedness 
either with isolates from raw poultry meat preparations imported from South America to 
the Netherlands or to isolates from samples from the broiler production chain in Brazil, an 
important exporter country. This similarity was extended to their general MDR profile, 
including the presence of the extended-spectrum cephalosporins-resistant CMY-2. The MDR 
character was also common to the vast majority (94.4%) of isolates from both serovars, 
where, several of them also carried the plasmid IncX1 containing a Type IV Secretion 
System, a well-known virulence mechanism. These results somehow mirror the scenario 
observed in the Netherlands, showing the introduction, through fresh imported poultry 
meat in compliance with European legislation, of MDR S. enterica serovar Heidelberg and 
serovar Minnesota isolates in Europe with the potential spread of their diverse resistance 
markers. The present study suggests the hygiene criteria for foodstuffs monitoring are in 
need of revision, with surveillance of the resistome, before foodstuffs are placed on the 
market, being an important contribute to avoid further dissemination of resistance markers. 
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 Introduction 
One of the main problems that 21st century medicine is facing concerns the rise of 
multidrug-resistant (MDR) bacteria (bacteria resistant to more than three different classes 
of antimicrobials)104,202. The use of antibiotics in humans, animals and plants has led to the 
widespread of mobile genetic elements carrying multiple antimicrobial resistance traits 112. 
As such, the food production industry and its globalization play an important role in the 
transmission, evolution and dissemination of clinically relevant MDR pathogens 
worldwide203. Salmonella remains the second most common cause of gastrointestinal 
disease in the EU162, and MDR Salmonella have become a major public health concern over 
the years, causing invasive infections that frequently require hospitalization and present 
high mortality rates204. 
In the food chain, poultry, especially chicken and turkey, are regarded as significant 
contributors for the salmonellosis burden, since their intestinal tracts are very often 
colonized with Salmonella205. Additionally, the transmission of Salmonella in flocks may 
occur from different routes, either from the infected breeding flocks (vertical transmission), 
or through previously infected flocks, contaminated feed or water (horizontal 
transmission). Consequently, the elimination of Salmonella from a facility may prove a 
difficult task 206. Several countries, including United States of America (USA) and Brazil, and 
the European Union (EU) have implemented, in the past decade, Salmonella control 
programmes in poultry flocks, aimed to reduce the presence of Salmonella spp., especially 
Salmonella enterica serovar Enteritidis and Salmonella enterica serovar Typhimurium, that 
cause most part of human infections205,207. Although resulting in a significant decrease of S. 
enterica serovar Enteritidis infection, these measures yielded a shift in the prevalence of 
Salmonella serovars in poultry and also in human salmonellosis, with an increase in the 
dissemination of successful clones of less frequent serovars, carrying several advantageous 
adaptation features accompanied with MDR mobile elements 205. However, between 2013 
and 2017, the proportion of S. enterica serovar Enteritidis human cases increased, mostly 
due to importation of eggs from one of the Member States208. 
S. enterica serovar Heidelberg and S. enterica serovar Minnesota are rarely reported 
in European countries, not only in human clinical cases but also in animals and 
foodstuffs87,162. However, S. enterica serovar Heidelberg is a frequent cause of 
gastroenteritis in North and South America, and is frequently isolated in poultry meat209–215. 
S. enterica serovar Minnesota has also been frequently isolated in poultry production in 
Brazil207,216. In this study, the Portuguese National Institute of Health (INSA) analysed 
samples of fresh poultry meat, collected within the Portuguese Official Inspection Plan for 
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imported foodstuffs coordinated by the General Directorate of Food and Veterinary (DGAV). 
In order to access the potential need for a more precise survey of these serovars, we 
determined the antibiotic resistance profile and performed whole-genome sequencing 
(WGS) on a set of these isolates, and put these data in frame with data reported in the 
literature regarding the isolation of these Salmonella serovars.  
 Materials and methods 
5.3.1. Sample dataset characterization  
S. enterica isolates were obtained from samples of imported fresh poultry meat, 
collected between 2012 and 2019. In total 163 samples, corresponding to 815 units of fresh 
poultry meat (mostly chicken gizzards) were collected by the General Directorate of Food 
and Veterinary, as part of official border control, and analysed in INSA. Forty-eight samples, 
corresponding to 58 units, tested positive for Salmonella spp.. Salmonella isolates were then 
serotyped by the slide agglutination method, according to the White-Kauffman-Le Minor 
scheme15 and antimicrobial susceptibility testing was performed by disc diffusion, following 
the European Committee on Antimicrobial Susceptibility Testing (EUCAST)193 
recommendations, on a panel of 18 antimicrobials: ampicillin, amoxicillin-clavulanic acid, 
azithromycin, cefepime, cefotaxime, cefoxitin, ceftazidime, ceftriaxone, chloramphenicol, 
erythromycin, gentamicin, meropenem, nalidixic acid, pefloxacin, sulfamethoxazole, 
tetracycline, tigecycline, and trimethoprim. Results were interpreted using current EUCAST 
breakpoints and Epidemiological cut-off values193,195–197,217–221. 
5.3.2. Whole Genome Sequencing and genome characterization 
Total DNA was extracted from fresh cultures on the NucliSens easyMAG platform 
(bioMérieux, France), according to the manufacturer’s instructions. Thirty-six isolates were 
selected for WGS, in order to have at least one representative from each batch of imported 
fresh poultry meat. WGS and bacterial de novo assembly were performed as previously 
described152. Briefly, for WGS, high-quality DNA samples quantified using Qubit 
(ThermoFisher, USA) were subjected to dual-indexed Nextera XT Illumina library 
preparation (Illumina, USA), prior to cluster generation and paired-end sequencing 
(2×250bp or 2x150bp) on either a MiSeq or a NextSeq 550 instrument (Illumina, USA) 
available at INSA, according to the manufacturer’s instructions. 
5.3.3. Genome assembly and annotation 
All genomes were de novo assembled using the INNUca v3.1 pipeline 
(https://github.com/B-UMMI/INNUca), an integrative bioinformatics pipeline that consists of 
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several integrated modules for reads QA/QC, de novo assembly and post-assembly 
optimization steps. Briefly, after reads’ quality analysis using FastQC v0.11.5 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and cleaning with Trimmomatic 
v0.36 153, genomes were assembled with SPAdes 3.10 154 and subsequently improved using 
Pilon v1.18 155. Draft genome sequences were annotated with RAST server 
(http://rast.theseed.org/FIG/rast.cgi) 222–224. 
5.3.4. Strains’ genomic characterization 
For each strain, in silico Multi Locus Sequence Type (MLST) prediction was 
performed using the mlst v2.4 software (https://github.com/tseemann/mlst), while serovar 
was predicted with SeqSero software 48, using both raw and trimmed reads as well as the 
assembled genomes. The ResFinder 3.1 web server 49 
(https://cge.cbs.dtu.dk/services/ResFinder/) was used to identify acquired antimicrobial 
resistance genes and/or chromosomal mutations, using a threshold of 80% identity. The 
predicted results were then compared with antimicrobial susceptibility testing results. 
PlasmidFinder 2.0 and plasmid MLST 50 were used to detect and characterize the plasmids 
present in these isolates (https://cge.cbs.dtu.dk/services/PlasmidFinder/; 
https://cge.cbs.dtu.dk/services/pMLST/), with a threshold for %ID ≥80% and a minimum % 
coverage of 60%. As a means to potentiate isolate discrimination, assemblies were also 
analysed using PHASTER 52 to determine the presence of phages. For simplification 
purposes, only hits with intact phages were considered for further analysis. Finally, 
SPIFinder 1.0 help to identify Salmonella pathogenicity islands (SPIs) in the sequenced 
isolates (https://cge.cbs.dtu.dk/services/SPIFinder/). 
5.3.5. Gene-by-gene analysis 
For comparative purposes regarding genomic relatedness, along with the 36 isolates 
imported to Portugal, 88 isolates identified in Brazil (82 serovar Heidelberg and 6 serovar 
Minnesota) 203 and 133 isolates of serovar Heidelberg identified in the Netherlands, that had 
also been found in poultry meat imported from Brazil 225, were included in the analysis 
(Supplementary Table 5-1). The genomes of this set of 221 isolates were also assembled as 
described above. Gene-by-gene analysis was performed by taking advantage of a publicly 
available panel of 8558 loci 156 derived from the EnteroBase Salmonella wgMLST schema 63, 
curated and prepared using the chewBBACA free software (https://github.com/B-
UMMI/chewBBACA) 157, downloaded on August 2018 
(http://doi.org/10.5281/zenodo.1323684). For all genomes, allele calling was performed using 
chewBBACA v2.0.11 157 with default parameters and a publicly available training file for S. 
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enterica (https://github.com/mickaelsilva/prodigal_training_files). Exact and inferred matches 
were used to construct an allelic profile matrix, where other allelic classifications (see 
https://github.com/B-UMMI/chewBBACA/wiki) were assumed as “missing” loci. 
To evaluate the genetic relationship between strains, minimum spanning trees 
(MSTs) were constructed taking advantage of goeBURST algorithm 158 implemented in the 
PHYLOViZ online web-based tool 61, based on 100% shared loci between all strains (i.e., 
shared-genome MLST) 159. In order to increase the resolution power for cluster analysis, the 
PHYLOViZ online 2.0 Beta version (http://online2.phyloviz.net/) was used, as it allows 
maximizing the shared genome in a dynamic manner, i.e., for each sub-set of strains under 
comparison, the maximum number of shared loci between them is automatically used for 
sub-tree construction. 
 Results 
5.4.1. Characterization of the isolates 
In total, we identified 37 S. enterica serovar Heidelberg isolates, 19 S. enterica 
serovar Minnesota, and 1 S. enterica 4,[5],12:i:-. The in silico serotyping of raw reads of the 
36 selected isolates (23 serovar Heidelberg and 13 serovar Minnesota) confirmed the 
classical serotyping results for the sequenced isolates (Table 5-1). 
All the isolates tested for antimicrobial resistance were susceptible to meropenem, 
chloramphenicol, and cefepime, however 94.4% were multidrug resistant (MDR) (Table 5-
1). Sulfamethoxazole and tetracycline resistance were the most common (94.0%), followed 
by nalidixic acid and ampicillin (83.3%), and pefloxacin resistance (80.5%). Resistance to 
2nd generation cephalosporin cefoxitin (77.7%), to 3rd generation cephalosporins 
cefotaxime (80.5%), ceftazidime (77.7%), and ceftriaxone (72.2%), were also frequently 
observed. Of note, resistance to tigecycline, trimethoprim, gentamicin and azithromycin 
were also found in a few isolates. For the most part, these phenotypic results were 
confirmed by the in silico predictions of ResFinder. Sulphonamide resistance was mainly 
caused by the presence of sul2, although four S. enterica serovar Heidelberg isolates 
additionally presented sul1 (PT15, PT23, PT30, PT34). Tetracyclines resistance was 
mediated by tet(A) (Table 5-1), similarly to what we previously found in S. enterica serovar 
Rissen (Chapter 4). Also, fluoroquinolone resistance was caused by the presence of 
mutations in gyrA (S83F) and parC (T57S) in S. enterica serovar Heidelberg, while in S. 
enterica serovar Minnesota it was mediated by the presence of qnrB genes (Table 5-1). 
Generally, β-lactams resistance was caused by the presence of the β-lactamase CMY-2 
(77.7%), but other β-lactamase (bla) genes, including blaTEM-1B, blaTEM-116, blaCTX-M-8, and 
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blaCTX-M-55 were also detected (PT1, PT8, PT15, PT31, PT33) (Table 5-1). The gene mphB, 
encoding the macrolide 2'-phosphotransferase II was detected in an erythromycin resistant 
S. enterica serovar Heidelberg isolate (PT15), while no known mutations associated with 
macrolides resistance or any common genes other than macA and macB were found in the 
azithromycin resistant S. enterica serovar Heidelberg PT29 isolate (Table 5-1). Gentamycin 
resistance was mediated either by aminoglycoside acetyltransferases (AAC(3)-IV and 
AAC(3)-Via) or by an aminoglycoside nucleotidyltransferase (ANT(2”)-Ia). The gene dfrA25 
was also detected in the only trimethoprim resistant isolate (PT30). Additionally, 17 S. 
enterica serovar Heidelberg isolates presented the gene fosA7, conferring resistance to 
fosfomycin. Finally, none of the isolates sequenced presented the mcr genes that confer 
resistance to colistin.  
Regarding the presence of plasmids, the 36 sequenced isolates harboured at least 
one, with 16 different plasmids being detected in total (Table 5-1). Overall, we detected five 
different Col plasmids (Col440I, Col8282, ColpVC, Col156, and ColRNAI), and 11 plasmids of 
seven different incompatibility groups (IncA/C2, IncFIB(pHCM2), IncFIB(AP001918), 
IncFII, IncFII(pHN7A8), IncFII(29), IncX1, IncI1, IncHI2, IncHI2A, and IncQ1). IncA/C2 (ST2) 
was present in 35 isolates and frequently carried tet(A), sul2, blaCMY-2, and the mercury 
resistance (mer) operon. In five S. enterica serovar Heidelberg isolates, the blaCMY-2 gene 
seemed to be chromosomally inserted. Additionally, IncX1 was present in 18 S. enterica 
serovar Heidelberg isolates and harboured the Type IV secretion system (T4SS). The mer 
operon was absent only in non-MDR isolate PT13. The qnr genes in S. enterica serovar 
Minnesota were all located in Col440I.  
PHASTER analysis identified 15 different phages (Supplementary Table 5-2) among 
both serovars, six in S. enterica serovar Heidelberg isolates (Gifsy-2, Sfi19, UAB Phi20, 
SPN1S, phiV10, SPN1S, and Gifsy-1) and 11 in S. enterica serovar Minnesota (phiV10, Gifsy-
1, Fels-2, Fels-1, SEN34, SfV, vB SemP Emek, SfII, ENT47670, P88, and SSU5). All S. enterica 
serovar Heidelberg isolates harboured lambdoid prophage Gifsy-2, which was absent in all 
S. enterica serovar Minnesota isolates. SPI analysis revealed that all isolates harbour SPI13, 
SPI14, and Centisome 63 pathogenicity island (C63PI) (Table 5-1). Also present in several 
isolates were SPI1 (only in S. enterica serovar Heidelberg), SPI2, SPI3, SPI4, and SPI5.  
.  
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Table 5-1 – Serovar, antibiotic resistance phenotype and genotype, plasmids and pathogenicity islands of the Salmonella enterica serovar Heidelberg and Salmonella enterica 
serovar Minnesota isolates enrolled in the present study. ST – sequence type. Amp - ampicillin, Azm - azithromycin, Ctx - cefotaxime, Fox - cefoxitin, Caz - ceftazidime, Cro - ceftriaxone, 
Ery - erythromycin, Gmn - gentamicin, Nal - nalidixic acid, Pef - pefloxacin, Smx - sulfamethoxazole, Tet - tetracycline, Tgc - tigecycline, and Tmp – trimethoprim. 
Isolate ID Year Serovar Batch ST Phenotype Genotype Plasmids Pathogenicity islands 
PT1 2012 S.Minnesota 1 548 
Amp, Fox, Caz, Ctx, Tet, 
Smx 
blaTEM-116, blaCMY-2, blaCMY-6, 
tet(A), sul2, qnrB, parC p.T57S 
IncA/C2, Col440I SPI2, SPI3, SPI13, SPI14, C63PI 
PT2 2012 S.Minnesota 2 548 Amp, Ctx, Tet, Smx blaCMY-2, tet(A), sul2, parC p.T57S IncA/C2, ColpVC SPI2, SPI3, SPI4, SPI13, SPI14, C63PI 
PT3 2013 S.Minnesota 3 548 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, qnrB, parC 
p.T57S 
IncA/C2, Col440I, ColRNAI SPI2, SPI13, SPI14, C63PI 
PT4 2013 S.Minnesota 3 ND 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx 
blaCMY-2, tet(A), sul2, parC p.T57S 
IncA/C2, IncFIB(AP001918), IncFII, 
IncFII(29), ColRNAI 
SPI13, SPI14, C63PI 
PT5 2013 S.Minnesota 4 ND 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx 
blaCMY-2, tet(A), sul2, parC p.T57S IncA/C2 SPI2, SPI4, SPI13, SPI14, C63PI 
PT6 2013 S.Heidelberg 5 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F, fosA7 
IncA/C2, IncI1, IncX1, ColpVC SPI2, SPI3, SPI4, SPI13, SPI14, C63PI 
PT7 2013 S.Minnesota 6 548 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx 
blaCMY-2, tet(A), sul2, qnrB, parC 
p.T57S 
IncA/C2, Col440I SPI2, SPI3, SPI4, SPI13, SPI14, C63PI 
PT8 2013 S.Heidelberg 7 ND 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-61, tet(A), sul2, parC p.T57S, 
gyrA p.S83F 
IncA/C2, IncI1, IncX1, ColpVC SPI1, SPI3, SPI5, SPI13, SPI14, C63PI 
PT9 2013 S.Heidelberg 8 15 
Amp, Fox, Caz, Ctx, Tet, 
Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F 
IncA/C2, ColpVC SPI1, SPI3, SPI5, SPI13, SPI14, C63PI 
PT10 2013 S.Heidelberg 9 15 Tet, Smx, Pef, Nal 
tet(A), sul2, parC p.T57S, gyrA p.S83F, 
fosA7 
IncA/C2, IncX1, ColpVC SPI2, SPI3, SPI4, SPI13, SPI14, C63PI 
PT11 2014 S.Heidelberg 10 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F, fosA7 
IncA/C2, IncX1, ColpVC SPI1, SPI3, SPI5, SPI13, SPI14, C63PI 
PT12 2014 S.Minnesota 11 548 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx 
blaCMY-2, tet(A), sul2, parC p.T57S IncA/C2, Col156 SPI2, SPI13, SPI14, C63PI 
PT13 2014 S.Heidelberg 12 15 Pef, Nal parC p.T57S, gyrA p.S83F, fosA7 IncX1, ColpVC SPI2, SPI3, SPI4, SPI13, SPI14, C63PI 
PT14 2014 S.Heidelberg 13 15 Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F 
IncA/C2, IncI1, ColpVC, ColRNAI SPI5, SPI13, SPI14, C63PI 
PT15 2015 S.Heidelberg 14 15 
Amp, Tet, Smx, Gmn, Pef, 
Nal, Ery 
blaTEM-1B, tet(A), sul1, sul2, mphB, 
aac(3)-VIa, parC p.T57S, gyrA p.S83F 
IncA/C2, IncHI2, IncI1, IncQ1, 
ColRNAI 
SPI13, SPI14, C63PI 
PT16 2015 S.Heidelberg 15 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F, fosA7 
IncA/C2, IncX1, ColpVC SPI3, SPI4, SPI5, SPI13, SPI14, C63PI 
PT17 2017 S.Heidelberg 16 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F, fosA7 
IncA/C2, IncX1, ColpVC, ColRNAI SPI3, SPI5, SPI13, SPI14, C63PI 
PT18 2017 S.Heidelberg 17 15 Tet, Smx, Pef, Nal tet(A), sul2, parC p.T57S, gyrA p.S83F IncA/C2, IncI1, ColpVC, ColRNAI SPI3, SPI5, SPI13, SPI14, C63PI 
PT19 2017 S.Heidelberg 18 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F, fosA7 
IncA/C2, IncX1, ColpVC 
SPI1, SPI2, SPI3, SPI5, SPI13, SPI14, 
C63PI 
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PT20 2017 S.Heidelberg 19 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
fosA7 
IncA/C2, IncX1, ColpVC 
SPI1, SPI2, SPI3, SPI4 SPI5, SPI13, 
SPI14, C63PI 
PT21 2018 S.Minnesota 20 ND 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, qnrB, parC 
p.T57S 
IncA/C2, Col440I SPI2, SPI3, SPI4, SPI13, SPI14, C63PI 
PT22 2018 S.Heidelberg 21 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F, fosA7 
IncA/C2, IncI1, IncX1 
SPI1, SPI2, SPI3, SPI5, SPI13, SPI14, 
C63PI 
PT23 2018 S.Heidelberg 22 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Gmn, Pef, Nal 
blaCMY-2, tet(A), sul1, sul2, aac(3)-VIa, 
parC p.T57S, gyrA p.S83F, fosA7 
IncA/C2, IncHI2A, IncHI2, IncX1, 
ColRNAI 
SPI2, SPI3, SPI5, SPI13, SPI14, C63PI 
PT24 2018 S.Minnesota 23 548 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, qnrB, parC 
p.T57S 
IncA/C2, Col440I SPI2, SPI3, SPI13, SPI14, C63PI 
PT25 2018 S.Heidelberg 23 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F, fosA7 
IncA/C2, ColpVC SPI5, SPI13, SPI14, C63PI 
PT26 2018 S.Heidelberg 24 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F, fosA7 
IncA/C2, IncQ1, IncX1 SPI2, SPI3, SPI5, SPI13, SPI14, C63PI 
PT27 2018 S.Heidelberg 24 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F, fosA7 
IncA/C2, IncQ1, IncX1 SPI2, SPI3, SPI5, SPI13, SPI14, C63PI 
PT28 2018 S.Minnesota 25 548 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, qnrB, parC 
p.T57S 
IncA/C2, Col440I SPI2, SPI3, SPI5, SPI13, SPI14, C63PI 
PT29 2019 S.Heidelberg 26 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Tgc, Smx, Azm, Pef, 
Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F, macA, macB 
IncA/C2, IncX1, ColpVC SPI2, SPI5, SPI13, SPI14, C63PI 
PT30 2019 S.Heidelberg 27 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Tmp, Smx, Gmn, Pef, 
Nal 
blaCMY-2, tet(A), dfrA25, sul1, sul2, 
aac(3)-IV, parC p.T57S, gyrA p.S83F, 
fosA7 
IncA/C2, IncX1, ColRNAI SPI2, SPI3, SPI5, SPI13, SPI14, C63PI 
PT31 2019 S.Minnesota 28 548 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCTX-M-8, tet(A), sul2, qnrB, parC 
p.T57S 
IncA/C2, Col440I SPI2, SPI3, SPI4, SPI13, SPI14, C63PI 
PT32 2019 S.Minnesota 29 548 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Tgc, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, qnrB, parC 
p.T57S 
IncA/C2, IncFIB(pHCM2), Col440I, 
Col8282 
SPI2, SPI3, SPI13, SPI14, C63PI 
PT33 2019 S.Minnesota 29 548 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Tgc, Smx, Pef, Nal 
blaTEM-1B, blaCTX-M-8, blaCTX-M-55, 
blaCMY-2, tet(A), sul2, qnrB, parC 
p.T57S 
IncA/C2, IncFII(pHN7A8), Col440I SPI2, SPI3, SPI13, SPI14, C63PI 
PT34 2019 S.Heidelberg 29 15 
Tet, Tgc, Smx, Gmn, Pef, 
Nal 
tet(A), sul1, sul2, ant(2'')-Ia, parC p.T57S, 
gyrA p.S83F, fosA7 
IncA/C2, IncX1, Col440I, ColpVC SPI5, SPI13, SPI14, C63PI 
PT35 2019 S.Heidelberg 30 15 
Tet, Tgc, Smx, Gmn, Pef, 
Nal 
tet(A), sul2, parC p.T57S, gyrA p.S83F, 
fosA7 
IncA/C2, IncX1, ColpVC SPI5, SPI13, SPI14, C63PI 
PT36 2019 S.Heidelberg 30 15 
Amp, Fox, Caz, Ctx, Cro, 
Tet, Smx, Pef, Nal 
blaCMY-2, tet(A), sul2, parC p.T57S, 
gyrA p.S83F, fosA7 
IncA/C2, IncI1, IncX1, ColpVC 
SPI1, SPI2, SPI3, SPI5, SPI13, SPI14, 
C63PI 
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5.4.2. WGS-based genomic relatedness analysis 
Although in four isolates the in silico MLST analysis was not possible to determine 
because one of the alleles was not found, all S. enterica serovar Heidelberg isolates obtained 
from fresh poultry meat imported from third countries to Portugal, belong to ST15 and all 
S. enterica serovar Minnesota belong to ST548. The initial MST (Figure 5-1A), based on 2843 
shared loci revealed two genetically distant clusters (2705 AD), each corresponding to a 
different serovar. Most part of the isolates obtained in the samples imported to Portugal 
clustered together with different sets of isolates from Brazil and/or Netherlands. Regarding 
only serovar Minnesota, the isolates share a total of 3458 loci with an overall mean pairwise 
distance of 85.2±80.6 allelic differences (AD) (Figure 5-2). Taking the isolates studied at 
INSA into consideration, they only present a mean pairwise distance of 26.3±7.1 AD. 
However, two S. enterica serovar Minnesota Brazilian isolates seem to be closer to the 
isolates of our study, presenting a mean pairwise distance of 25.7±6.6 AD, and sharing the 
same antibiotic resistance phenotype and genotype of some of the isolates. SRR7130551, is 
resistant to cephalosporins, penicillins, tetracyclines, and fluoroquinolones203, presenting 
the same resistance markers of isolates PT24 and PT33, including plasmids IncA/C2 and 
Col440I (Table 5-1). However, this isolate contains an additional pathogenicity island, SPI4, 
absent in both PT isolates. SRR7130561, presents the same resistance profile and plasmids 
of PT31, but not SPI4 that is present in this strain. 
. 
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Figure 5-1 – Global phylogeny of Salmonella enterica serovars Heidelberg and Minnesota isolates, based on a dynamic gene-by-gene approach using a wgMLST schema 
with 8558 loci. The minimum spanning tree enrolling 133 Brazil-imported isolates identified in Netherlands (van der Berg RR et al, 2019), 88 isolates identified in 
Brazil (Monte DF et al, 2019) and 36 imported isolates identified in Portugal, was constructed based on the allelic diversity of 2843 shared loci, using the goeBURST 
algorithm implemented in the PHYLOViZ online platform. Filled circles (nodes) represent unique allelic profiles, and are colored according to isolates’ isolation 
country. For simplification purposes, only the allele difference between both serovars is shown. The dashed black line segregates S. enterica serovars Heidelberg and 
Minnesota isolates. 
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Figure 5-2 – Phylogenic relationships based on a dynamic gene-by-gene approach and allelic differences between Salmonella enterica serovar Minnesota isolates. A 
The minimum spanning tree was constructed using the goeBURST algorithm implemented in the PHYLOViZ online platform, and is based on the allelic diversity found 
among the 3458 genes shared by all S. enterica serovar Minnesota isolates. Unique allelic profiles are shown as filled circles coloured according to isolates’ isolation 
country. The numbers in grey on the connecting lines represent the allele differences between isolates. Marked with an asterisk are the two isolates from Brazil, 
SRR7130551 and SRR7130561, which display an AD to some PT isolates lower than the mean AD among all PT isolates (26.3). B Plot depicting the allelic differences 
between the overall population and between isolates of each country. 
CHAPTER 5. MDR SALMONELLA ENTERICA FROM IMPORTED POULTRY MEAT IN PORTUGAL 
 
82 
 
Nevertheless, we also found cases for which an apparent discrete allelic distance is 
not concordant with the differential presence of other genetic features. For instance, 
although S. enterica serovar Minnesota PT3 and PT4 were isolated from units of the same 
batch and reveal 13 AD, PT3 presents SPI2, absent in PT4, and Col440I harbouring qnrB, 
while PT4 presents several IncF plasmids and phages Fels 1 and Fels 2. Similarly, isolates 
PT32, PT33, and PT34, from another batch, also presented several differences. Firstly, this 
batch contained isolates of serovar Minnesota (PT32 and PT33) and serovar Heidelberg 
(PT34). Secondly, PT33, that presents a mean pairwise distance of 8 AD with PT32, besides 
harbouring blaCMY-2 like PT32, harbours additional bla genes, blaTEM1, blaCTX-M-8, and 
blaCTX-M55 (Table 5-1). These isolates also have different phage content (Supplementary 
Table 5-2). 
Analysis of S. enterica serovar Heidelberg isolates revealed they share 3041 loci, 
with a mean pairwise distance of 18.2±9.5 AD between all isolates (Figure 5-3). This serovar 
revealed a low level of genetic variability, as previously described226,227. Interestingly, 
isolate PT10, Brazilian isolate SRR7130373203, and isolates from cluster VI225 from the 
Netherlands are closely related, sharing a mean pairwise distance of 2.7±2.1. PT11 presents 
a mean pairwise distance of 5 AD from Batch BI225, original from Santa Catarina state in 
Brazil. The same resistance genotype and plasmids were detected in these isolates. 
Although PT13 only shares 5 AD with isolates from batch AI from Netherlands225, we 
identified a high level of genetic diversity among these isolates, mainly regarding their 
antimicrobial resistance profiles.  
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Figure 5-3 – Phylogenic relationships based on a dynamic gene-by-gene approach and allelic differences of Salmonella enterica serovar Heidelberg isolates. A The 
minimum spanning tree enrolls a total of 3041 shared loci and was constructed using the goeBURST algorithm implemented in the PHYLOViZ online platform. Unique 
allelic profiles are shown as filled circles colored according to isolates’ isolation country. The numbers in grey on the connecting lines represent the allele differences 
(AD) between isolates. For simplification purposes, AD <5 are not shown. Marked with an asterisk are isolates from Brazil, and Netherlands, which are closest to the, 
also marked with an asterisk, isolates PT10, PT11, and PT13 imported to Portugal. B Plot depicting the allelic differences between the overall population and between 
isolates of each country.
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 Discussion 
One of the most known and appreciated typical dishes in Portugal are stewed 
chicken gizzards, to an extent that national production is not sufficient to cover the market’s 
requirements. As such, part of this fresh poultry meat consumed in Portugal is imported 
from third countries. Portugal, being one of the entry points to the EU market, has Border 
Inspection Posts in its airports and ports, where samples of imported foods of animal origin 
are inspected by the competent authority DGAV. Regarding Salmonella in fresh poultry 
meat, the specific requirements were revised in the light of the serovars of Salmonella 
causing the higher percentage of human salmonellosis, namely S. enterica serovar 
Enteritidis, S. enterica serovar Typhimurium, and S. enterica serovar 4,[5],12:i:-. The 
Commission Regulation (EC) No 2073/2005228, and subsequent amendments229, lay down 
the food hygiene criterion for Salmonella in poultry carcasses of broilers and turkeys, after 
chilling in slaughterhouses, where 50 units must be tested (n=50) and 7 units may test 
positive for Salmonella (c=7). Additionally, testing against the food safety criterion must be 
carried out in five units (n=5) and all five units must test negative for Salmonella (c=0). For 
compliance with the regulation, for S. enterica serovar Typhimurium, S. enterica serovar 
1,4,[5],12:i:-, and S. enterica serovar Enteritidis the result must be “Not detected”, in 25 g of 
fresh poultry meat. This criterion for products placed on the market during their shelf-life 
aims to control the two most common serovars with public health significance in the EU, 
without detrimental economic consequences due to the application of the legislation. 
However, this means that if any other serovar of Salmonella is detected, the foodstuff is 
proper for human consumption and in compliance with the food safety microbiological 
criteria.  
In this study, we isolated, between 2012 and 2019, from 163 samples (each one 
comprising 5 units) of fresh poultry meat imported from third countries, 37 S. enterica 
serovar Heidelberg isolates, 19 S. enterica serovar Minnesota, and 1 S. enterica 4,[5],12:i:-. 
Moreover, WGS of a set of these isolates involving all batches revealed a high genetic 
diversity within serovar Heidelberg and serovar Minnesota, suggesting multiple sources. In 
fact, when comparing the isolates detected in fresh poultry meat imported to Portugal with 
isolates characterized in Brazil203, and in the Netherlands, we found several genetically 
related isolates also sharing phenotypic and genotypic features that suggest the existence 
of common geographical contaminated sources, translated in several entry points in the EU 
and in the dissemination of diverse MDR clones. 
Although S. enterica serovar Heidelberg and S. enterica serovar Minnesota are 
infrequently reported in Europe, the dissemination of these two serovars in the American 
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continent has been frequently reported203,213–216,230–232. While the detection of these serovars 
in fresh poultry meat placed on the market, is in compliance with the Commission 
Regulation (EC) Nº 2073/2005, the presence of antibiotic resistance markers may 
constitute a health threat due to the frequent and well-known horizontal contamination. 
This is especially a concern when those markers confer resistance to antimicrobials used to 
treat severe infections, such is the case of cephalosporins and fluoroquinolones. 
Considering that Salmonella can spread to humans through contaminated foods, to prevent 
or reduce this risk, whenever Salmonella is identified but the requirements established in 
the European legislation for Salmonella in fresh poultry meat are fulfilled, “(…) the batches 
of those products placed on the market must be clearly labelled by the manufacturer in order 
to inform the consumer of the need of thorough cooking prior to consumption”. Additionally, 
the principles contained in the World Health Organization (WHO) Manual “Five Keys to 
Safer Food” must be followed by consumers and retailers233. S. enterica serovar Heidelberg 
and S. enterica serovar Minnesota have been found to present extended-spectrum 
cephalosporin-resistance associated with AmpC β-lactamases 
CMY207,209,211,212,216,226,230,231,234. In our study, antimicrobial resistance testing of several 
isolates revealed a high percentage of multidrug resistance (94%) which is most likely due 
to misuse of antimicrobials in poultry production216. A high frequency of isolates presenting 
resistance to sulfamethoxazole, tetracycline, β-lactams and fluoroquinolones was detected. 
Fluoroquinolones, sulphonamides and tetracyclines are usually administered in poultry 
industry as therapeutic agents for bacterial infections and growth promoters, which might 
explain the high frequency of isolates with resistance to these groups of antibiotics216,235. 
WGS of the isolates identified in INSA further revealed the generalized presence of blaCMY-2, 
but also, less frequently, the presence of other widely disseminated bla genes. In this work, 
blaCMY-2 was associated with IncA/C2 other than Inc1, as previously reported209,230. In a few 
cases, blaCMY-2 was apparently inserted in the chromosome. Typically, IncA/C2 also carried 
tet(A), sul2, and the mercury tolerance operon. This plasmid is widely distributed across the 
American continent and is known to be responsible for the dissemination of several 
important resistance markers230. Additionally, IncX1 carrying T4SS was identified in 18 S. 
enterica serovar Heidelberg isolates. This secretion system is known to play not only an 
important part in pathogenesis, namely in the ability to invade and persist in macrophages 
and intestinal epithelial cells, but also in horizontal gene transfer, since it can transfer 
nucleoprotein complexes besides effector proteins227,236,237. Remarkably, these plasmids 
also carried toxin-antitoxin systems previously described to confer plasmid stability227. 
Other Inc plasmids were also detected as well as Col plasmids. We also detected the gene 
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fosA7, previously identified in S. enterica serovar Heidelberg isolated from broiler chickens 
in Canada, in 17 isolates of this serovar238.  
Although the Portuguese National Reference Laboratory for Gastrointestinal 
Infections has not identified to date any S. enterica serovar Heidelberg nor S. enterica 
serovar Minnesota with these resistance profiles, associated with human infection, the 
presence of these MDR isolates in fresh poultry meat for human consumption is still a risk, 
especially if in the environment of food production, distribution, and also in private houses, 
good hygiene practices concerning foods and surfaces are not followed. In the United States 
and Canada, S. enterica serovar Heidelberg is more frequently associated with invasive 
human infections, such as myocarditis and septicaemia, than other Non-typhoidal 
Salmonella, and is the second serovar mostly associated with deaths in the US226,227. S. 
enterica serovar Heidelberg and S. enterica serovar Minnesota seem to be highly successful 
and persistent clones, surely due to their enhanced capacity to intake so many resistance 
markers and virulence traits. Moreover, the isolates identified in this study are resistant to 
antimicrobials typically used as treatment of severe Salmonella infections. The further 
spread of these traits to other bacteria, and even to commensal microbiota (prior to cooking 
the contaminated foodstuffs), represents an added risk that should be taken into account. 
In summary, we detected two distinct serovars of MDR Salmonella in fresh poultry 
meat imported from third countries and entering the EU through Portugal. S. enterica 
serovar Heidelberg seems to be a highly clonal population, while S. enterica serovar 
Minnesota isolates present higher genomic variability. Nonetheless, both serovars present 
several fitness traits that enhance their capacity to spread and persist alike other successful 
Salmonella epidemic clones. In an era where the global spread of MDR bacteria is one of the 
major public health concerns, the criteria for foodstuffs monitoring, especially when 
concerning imported goods, are quite possibly in need of reviewing. The surveillance of the 
antibiotic resistance of Salmonella serovars isolated from fresh poultry meat, would be an 
important contribute for evaluating and understanding the dissemination of antibiotic 
resistance from animals for food production, to food, and then humans, before foodstuffs of 
this food category are placed on the market. 
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6. Final overview, concluding remarks and future perspectives 
The main objective of this PhD dissertation was to contribute to the determination 
of the genomic structure of Salmonella enterica serovars identified in Portugal, mainly 
through whole-genome sequencing. The importance of this objective stems from the fact 
that salmonellosis remains the second most common cause of gastrointestinal disease in the 
European Union, and as such has a high economic impact and a high burden of disease 
worldwide. The use of whole-genome sequencing in Salmonella surveillance has gained 
steady ground during the course of this PhD, and so, the need for the Portuguese National 
Reference Laboratory for Salmonella to implement this methodology was inevitable. An 
important collaborative work, INNUENDO, allowed the implementation of well-established 
pipelines for bacterial genome assembly used throughout the analysis of the isolates in this 
dissertation. 
The role of the NRL implies, not only the implementation of new molecular 
approaches for Salmonella surveillance, but also the analysis of the data obtained and its 
release both to the scientific community and health authorities. Decades of work in 
Salmonella surveillance resulted in the collection of data that was in dire need of a 
retrospective analysis to illustrate the dynamics of the most relevant serovars in Portugal. 
In this scope, in chapter 2, we analysed the existing data for the past 21 years, from classical 
typing to antimicrobial susceptibility testing, maintaining the focus on the data and not on 
the methodology, which suffered a few changes over time. We found that, the trend of the 
total number of detected Salmonella enterica has, over the years, been accompanied by the 
trend of Salmonella enterica serovar Enteritidis, a serovar that used to be responsible for 
most part of salmonellosis cases in Portugal. This serovar, mainly found in poultry and 
poultry products, suffered a significant decrease when control measures at the primary 
production level were introduced. The decrease of Salmonella enterica serovar Enteritidis, 
allowed for other serovars, less frequent at that time, to occupy new niches and infect new 
hosts. Consequently, a new serovar, also isolated in poultry, Salmonella enterica serovar 
1,4,[5],12:i:-, emerged and became the most frequent serovar in recent years in parallel with 
the serovar Enteritidis.  
A better understanding of Salmonella enterica in general, and certain serovars in 
specific is crucial so that the control measures introduced result in the reduction of the 
number of cases and not just an inversion of a trend. In chapter 3, we investigated the 
genomic diversity of the most frequent serovar in Portugal (in the period of study), 
Salmonella enterica serovar Enteritidis. Also, due to a suspected outbreak of a rare serovar, 
Salmonella enterica serovar Newport was also included in this study as it relies on an 
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ongoing investigation with the participation of the NRL. A retrospective MLVA typing 
analysis of Salmonella enterica serovar Enteritidis revealed that almost half of the isolates 
belonged to three endemic MLVA profiles while the other half was mainly composed by 
several sporadic MLVA types. While MLVA allowed the confirmation of a suspected 
outbreak signalled by the Portuguese Health Authorities in 2016, it hardly gave any 
information without any epidemiological context. Whole-genome sequencing, however, has 
higher resolution than MLVA, and allowed, not only the confirmation of the 2016 outbreak, 
but also allowed the detection of two undetected outbreaks. WGS discriminatory power is 
unquestionable, as 63 nodes were detected among the 65 isolates, although these were 
clustered in only two distinct MLVA profiles. Whole-genome sequencing also allowed us to 
confirm that the sudden increase in 2019 of the number of cases of salmonellosis caused by 
Salmonella enterica serovar Newport was quite possibly an outbreak as this serovar was 
rarely isolated in the previous years. Although other isolates will be sequenced in the 
following weeks in order to have a more complete scenario, our preliminary data confirms 
the existence of an outbreak due to the high genetic relatedness of most of the isolates 
sequenced so far. On the epidemiological point of view, the recent data collection signifies 
that the investigation of this outbreak by the competent authorities is still ongoing. In 
summary, whole-genome sequencing proved to be a highly discriminatory tool for outbreak 
detection, which will surely lead to signalling of even more clusters of interest allowing 
proper investigations to take part. 
Other serovars, non-related with poultry, such as Salmonella enterica serovar Rissen 
also emerged recently, mainly in Azores. Chapter 4 is focused on the study of the genetic 
diversity of this serovar in Portugal precisely to investigate the putative existence of 
outbreaks and try to decipher transmission links. Another hypothesis underlying the 
increase of this serovar is that these strains might carry genetic determinants conferring 
fitness advantages, which could also be investigated through the genetic analysis. Whole-
genome sequencing revealed a high degree of similarity among the Salmonella enterica 
serovar Rissen population, enrolling 60 Portuguese isolates and 270 isolates from different 
countries. We establish several genetic links among isolates from different sources, 
including human, animal, and food, in the Portuguese continent that show a perfect 
clustering with the isolates from Azores. Although the apparent relatedness between 
several isolates, given the high degree of genetic similarity within this serovar, an 
epidemiological link could be inexistent. Nonetheless, we identified two multidrug-resistant 
clones in the Azores archipelago, already spread to the continent. The fact that the majority 
of the isolates are multidrug-resistant, including antimicrobials of great clinical importance 
such as macrolides and cephalosporins, is worrisome. An additional concern was the 
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identification of metal tolerance genes, believed to have a significant role in emergence and 
widespread of certain multidrug-resistant clones, as a means of survival in metal 
contaminated environments. Similarly, chapter 5 consisted in the study of Salmonella 
enterica serovar Heidelberg and Salmonella enterica serovar Minnesota isolates identified 
in Portugal. Given the origin of the isolates (imported poultry meat from third countries) 
and the recent studies on the genetic diversity of isolates from poultry meat in Brazil and 
imported to the Netherlands, we aimed for the phenotypic and genotypic integration of the 
isolates recovered in Portugal. Our major findings suggest that, the isolates imported to 
Portugal present high genetic relatedness with isolates imported to the Netherlands and 
from isolated identified in Brazil. Interestingly, while Salmonella enterica serovar 
Heidelberg population seems to be highly clonal, Salmonella enterica serovar Minnesota 
isolates present great genetic variability. Nonetheless, both serovars, like Salmonella 
enterica serovar Rissen, present fitness traits that enhance their capacity to spread and 
persist in the environment. Although these serovars are not frequent human pathogens, 
their antibiotic resistance markers can be potentially transferred to typical pathogens that 
share the same biological niche (i.e., food and environment), thus increasing the probability 
of severe human infections. In highlight, there is an urgent need for the revision of the 
regulations for foodstuffs monitoring and for the implementation of safe control measures 
in animal production, in order to avoid the spread of successful clones carrying genetic 
markers that can either cause severe infections, or further spread those markers to other 
relevant gastrointestinal bacteria. 
In conclusion, this PhD dissertation constitutes an important contribution to gain 
insight on the characteristics of relevant Salmonella enterica isolates circulating in Portugal, 
as well as a contribution for the reinforcement of the capacitation of the Portuguese 
National Reference Laboratory. Not only was it possible to frame Salmonella surveillance in 
the past decades, but also to implement whole-genome sequencing as a tool for the 
detection of several outbreaks, allowing a more precise and real-time communication with 
the Health Authorities towards a more effective control of salmonellosis.  
Future perspectives 
As future perspectives we will carry on the surveillance of Salmonella enterica 
through whole-genome sequencing, continuing the study of the serovars included in this 
dissertation, as well as other relevant serovars. In particular, we will soon focus on 
Salmonella enterica serovar 1,4,[5],12:i:-, since we have a large collection of isolates, 
including the first isolates to be identified in the world, back in 1987. We already started 
sequencing these isolates and will soon start studying the genomic evolution of this 
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particular serovar, through several decades, as well as resistance markers (this serovar is 
usually multidrug resistant), and other fitness traits of interest.  
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8. Supplementary material 
Supplementary Table 4-1 – Metadata, genome assembly statistics, antibiotic resistance phenotype and genotype and heavy metal tolerance genotype of the 
Salmonella enterica serovar Rissen isolates enrolled in the present study. R -Resistant; S - Susceptible; (+) - Present; (-) - Absent; MDR - Multidrug resistant; NUT - 
Nomenclature of Territorial Units for Statistics; Amc – amoxicillin/clavulanic acid; Amp – ampicillin; Azm – azithromycin; Chl – chloramphenicol; Fep – cefepime; Ctx 
– cefotaxime; Fox – cefoxitin; Caz – ceftazidime; Cro – ceftriaxone; Gmn – gentamicin; Mem – meropenem; Nal - nalidixic acid; Pef – pefloxacin; Smx – sulfamethoxazole; 
Tet – tetracycline; Tgc – tigecycline; and Tmp – trimethoprim. 
Isolate ID Lab. ID Location Region (NUTII) Collection Date Sample Source Product 
Mean depth 
of coverage 
Genome 
size (bp) 
# of 
contigs 
ST 
Read 
size 
(bp) 
Sequencing 
Aparatus 
(Illumina) 
ENA 
Accession #  
ENA ID 
PT01 Se_157-14 Braga North July 2014 Food Pig Fresh sausages 41.14 4907173 108 469 250 MiSeq ERS3404912 PT_SE0001 
PT02 Se_197-14 Azores Azores August 2014 Clinical Human Urine 64.84 4905194 93 469 150 NextSeq ERS3404913 PT_SE0002 
PT03 Se_290-14 Aveiro North October 2014 Clinical Human Not Available 63.47 4914066 104 469 250 MiSeq ERS3404914 PT_SE0003 
PT04 Se_297-14 Lisbon Lisbon Metropolitan area November 2014 Clinical Human Faeces 90.53 4919725 112 469 150 NextSeq ERS3404915 PT_SE0004 
PT05 Se_4-15 Azores Azores January 2015 Clinical Human Blood 39.5 4937155 112 469 250 MiSeq ERS3404916 PT_SE0005 
PT06 Se_72-15 Azores Azores February 2015 Clinical Human Faeces 55.52 4938746 76 469 250 MiSeq ERS3404917 PT_SE0006 
PT07 Se_90-15 Azores Azores March 2015 Clinical Human Faeces 53.44 4944290 103 469 250 MiSeq ERS3404918 PT_SE0007 
PT08 Se_123-15 Oporto North April 2015 Clinical Human Faeces 90.93 4892381 107 469 150 NextSeq ERS3404919 PT_SE0008 
PT09 Se_128-15 Oporto North April 2015 Clinical Human Faeces 80.99 4963973 112 469 150 NextSeq ERS3404920 PT_SE0009 
PT10 Se_171-15 Lisbon Lisbon Metropolitan area June 2015 Clinical Human Faeces 58.84 4863424 161 469 150 NextSeq ERS3404921 PT_SE0010 
PT11 Se_PIGA-2 Azores Azores June 2015 Food Bovine Frozen minced meat 53.46 4867520 74 469 250 MiSeq ERS3404922 PT_SE0011 
PT12 Se_PIGA-4 Not Available Alentejo June 2015 Food Not Available Blood chorizo 56.62 4975525 103 469 250 MiSeq ERS3404923 PT_SE0012 
PT13 Se_PIGA-7 Azores Azores June 2015 Food Pig Meat chorizo 59.02 4944337 84 469 250 MiSeq ERS3404924 PT_SE0013 
PT14 Se_PIGA-8 Not Available Lisbon Metropolitan area June 2015 Food Pig Meat 64.89 4945078 102 469 250 MiSeq ERS3404925 PT_SE0014 
PT15 Se_PIGA-9 Not Available Lisbon Metropolitan area June 2015 Animal Pig Piglet 75.94 4946168 79 469 250 MiSeq ERS3404926 PT_SE0015 
PT16 Se_PVRAM-7-15 Not Available Not Available June 2015 Animal Pig Piglet carcass 60.58 4995231 144 469 150 NextSeq ERS3404927 PT_SE0016 
PT17 Se_227-15 Aveiro North July 2015 Clinical Human Not Available 52.81 4843182 131 469 150 NextSeq ERS3404928 PT_SE0017 
PT18 Se_254-15 Oporto North August 2015 Clinical Human Faeces 48.15 5012266 89 469 250 MiSeq ERS3404929 PT_SE0018 
PT19 Se_266-15 Setúbal Lisbon Metropolitan area August 2015 Clinical Human Faeces 63.42 4886200 80 469 250 MiSeq ERS3404930 PT_SE0019 
PT20 Se_270-15 Azores Azores August 2015 Clinical Human Faeces 42.3 4945266 97 469 250 MiSeq ERS3404931 PT_SE0020 
PT21 Se_305-15 Coimbra Centre August 2015 Environmental NA Water 125.42 5066848 125 469 250 MiSeq ERS3404932 PT_SE0021 
PT22 Se_479-15 Oporto North November 2015 Clinical Human Faeces 58.32 4909000 109 469 250 MiSeq ERS3404933 PT_SE0022 
PT23 Se_PIGA-2-16 Azores Azores November 2015 Food Pig Hamburger 80.69 4940239 84 469 250 MiSeq ERS3404934 PT_SE0023 
PT24 Se_PIGA-3-16 Azores Azores November 2015 Food Pig Raw Chorizo 48.04 4873930 94 469 250 MiSeq ERS3404935 PT_SE0024 
PT25 Se_PIGA-4-16 Azores Azores November 2015 Food Pig Raw meat 58.24 4940367 98 469 250 MiSeq ERS3404936 PT_SE0025 
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PT26 Se_PIGA-5-16 Azores Azores January 2016 Food Pig Chorizo 52.54 4938840 85 469 250 MiSeq ERS3404937 PT_SE0026 
PT27 Se_R33-16 Oporto North March 2016 Animal Bovine Carcass 60.86 4924248 96 469 250 MiSeq ERS3404938 PT_SE0027 
PT28 Se_R39-16 Azores Azores March 2016 Animal Pig Carcass 55.48 4938922 93 469 250 MiSeq ERS3404939 PT_SE0028 
PT29 Se_R70-16 Not Available Not Available May 2016 Food Pig Pork skewers 56.54 4879946 112 469 150 NextSeq ERS3404940 PT_SE0029 
PT30 Se_R71-16 Not Available Not Available May 2016 Food Pig Pork skewers 138.65 4880717 91 469 150 NextSeq ERS3404941 PT_SE0030 
PT31 Se_R72-16 Not Available Not Available May 2016 Food Pig Pork skewers 99.05 4889369 102 469 150 NextSeq ERS3404942 PT_SE0031 
PT32 Se_R73-16 Not Available Not Available May 2016 Food Pig Pork skewers 68.58 4876907 110 469 150 NextSeq ERS3404943 PT_SE0032 
PT33 Se_R74-16 Not Available Not Available May 2016 Food Pig Pork skewers 221.84 4881425 87 469 150 NextSeq ERS3404944 PT_SE0033 
PT34 Se_R92-16 Not Available Not Available May 2016 Environmental NA Mud 75.75 4917595 110 469 150 NextSeq ERS3404945 PT_SE0034 
PT35 Se_R110-16 Azores Azores June 2016 Animal Pig Carcass 56.04 4919561 123 469 150 NextSeq ERS3404946 PT_SE0035 
PT36 Se_R134-16 Setúbal Lisbon Metropolitan area August 2016 Animal Bivalve Bivalve mollusc 186.4 4910852 85 469 150 NextSeq ERS3404947 PT_SE0036 
PT37 Se_R151-16 Azores Azores August 2016 Animal Pig Carcass 64.27 4953004 147 469 150 NextSeq ERS3404948 PT_SE0037 
PT38 Se_S176 Azores Azores August 2016 Clinical Human Faeces 71.69 4937185 83 469 250 MiSeq ERS3404949 PT_SE0038 
PT39 Se_S208 Azores Azores August 2016 Clinical Human Urine 57.31 4941276 117 469 250 MiSeq ERS3404950 PT_SE0039 
PT40 Se_PVRAM-46-16 Viseu Centre October 2016 Animal Chicken Carcass 68.29 4854659 105 469 150 NextSeq ERS3404951 PT_SE0040 
PT41 Se_S308 Azores Azores October 2016 Clinical Human Exudate 86.48 4979091 118 469 250 MiSeq ERS3404952 PT_SE0041 
PT42 Se_R196-16 Not Available Not Available November 2016 Food Pig Raw sausage 291.87 4877328 89 469 150 NextSeq ERS3404953 PT_SE0042 
PT43 Se_R199-16 Azores Azores November 2016 Animal Bovine Carcass 39.49 4947413 203 469 150 NextSeq ERS3404954 PT_SE0043 
PT44 Se_R200-16 Spain Spain November 2016 Food Chicken Meat 69.09 4888699 110 469 150 NextSeq ERS3404955 PT_SE0044 
PT45 Se_R217-16 Lisbon Lisbon Metropolitan area December 2016 Food Chicken Raw meat 63.82 4887212 120 469 150 NextSeq ERS3404956 PT_SE0045 
PT46 Se_PIGA-7-16 Azores Azores January 2016 Food Pig Chorizo 77.72 4921583 108 469 150 NextSeq ERS3404957 PT_SE0046 
PT47 Se_R65-17 Not Available Not Available March 2017 Food Turkey Turkey skewers 83.93 4930828 79 469 150 NextSeq ERS3404958 PT_SE0047 
PT48 Se_S398 Azores Azores March 2017 Clinical Human Bronchial aspirate 62.66 4920188 116 469 250 MiSeq ERS3404959 PT_SE0048 
PT49 Se_S402 Azores Azores March 2017 Clinical Human Urine 46.6 4917517 100 469 250 MiSeq ERS3404960 PT_SE0049 
PT50 Se_S420 Lisbon Lisbon Metropolitan area March 2017 Clinical Human Urine 39.09 4903866 123 469 250 MiSeq ERS3404961 PT_SE0050 
PT51 Se_R74-17 Azores Azores April 2017 Animal Bovine Carcass 77.31 4963946 117 469 150 NextSeq ERS3404962 PT_SE0051 
PT52 Se_S473 Azores Azores May 2017 Clinical Human Faeces 46.96 4939749 93 469 250 MiSeq ERS3404963 PT_SE0052 
PT53 Se_PVRAM-2-17 Leiria Centre June 2017 Animal Bovine Carcass 59.02 4925286 115 469 150 NextSeq ERS3404964 PT_SE0053 
PT54 Se_PVRAM-3-17 Azores Azores July 2017 Animal Pig Carcass 46.47 4936820 229 469 150 NextSeq ERS3404965 PT_SE0054 
PT55 Se_PVRAM-10-17 Azores Azores August 2017 Animal Pig Carcass 127.85 4961638 130 469 150 NextSeq ERS3404966 PT_SE0055 
PT56 Se_PVRAM-17-17 Leiria Centre August 2017 Animal Pig Carcass 49.42 4913428 123 469 150 NextSeq ERS3404967 PT_SE0056 
PT57 Se_PIGA-8-17 Not Available Centre September 2017 Food Pig Chorizo 49.41 4909916 176 469 150 NextSeq ERS3404968 PT_SE0057 
PT58 Se_PVRAM-19-17 Leiria Centre September 2017 Animal Pig Carcass 63.03 4917601 123 469 150 NextSeq ERS3404969 PT_SE0058 
PT59 Se_S674 Lisbon Lisbon Metropolitan area September 2017 Clinical Human Pus 44.34 4924957 182 469 150 NextSeq ERS3404970 PT_SE0059 
PT60 Se_R258-17 Not Available Not Available October 2017 Food Bovine/pork Gourmet Hamburguer 65.2 5090350 122 469 150 NextSeq ERS3404971 PT_SE0060 
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PT01 MDR R S + R S + S - - - R + - R + - S - S - + + + - S S - - - + S S S S S S - + + + + 
PT02 MDR S S - R S + R + - - R + - R + - S - S - + - + - S S - - - + S S S S S S - + + + + 
PT03 MDR R R + R S + R - + - R - + R + + S - I + + + + - S S - - - + S S S S S S + + + + + 
PT04 MDR R S + S S - R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + + + 
PT05 MDR S S + R S + S - - - R + - R + - R + S - - - + + S S - - - + S S S S S S - + + + + 
PT06 MDR R S + R S + R + - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT07 MDR R S + R S + R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + - + 
PT08 MDR R S + R S + S - - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT09 MDR R S + R S + R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + + + 
PT10 
non-
MDR R S + S S - S - - - S - - S - - S - S - - - + - S S - - - + S S S S S S - + + + + 
PT11 
non-
MDR S S - S S - S - - - S - - S - - S - S - - - + - S S - - - + S S S S S S - + + + + 
PT12 
non-
MDR S S + S S + S - - - S + - R + - S - S - + + + - S S - - - + S S S S S S - + + + + 
PT13 MDR R S + R S + R + - - R + - R + - R + S - - - + + S S - - - + S S S S S S - + + + + 
PT14 MDR R S + R S + R + - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT15 MDR R S + R S + R + - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT16 MDR S S - R S + S - - - R + - R + - R + S - + - + - S S - - - + S S S S S S - + + + + 
PT17 
non-
MDR S S - R S + S - - - S - - S - - S - S - - - + - S S - - - + S S S S S S - + + + + 
PT18 MDR R S + R S + S - - - R + - R + - S - S - + + + - S S - - - + S S S S S S - + + + + 
PT19 
non-
MDR S S - R S + S - - - S - - S - - S - S - - - + - S S - - - + S S S S S S - + + + + 
PT20 MDR R S + R S + R + - - R + - R + - R + S - - - + + S S - - - + S S S S S S - + + + + 
PT21 MDR R S + R S + S - - - R + - R + - S - S - + + + - S S - - - + S S S S S S - + + + + 
PT22 MDR R S + R S + R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + + + 
PT23 MDR R R + R S + R + - - R + - R + + R + S - - - + + S S - - - + S S S S S S - + + + + 
PT24 MDR S S - R S + R - + - S - - R - + S - S - + + + - S S - - - + S S S S S S - + + + + 
PT25 MDR R R + R S + S - - - R + - R + - R + S - - - + + S S - - - + S S S S S S - + + + + 
PT26 MDR S S - R S + S - - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT27 
non-
MDR R S - S S - S - - - S - - S - - S - S - - - + - S S - - - + S S S S S S - + + + + 
PT28 MDR S S - R S + S - - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT29 MDR R S + R S + R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + - + 
PT30 MDR R S + R S + R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + - + 
PT31 MDR R S + R S + R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + - + 
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PT32 MDR R S + R S + R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + - + 
PT33 MDR R S + R S + R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + - + 
PT34 MDR R S + R S + R + - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT35 MDR R S + R S + R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + - + 
PT36 MDR R S + R S + S - - - R + - R + - S - S - + + + - S S - - - + S S S S S S - + + + + 
PT37 MDR R S + R S + S - - - R + - R + - R + S - - - + + S S - - - + S S S S S S - + + + + 
PT38 MDR R R + R S + S - - - R + - R + - R + S - - - + + S S - - - + S S S S S S - + + + + 
PT39 MDR R R + R S + S + - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT40 
non-
MDR S S - R S + S - - - S - - S - - S - S - - - + - S S - - - + S S S S S S - + + + + 
PT41 MDR R S + R S + R + - - R + - R + - R + S - - - + + S S - - - + S S S S S S - + + + + 
PT42 MDR S S - R S + R + - - R + - R + - R + S - + - + - S S - - - + S S S S S S - + + + + 
PT43 MDR R S + R S + R + - - R + - R + - R + S - - - + + S S - - - + S S S S S S - + + + + 
PT44 MDR S S - S S - S - - - R + - R + - R + S - + - + - S R - + + + S S S S S S - + + + + 
PT45 MDR S S - S S - S - - - R + - R + - R + S - + - + - S S - - + + S S S S S S - + + + + 
PT46 MDR S S - R S + S - - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT47 MDR R R + R S + R + - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT48 
non-
MDR R R + S S - R + - - S - - S - - S - S - - + + - S S - - - + S S S S S S - + + + + 
PT49 
non-
MDR R R + S S - R + - - S - - S - - S - S - - + + - S S - - - + S S S S S S - + + + + 
PT50 MDR R S + S S - R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + + + 
PT51 MDR R S + R S + S - - - R + - R + - R + S - - - + + S S - - - + S S S S S S - + + + + 
PT52 MDR R R + R S + S - - - R + - R + - R + S - - - + + S S - - - + S S S S S S - + + + + 
PT53 MDR R S + S S - R - + - R - + R + + S - S - + + + - S S - - - + S S S S S S + + + + + 
PT54 MDR S S - R S + S - - - R + - R + - R + S - - + + - S S - - - + S S S S S S - + + + + 
PT55 MDR R S + R S + S - - - R + - R + - R + S - - - + + S S - - - + S S S S S S - + + + + 
PT56 MDR R S + R S + R + - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT57 MDR R S + R S + R + - - R + - R + - R + S - - + + - S S - - - + S S S S S S - + + + + 
PT58 MDR R S + R S + R + - - R + - R + - R + S - + + + - S S - - - + S S S S S S - + + + + 
PT59 
non-
MDR R R + R S + S - - - S - - S - - S - S - - + + - S S - - - + S S S S S S - + + + + 
PT60 MDR R R + R S + R - - + S - - S - - S - S - - - + - R R + - - + S S S S S S - + + + + 
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Supplementary Table 4-2 - List of publicly available Salmonella enterica serovar Rissen genomes 
used in the present study. All read datasets were downloaded from the European Nucleotide Archive. 
Strain ID Sample source Year Location ENA Accession # 
BCW_2764 Human 2002 Denmark SAMN02368641 
CRJJGF_00114 Food 2004 United States SAMN02908621 
BCW_2766 Unknown 2004 Thailand SAMN02368643 
BCW_2765 Livestock 2004 Denmark SAMN02368642 
FDA00001049 Environment 2006 Turkey SAMN02844434 
FDA00001046 Environment 2006 Vietnam SAMN02844431 
FDA00004496 Animal feed 2008 United States SAMN02918550 
IEH_NGS_SAL_00172 Environment 2009 United States SAMN02265259 
FDA00002917 Environment 2009 United States SAMN02846301 
FDA00002912 Environment 2009 United States SAMN02846296 
FDA00002855 Food 2009 United States SAMN02846239 
FDA00002853 Environment 2009 United States SAMN02846237 
FDA00002914 Environment 2009 United States SAMN02846298 
FDA00002915 Environment 2009 United States SAMN02846299 
FDA00002913 Environment 2009 United States SAMN02846297 
FDA00002854 Food 2009 United States SAMN02846238 
FDA00002916 Environment 2009 United States SAMN02846300 
FDA00002850 Environment 2009 United States SAMN02846234 
FDA00002849 Environment 2009 United States SAMN02846233 
FDA00002481 Environment 2009 United States SAMN02845865 
FDA00002848 Environment 2009 United States SAMN02846232 
FDA00002852 Environment 2009 United States SAMN02846236 
FDA00002851 Environment 2009 United States SAMN02846235 
FDA00002939 Food 2009 United States SAMN02846323 
FDA00002788 Food 2009 United States SAMN02846172 
FDA00002938 Food 2009 United States SAMN02846322 
CFSAN031935 Environment 2009 United States SAMN03577468 
CFSAN031930 Environment 2009 United States SAMN03577463 
CFSAN031937 Environment 2009 United States SAMN03577470 
32309.31 Environment 2009 United States SAMN10253329 
FDA00003115 Environment 2010 United States SAMN02846535 
FDA00003545 Aquatic 2010 Vietnam SAMN02846965 
FDA00003544 Aquatic 2010 Vietnam SAMN02846964 
FNW19G96 Aquatic 2010 Vietnam SAMN02344903 
FDA00004662 Food 2010 United States SAMN02918711 
FDA00001453 Environment 2010 Dominican Republic SAMN02844838 
NC_S803 Livestock 2010 United States SAMN07469595 
NC_S812 Livestock 2010 United States SAMN07469592 
NC_S810 Livestock 2010 United States SAMN07469594 
NC_S811 Livestock 2010 United States SAMN07469593 
NC_S801 Livestock 2010 United States SAMN07469597 
NC_S802 Livestock 2010 United States SAMN07469596 
FAR0094 Food 2011 China SAMN02345345 
FSE0050 Food 2011 Vietnam SAMN02345332 
FSW0031 Environment 2011 Philippines SAMN02345262 
CFSAN030098 Food 2012 United States SAMN03464584 
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H124020495 Food 2012 United Kingdom SAMN03168707 
H125180332 Food 2012 United Kingdom SAMN03168603 
FAR0091 Food 2012 Unknown SAMN02345586 
FAR0099 Environment 2012 Mexico SAMN02345539 
PNUSAS002751 Unknown 2012 United States SAMN06198443 
CFSAN031334 Livestock 2013 Thailand SAMN03576868 
CFSAN031330 Livestock 2013 Thailand SAMN03576864 
CFSAN031335 Livestock 2013 Thailand SAMN03576869 
CFSAN031332 Livestock 2013 Thailand SAMN03576866 
CFSAN031331 Livestock 2013 Thailand SAMN03576865 
CFSAN031321 Livestock 2013 Thailand SAMN03576855 
CFSAN031320 Livestock 2013 Thailand SAMN03576854 
CFSAN031313 Livestock 2013 Thailand SAMN03576847 
CFSAN031314 Livestock 2013 Thailand SAMN03576848 
CFSAN031318 Livestock 2013 Thailand SAMN03576852 
CFSAN031312 Livestock 2013 Thailand SAMN03576846 
CFSAN031308 Livestock 2013 Thailand SAMN03576842 
CFSAN031315 Livestock 2013 Thailand SAMN03576849 
CFSAN031324 Livestock 2013 Thailand SAMN03576858 
CFSAN031309 Livestock 2013 Thailand SAMN03576843 
CFSAN031327 Livestock 2013 Thailand SAMN03576861 
CFSAN031325 Livestock 2013 Thailand SAMN03576859 
CFSAN031322 Livestock 2013 Thailand SAMN03576856 
CFSAN031316 Livestock 2013 Thailand SAMN03576850 
CFSAN031323 Livestock 2013 Thailand SAMN03576857 
CFSAN031311 Livestock 2013 Thailand SAMN03576845 
CFSAN031310 Livestock 2013 Thailand SAMN03576844 
CFSAN031319 Livestock 2013 Thailand SAMN03576853 
CFSAN031307 Livestock 2013 Thailand SAMN03576841 
CFSAN031306 Livestock 2013 Thailand SAMN03576840 
FNE0189 Food 2013 Thailand SAMN02698353 
CFSAN045275 Livestock 2013 Thailand SAMN04431411 
CFSAN045273 Livestock 2013 Thailand SAMN04431409 
CFSAN045268 Livestock 2013 Thailand SAMN04431404 
CFSAN045265 Livestock 2013 Thailand SAMN04431401 
CFSAN045263 Livestock 2013 Thailand SAMN04431399 
CFSAN045340 Livestock 2013 Thailand SAMN04431476 
CFSAN045327 Livestock 2013 Thailand SAMN04431463 
CFSAN045326 Livestock 2013 Thailand SAMN04431462 
CFSAN045324 Livestock 2013 Thailand SAMN04431460 
OH-1302304 Unknown 2013 United States SAMN05721584 
CVM N44364F Livestock 2013 United States SAMN06287508 
CFSAN084068 Environment 2013 United States SAMN09756362 
S280 Unknown 2014 Portugal SAMEA3476860 
73107 Human 2014 United Kingdom SAMN03479841 
5965 Human 2014 United Kingdom SAMN03479663 
40781 Food 2014 United Kingdom SAMN03478634 
68669 ND 2014 United Kingdom SAMN03477972 
31626 Human 2014 United Kingdom SAMN03476772 
5839 Human 2014 United Kingdom SAMN03476472 
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13420 Human 2014 United Kingdom SAMN03473985 
CFSAN045347 Livestock 2014 Thailand SAMN04431483 
CFSAN045343 Livestock 2014 Thailand SAMN04431479 
CVM N57959F Unknown 2014 United States SAMN04577502 
CVM N57219F Livestock 2014 United States SAMN04577270 
NC_NCF3D0-L5 Environment 2014 United States SAMN06322129 
FDA00008934 Food 2015 Mexico SAMN03495909 
FDA00008935 Food 2015 Mexico SAMN03495910 
91210 Food 2015 United Kingdom SAMN03480405 
91281 Human 2015 United Kingdom SAMN03480200 
91246 Human 2015 United Kingdom SAMN03480194 
91209 Food 2015 United Kingdom SAMN03479124 
91211 Food 2015 United Kingdom SAMN03478922 
91208 Food 2015 United Kingdom SAMN03478809 
91212 Food 2015 United Kingdom SAMN03476328 
FDA00009504 Aquatic animal 2015 Vietnam SAMN04148250 
FSIS1502596 Livestock 2015 United States SAMN04331735 
FSIS1503283 Livestock 2015 United States SAMN04331725 
ADRDL-15-8159 Poultry 2015 United States SAMN04240670 
FSIS1605466 Livestock 2015 United States SAMN04530405 
CVM N57971 Poultry 2015 United States SAMN04576648 
182090 Human 2015 United Kingdom SAMN04600580 
185971 Human 2015 United Kingdom SAMN04600398 
129524 Human 2015 United Kingdom SAMN04600236 
CVM N57978 Poultry 2015 United States SAMN05771731 
MS150107 Human 2015 Ireland SAMEA81466918 
NC_NCF6D0-A13 Environment 2015 United States SAMN06322119 
NC_NCF6D0-A18 Environment 2015 United States SAMN06322118 
NC_NCF6D0-A4 Environment 2015 United States SAMN06322126 
NC_NCF6D0-L9 Environment 2015 United States SAMN06322127 
NC_NCF6D0-L8 Environment 2015 United States SAMN06322128 
NC_NCF6D0-A20 Environment 2015 United States SAMN06322116 
151916 Livestock 2015 Spain SAMEA104142963 
PAT-15-27861SA Livestock 2015 Portugal SAMEA104142939 
PAT-15-19702SA Livestock 2015 Portugal SAMEA104142937 
15Q003557 Livestock 2015 France SAMEA104142871 
ADRDL-15-2378 Livestock 2015 United States SAMN07351348 
CFSAN069222 Environment 2015 United States SAMN07714159 
2187_Se_151916 Livestock 2015 Spain SAMEA104354224 
2176_Se_PAT_15_27861SA Livestock 2015 Portugal SAMEA104354222 
2174_Se_PAT_15_19702SA Livestock 2015 Portugal SAMEA104354221 
34927 Livestock 2015 United States SAMN07420494 
170460 Human 2015 United Kingdom SAMN09423139 
FDA00009757 Food 2015 Jamaica SAMN04385807 
FDA00009756 Food 2015 Jamaica SAMN04385806 
191884 Human 2015 United Kingdom SAMN09484447 
195784 Human 2015 United Kingdom SAMN10140147 
FDA00010268 Food 2016 Unresolved SAMN05232953 
FDA00010267 Environment 2016 Unresolved SAMN05232952 
PNUSAS004417 Unknown 2016 United States SAMN05877103 
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ADRDL-16-9998 Livestock 2016 United States SAMN05781501 
FSIS1608386 Livestock 2016 United States SAMN06048830 
CFSAN058818 Environment 2016 United States SAMN06175263 
CFSAN058816 Environment 2016 United States SAMN06175307 
FSIS1609588 Livestock 2016 United States SAMN06229944 
FDA00011195 Animal feed 2016 United States SAMN06214692 
FDA00011193 Animal feed 2016 United States SAMN06214694 
271097 Human 2016 United Kingdom SAMN06278620 
CFSAN059804 Environment 2016 United States SAMN06270186 
ADRDL-902 Livestock 2016 United States SAMN06330644 
OH-16-23867-16 Poultry 2016 United States SAMN07138205 
OH-16-26883-1 Poultry 2016 United States SAMN07184770 
CFSAN071463 Environment 2016 United States SAMN08017022 
CVM N16S193 Poultry 2016 United States SAMN08114066 
CVM N16S274 Poultry 2016 United States SAMN08114143 
CFSAN075243 Feed 2016 United States SAMN08395358 
CFSAN071961 Environment 2016 United States SAMN08057881 
CFSAN080464 Feed 2016 United States SAMN09071683 
227073 Human 2016 United Kingdom SAMN09403226 
216348 Human 2016 United Kingdom SAMN09403232 
217006 Human 2016 United Kingdom SAMN09610602 
212747 Food 2016 United Kingdom SAMN09634347 
FSIS1710520 Poultry 2017 United States SAMN06459939 
FSIS1710555 Livestock 2017 United States SAMN06459285 
FSIS1700028 Livestock 2017 United States SAMN06701838 
FDA00011518 Food 2017 Mexico SAMN06689639 
FSIS1700448 Livestock 2017 United States SAMN06882344 
FSIS1700956 Livestock 2017 United States SAMN06899446 
FSIS1701130 Livestock 2017 United States SAMN07141738 
367310 Human 2017 United Kingdom SAMN07155624 
360374 Human 2017 United Kingdom SAMN07155217 
367265 Human 2017 United Kingdom SAMN07180765 
333422 Food 2017 United Kingdom SAMN07180676 
333421 Food 2017 United Kingdom SAMN07180660 
362108 Human 2017 United Kingdom SAMN07180311 
363492 Human 2017 United Kingdom SAMN07180216 
FSIS1701469 Livestock 2017 United States SAMN07237724 
FSIS1702121 Livestock 2017 United States SAMN07260890 
FSIS1703115 Livestock 2017 United States SAMN07424747 
FSIS1703367 Livestock 2017 United States SAMN07501501 
FSIS1703368 Livestock 2017 United States SAMN07501502 
FDA00012093 Animal feed 2017 Argentina SAMN07510071 
PNUSAS021809 Unknown 2017 United States SAMN07561485 
FSIS21720373 Livestock 2017 United States SAMN07819022 
FSIS11704588 Livestock 2017 United States SAMN07835489 
FDA00012295 Aquatic animal 2017 Vietnam SAMN07981379 
FSIS11705536 Livestock 2017 United States SAMN08114352 
CFSAN071971 Environment 2017 United States SAMN08057833 
CFSAN071970 Environment 2017 United States SAMN08057822 
FSIS1701253 Livestock 2017 United States SAMN09098834 
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412138 Human 2017 United Kingdom SAMN09298461 
CFSAN081790 Feed 2017 United States SAMN09262024 
456191 Human 2017 United Kingdom SAMN09388861 
371818 Human 2017 United Kingdom SAMN09423133 
388672 Human 2017 United Kingdom SAMN09431486 
445933 Human 2017 United Kingdom SAMN09445526 
378690 Food 2017 United Kingdom SAMN09643791 
CVM N17S1456 Livestock 2017 United States SAMN09771059 
413029 Human 2017 United Kingdom SAMN09433805 
PNUSAS032562 Environment 2018 United States SAMN08383811 
FSIS31800061 Livestock 2018 United States SAMN08432325 
ADRDL-1843 Livestock 2018 United States SAMN08579906 
FSIS11808313 Livestock 2018 United States SAMN08767328 
FSIS21821362 Poultry 2018 United States SAMN08848643 
FSIS11808806 Livestock 2018 United States SAMN08886742 
FSIS11809218 Livestock 2018 United States SAMN08967083 
529250 Human 2018 United Kingdom SAMN09076426 
FSIS21821653 Poultry 2018 United States SAMN09225336 
520599 Human 2018 United Kingdom SAMN09388937 
FSIS11810650 Livestock 2018 United States SAMN09444133 
533995 Human 2018 United Kingdom SAMN09522091 
sam Human 2018 Ireland SAMEA4730812 
550127 Human 2018 United Kingdom SAMN09607167 
503417 Human 2018 United Kingdom SAMN09634155 
526142 Human 2018 United Kingdom SAMN09651916 
FSIS11811376 Livestock 2018 United States SAMN09633410 
570850 Human 2018 United Kingdom SAMN09683619 
FSIS11810870 Poultry 2018 United States SAMN09533147 
FSIS31800980 Poultry 2018 United States SAMN09994491 
FSIS11813906 Livestock 2018 United States SAMN10064108 
FSIS11808310 Livestock 2018 United States SAMN08767326 
06-1346 Unknown Unknown Unknown SAMEA1484347 
PNUSAS001935 Unknown Unknown United States SAMN04893774 
VNB1121-sc-2280660 Unknown Unknown Unknown SAMEA3447772 
2452-sc-2280574 Unknown Unknown Unknown SAMEA3447686 
74_H_097-sc-2280751 Unknown Unknown Unknown SAMEA3447861 
72_H_175-sc-2280732 Unknown Unknown Unknown SAMEA3447843 
71_H_195-sc-2280689 Unknown Unknown Unknown SAMEA3447801 
71_H_131-sc-2280683 Unknown Unknown Unknown SAMEA3447795 
VNSC2361-sc-2280610 Unknown Unknown Unknown SAMEA3447722 
VNB1504-sc-2280704 Unknown Unknown Unknown SAMEA3447816 
01-0479 Unknown Unknown Unknown SAMN03264955 
00-0084 Unknown Unknown Unknown SAMN03264954 
2012K-0157 Unknown Unknown Unknown SAMN03264953 
BCW_2864 Unknown Unknown Unknown SAMN02368730 
PNUSAS002711 Unknown Unknown United States SAMN05603672 
PNUSAS004670 Unknown Unknown United States SAMN05919885 
S02948-14 Unknown Unknown Unknown SAMEA4064117 
S02707-14 Unknown Unknown Unknown SAMEA4064114 
PNUSAS006373 Unknown Unknown United States SAMN06213966 
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SAMEA4412641 Unknown Unknown Unknown SAMEA4412641 
PNUSAS007242 Unknown Unknown United States SAMN06220355 
PNUSAS007916 Unknown Unknown United States SAMN06310818 
PNUSAS009904 Unknown Unknown United States SAMN06625047 
PNUSAS014086 Unknown Unknown United States SAMN07161029 
PNUSAS023317 Unknown Unknown United States SAMN07806985 
PNUSAS025277 Unknown Unknown United States SAMN07949738 
PNUSAS027824 Unknown Unknown United States SAMN08016445 
PNUSAS030901 Unknown Unknown United States SAMN08240237 
PNUSAS032846 Unknown Unknown United States SAMN08432357 
PNUSAS029879 Unknown Unknown United States SAMN08470840 
PNUSAS035109 Unknown Unknown United States SAMN08616364 
PNUSAS036743 Unknown Unknown United States SAMN08823502 
PNUSAS037800 Unknown Unknown United States SAMN08865617 
PNUSAS037136 Unknown Unknown United States SAMN08865508 
PNUSAS037130 Unknown Unknown United States SAMN08865514 
PNUSAS037097 Unknown Unknown United States SAMN08922760 
PNUSAS042247 Unknown Unknown United States SAMN09381922 
PNUSAS042313 Unknown Unknown United States SAMN09501102 
PNUSAS043909 Unknown Unknown United States SAMN09534158 
PNUSAS044558 Unknown Unknown United States SAMN09636247 
PNUSAS045202 Unknown Unknown United States SAMN09650791 
14ARS_VSM0382 Unknown Unknown Unknown SAMEA104162236 
14ARS_VSM0381 Unknown Unknown Unknown SAMEA104162235 
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Supplementary Table 5-1 – List of publicly available Salmonella enterica serovar Heidelberg and 
Salmonella enterica serovar Minnesota genomes used in the present study.  
Id Species Serotype Origin_country Isolation 
SRR6881714 S. enterica Heidelberg Brazil Brazil 
SRR7064459 S. enterica Heidelberg Brazil Brazil 
SRR7064627 S. enterica Heidelberg Brazil Brazil 
SRR7064868 S. enterica Heidelberg Brazil Brazil 
SRR7064945 S. enterica Heidelberg Brazil Brazil 
SRR7064960 S. enterica Heidelberg Brazil Brazil 
SRR7064964 S. enterica Heidelberg Brazil Brazil 
SRR7065001 S. enterica Heidelberg Brazil Brazil 
SRR7065005 S. enterica Heidelberg Brazil Brazil 
SRR7071937 S. enterica Minnesota Brazil Brazil 
SRR7071939 S. enterica Heidelberg Brazil Brazil 
SRR7071959 S. enterica Heidelberg Brazil Brazil 
SRR7071960 S. enterica Heidelberg Brazil Brazil 
SRR7072121 S. enterica Heidelberg Brazil Brazil 
SRR7072128 S. enterica Heidelberg Brazil Brazil 
SRR7072141 S. enterica Heidelberg Brazil Brazil 
SRR7072143 S. enterica Heidelberg Brazil Brazil 
SRR7072145 S. enterica Heidelberg Brazil Brazil 
SRR7072176 S. enterica Heidelberg Brazil Brazil 
SRR7072177 S. enterica Heidelberg Brazil Brazil 
SRR7072178 S. enterica Heidelberg Brazil Brazil 
SRR7072198 S. enterica Heidelberg Brazil Brazil 
SRR7072200 S. enterica Heidelberg Brazil Brazil 
SRR7072202 S. enterica Heidelberg Brazil Brazil 
SRR7072208 S. enterica Heidelberg Brazil Brazil 
SRR7072217 S. enterica Heidelberg Brazil Brazil 
SRR7073432 S. enterica Heidelberg Brazil Brazil 
SRR7079287 S. enterica Heidelberg Brazil Brazil 
SRR7079314 S. enterica Heidelberg Brazil Brazil 
SRR7130373 S. enterica Heidelberg Brazil Brazil 
SRR7130375 S. enterica Heidelberg Brazil Brazil 
SRR7130551 S. enterica Minnesota Brazil Brazil 
SRR7130561 S. enterica Minnesota Brazil Brazil 
SRR7130567 S. enterica Heidelberg Brazil Brazil 
SRR7186260 S. enterica Minnesota Brazil Brazil 
SRR7186369 S. enterica Minnesota Brazil Brazil 
SRR7186454 S. enterica Minnesota Brazil Brazil 
SRR7188845 S. enterica Heidelberg Brazil Brazil 
SRR7189240 S. enterica Heidelberg Brazil Brazil 
SRR7189510 S. enterica Heidelberg Brazil Brazil 
SRR7190735 S. enterica Heidelberg Brazil Brazil 
SRR7192261 S. enterica Heidelberg Brazil Brazil 
SRR7192445 S. enterica Heidelberg Brazil Brazil 
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SRR7192446 S. enterica Heidelberg Brazil Brazil 
SRR7219557 S. enterica Heidelberg Brazil Brazil 
SRR7221031 S. enterica Heidelberg Brazil Brazil 
SRR7221243 S. enterica Heidelberg Brazil Brazil 
SRR7221348 S. enterica Heidelberg Brazil Brazil 
SRR7221431 S. enterica Heidelberg Brazil Brazil 
SRR7221474 S. enterica Heidelberg Brazil Brazil 
SRR7221475 S. enterica Heidelberg Brazil Brazil 
SRR7221476 S. enterica Heidelberg Brazil Brazil 
SRR7221528 S. enterica Heidelberg Brazil Brazil 
SRR7221529 S. enterica Heidelberg Brazil Brazil 
SRR7221614 S. enterica Heidelberg Brazil Brazil 
SRR7221645 S. enterica Heidelberg Brazil Brazil 
SRR7221647 S. enterica Heidelberg Brazil Brazil 
SRR7221657 S. enterica Heidelberg Brazil Brazil 
SRR7229075 S. enterica Heidelberg Brazil Brazil 
SRR7229077 S. enterica Heidelberg Brazil Brazil 
SRR7230389 S. enterica Heidelberg Brazil Brazil 
SRR7230673 S. enterica Heidelberg Brazil Brazil 
SRR7230743 S. enterica Heidelberg Brazil Brazil 
SRR7230883 S. enterica Heidelberg Brazil Brazil 
SRR7232306 S. enterica Heidelberg Brazil Brazil 
SRR7232379 S. enterica Heidelberg Brazil Brazil 
SRR7232380 S. enterica Heidelberg Brazil Brazil 
SRR7232613 S. enterica Heidelberg Brazil Brazil 
SRR7232983 S. enterica Heidelberg Brazil Brazil 
SRR7232984 S. enterica Heidelberg Brazil Brazil 
SRR7232990 S. enterica Heidelberg Brazil Brazil 
SRR7233008 S. enterica Heidelberg Brazil Brazil 
SRR7233581 S. enterica Heidelberg Brazil Brazil 
SRR7233615 S. enterica Heidelberg Brazil Brazil 
SRR7233616 S. enterica Heidelberg Brazil Brazil 
SRR7241938 S. enterica Heidelberg Brazil Brazil 
SRR7241940 S. enterica Heidelberg Brazil Brazil 
SRR7242751 S. enterica Heidelberg Brazil Brazil 
SRR7242913 S. enterica Heidelberg Brazil Brazil 
SRR7244087 S. enterica Heidelberg Brazil Brazil 
SRR7244211 S. enterica Heidelberg Brazil Brazil 
SRR7249331 S. enterica Heidelberg Brazil Brazil 
SRR7249775 S. enterica Heidelberg Brazil Brazil 
SRR7249857 S. enterica Heidelberg Brazil Brazil 
SRR7250105 S. enterica Heidelberg Brazil Brazil 
SRR7250125 S. enterica Heidelberg Brazil Brazil 
SRR8663248 S. enterica Heidelberg Venezuela Brazil 
SRR7232219 S. enterica Heidelberg Brazil Brazil 
ERR3420975 S. enterica Heidelberg Brazil Netherlands 
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ERR3420976 S. enterica Heidelberg Brazil Netherlands 
ERR3420977 S. enterica Heidelberg Brazil Netherlands 
ERR3420978 S. enterica Heidelberg Brazil Netherlands 
ERR3420979 S. enterica Heidelberg Brazil Netherlands 
ERR3420980 S. enterica Heidelberg Brazil Netherlands 
ERR3420981 S. enterica Heidelberg Brazil Netherlands 
ERR3420982 S. enterica Heidelberg Brazil Netherlands 
ERR3420983 S. enterica Heidelberg Brazil Netherlands 
ERR3420984 S. enterica Heidelberg Brazil Netherlands 
ERR3420985 S. enterica Heidelberg Brazil Netherlands 
ERR3420986 S. enterica Heidelberg Brazil Netherlands 
ERR3420987 S. enterica Heidelberg Brazil Netherlands 
ERR3420988 S. enterica Heidelberg Brazil Netherlands 
ERR3420989 S. enterica Heidelberg Brazil Netherlands 
ERR3420990 S. enterica Heidelberg Brazil Netherlands 
ERR3420991 S. enterica Heidelberg Brazil Netherlands 
ERR3420992 S. enterica Heidelberg Brazil Netherlands 
ERR3420993 S. enterica Heidelberg Brazil Netherlands 
ERR3420994 S. enterica Heidelberg Brazil Netherlands 
ERR3420995 S. enterica Heidelberg Brazil Netherlands 
ERR3420996 S. enterica Heidelberg Brazil Netherlands 
ERR3420997 S. enterica Heidelberg Brazil Netherlands 
ERR3420998 S. enterica Heidelberg Brazil Netherlands 
ERR3420999 S. enterica Heidelberg Brazil Netherlands 
ERR3421000 S. enterica Heidelberg Brazil Netherlands 
ERR3421001 S. enterica Heidelberg Brazil Netherlands 
ERR3421002 S. enterica Heidelberg Brazil Netherlands 
ERR3421003 S. enterica Heidelberg Brazil Netherlands 
ERR3421004 S. enterica Heidelberg Brazil Netherlands 
ERR3421005 S. enterica Heidelberg Brazil Netherlands 
ERR3421006 S. enterica Heidelberg Brazil Netherlands 
ERR3421007 S. enterica Heidelberg Brazil Netherlands 
ERR3421008 S. enterica Heidelberg Brazil Netherlands 
ERR3421009 S. enterica Heidelberg Brazil Netherlands 
ERR3421010 S. enterica Heidelberg Brazil Netherlands 
ERR3421011 S. enterica Heidelberg Brazil Netherlands 
ERR3421012 S. enterica Heidelberg Brazil Netherlands 
ERR3421013 S. enterica Heidelberg Brazil Netherlands 
ERR3421014 S. enterica Heidelberg Brazil Netherlands 
ERR3421017 S. enterica Heidelberg Brazil Netherlands 
ERR3421018 S. enterica Heidelberg Brazil Netherlands 
ERR3421019 S. enterica Heidelberg Brazil Netherlands 
ERR3421020 S. enterica Heidelberg Brazil Netherlands 
ERR3421021 S. enterica Heidelberg Brazil Netherlands 
ERR3421022 S. enterica Heidelberg Brazil Netherlands 
ERR3421023 S. enterica Heidelberg Brazil Netherlands 
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ERR3421024 S. enterica Heidelberg Brazil Netherlands 
ERR3421025 S. enterica Heidelberg Brazil Netherlands 
ERR3421026 S. enterica Heidelberg Brazil Netherlands 
ERR3421027 S. enterica Heidelberg Brazil Netherlands 
ERR3421028 S. enterica Heidelberg Brazil Netherlands 
ERR3421029 S. enterica Heidelberg Brazil Netherlands 
ERR3421030 S. enterica Heidelberg Brazil Netherlands 
ERR3421031 S. enterica Heidelberg Brazil Netherlands 
ERR3421032 S. enterica Heidelberg Brazil Netherlands 
ERR3421033 S. enterica Heidelberg Brazil Netherlands 
ERR3421034 S. enterica Heidelberg Brazil Netherlands 
ERR3421035 S. enterica Heidelberg Brazil Netherlands 
ERR3421036 S. enterica Heidelberg Brazil Netherlands 
ERR3421037 S. enterica Heidelberg Brazil Netherlands 
ERR3421038 S. enterica Heidelberg Brazil Netherlands 
ERR3421039 S. enterica Heidelberg Brazil Netherlands 
ERR3421040 S. enterica Heidelberg Brazil Netherlands 
ERR3421041 S. enterica Heidelberg Brazil Netherlands 
ERR3421042 S. enterica Heidelberg Brazil Netherlands 
ERR3421043 S. enterica Heidelberg Brazil Netherlands 
ERR3421044 S. enterica Heidelberg Brazil Netherlands 
ERR3421045 S. enterica Heidelberg Brazil Netherlands 
ERR3421046 S. enterica Heidelberg Brazil Netherlands 
ERR3421047 S. enterica Heidelberg Brazil Netherlands 
ERR3421048 S. enterica Heidelberg Brazil Netherlands 
ERR3421049 S. enterica Heidelberg Brazil Netherlands 
ERR3421050 S. enterica Heidelberg Brazil Netherlands 
ERR3421051 S. enterica Heidelberg Brazil Netherlands 
ERR3421052 S. enterica Heidelberg Brazil Netherlands 
ERR3421053 S. enterica Heidelberg Brazil Netherlands 
ERR3421054 S. enterica Heidelberg Brazil Netherlands 
ERR3421055 S. enterica Heidelberg Brazil Netherlands 
ERR3421058 S. enterica Heidelberg Brazil Netherlands 
ERR3421059 S. enterica Heidelberg Brazil Netherlands 
ERR3421060 S. enterica Heidelberg Brazil Netherlands 
ERR3421061 S. enterica Heidelberg Brazil Netherlands 
ERR3421062 S. enterica Heidelberg Brazil Netherlands 
ERR3421063 S. enterica Heidelberg Brazil Netherlands 
ERR3421064 S. enterica Heidelberg Brazil Netherlands 
ERR3421065 S. enterica Heidelberg Brazil Netherlands 
ERR3421067 S. enterica Heidelberg Brazil Netherlands 
ERR3421068 S. enterica Heidelberg Brazil Netherlands 
ERR3421069 S. enterica Heidelberg Brazil Netherlands 
ERR3421070 S. enterica Heidelberg Brazil Netherlands 
ERR3421071 S. enterica Heidelberg Brazil Netherlands 
ERR3421072 S. enterica Heidelberg Brazil Netherlands 
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ERR3421073 S. enterica Heidelberg Brazil Netherlands 
ERR3421074 S. enterica Heidelberg Brazil Netherlands 
ERR3421075 S. enterica Heidelberg Brazil Netherlands 
ERR3421076 S. enterica Heidelberg Brazil Netherlands 
ERR3421077 S. enterica Heidelberg Brazil Netherlands 
ERR3421078 S. enterica Heidelberg Brazil Netherlands 
ERR3421079 S. enterica Heidelberg Brazil Netherlands 
ERR3421080 S. enterica Heidelberg Brazil Netherlands 
ERR3421081 S. enterica Heidelberg Brazil Netherlands 
ERR3421082 S. enterica Heidelberg Brazil Netherlands 
ERR3421083 S. enterica Heidelberg Brazil Netherlands 
ERR3421084 S. enterica Heidelberg Brazil Netherlands 
ERR3421085 S. enterica Heidelberg Brazil Netherlands 
ERR3421086 S. enterica Heidelberg Brazil Netherlands 
ERR3421087 S. enterica Heidelberg Brazil Netherlands 
ERR3421088 S. enterica Heidelberg Brazil Netherlands 
ERR3421089 S. enterica Heidelberg Brazil Netherlands 
ERR3421090 S. enterica Heidelberg Brazil Netherlands 
ERR3421091 S. enterica Heidelberg Brazil Netherlands 
ERR3421092 S. enterica Heidelberg Brazil Netherlands 
ERR3421093 S. enterica Heidelberg Brazil Netherlands 
ERR3421094 S. enterica Heidelberg Brazil Netherlands 
ERR3421095 S. enterica Heidelberg Brazil Netherlands 
ERR3421096 S. enterica Heidelberg Brazil Netherlands 
ERR3421097 S. enterica Heidelberg Brazil Netherlands 
ERR3421098 S. enterica Heidelberg Brazil Netherlands 
ERR3421099 S. enterica Heidelberg Brazil Netherlands 
ERR3421100 S. enterica Heidelberg Brazil Netherlands 
ERR3421101 S. enterica Heidelberg Brazil Netherlands 
ERR3421102 S. enterica Heidelberg Brazil Netherlands 
ERR3421103 S. enterica Heidelberg Brazil Netherlands 
ERR3421104 S. enterica Heidelberg Brazil Netherlands 
ERR3421105 S. enterica Heidelberg Brazil Netherlands 
ERR3421106 S. enterica Heidelberg Brazil Netherlands 
ERR3421107 S. enterica Heidelberg Brazil Netherlands 
ERR3421108 S. enterica Heidelberg Brazil Netherlands 
ERR3421109 S. enterica Heidelberg Brazil Netherlands 
ERR3421110 S. enterica Heidelberg Brazil Netherlands 
ERR3421111 S. enterica Heidelberg Brazil Netherlands 
ERR3421112 S. enterica Heidelberg Brazil Netherlands 
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Supplementary table 5-2 - Phage presence in the 36 sequenced isolates of Salmonella enterica 
serovar Heidelberg and Salmonella enterica serovar Minnesota  
Isolate 
ID 
Region 
Length 
Score 
# Total 
Proteins 
Most 
Common 
Phage 
(proteins) 
GC % 
PT1 
33.3Kb 100 18 Fels 1 (5) 49.39% 
40Kb 150 49 Fels 2 (35) 52.92% 
PT2 
92.5Kb 150 112 phiV10 (33) 52.13% 
33.3Kb 100 18 Fels 1 (5) 49.39% 
9.8Kb 100 16 Gifsy 1 (1) 51.41% 
33.8Kb 120 45 SEN34 (15) 49.68% 
31.9Kb 150 46 SfV (38) 51.75% 
PT3 9.8Kb 100 16 Gifsy 1 (1) 51.41% 
PT4 
40Kb 150 48 Fels 2 (36) 52.92% 
33.3Kb 100 17 Fels 1 (5) 49.39% 
9.8Kb 100 18 Gifsy 1 (1) 51.41% 
PT5 44.1Kb 120 57 phiV10 (33) 51.99% 
PT6 44.9Kb 150 62 Gifsy 2 (34) 51.03% 
PT7 
44.1Kb 120 57 phiV10 (33) 51.99% 
33.3Kb 100 18 Fels 1 (5) 49.39% 
PT8 44.9Kb 150 62 Gifsy 2 (34) 51.03% 
PT9 37.9Kb 150 49 Gifsy 2 (31) 51.55% 
PT10 44.9Kb 150 62 Gifsy 2 (34) 51.03% 
PT11 44.9Kb 150 62 Gifsy 2 (34) 51.03% 
PT12 
45Kb 140 56 phiV10 (32) 51.82% 
42.9Kb 150 57 SfV (39) 51.97% 
30.8Kb 150 37 Fels 2 (28) 53.38% 
9.8Kb 100 18 Gifsy 1 (1) 51.41% 
PT13 44.9Kb 150 62 Gifsy 2 (34) 51.03% 
PT14 
34.8Kb 150 47 Gifsy 2 (30) 51.95% 
9.8Kb 100 18 Gifsy 1 (1) 51.41% 
PT15 34Kb 150 45 Gifsy 2 (30) 52.26% 
PT16 
42.3Kb 132 52 SPN1S (46) 50.53% 
45.4Kb 150 57 Gifsy 2 (33) 51.25% 
PT17 44.9Kb 150 60 Gifsy 2 (34) 51.03% 
PT18 44.9Kb 150 60 Gifsy 2 (34) 51.03% 
PT19 44.9Kb 150 60 Gifsy 2 (34) 51.03% 
PT20 44.9Kb 150 60 Gifsy 2 (34) 51.03% 
PT21 
33.3Kb 100 18 Fels 1 (5) 49.39% 
44.3Kb 150 66 SfII (37) 51.31% 
44.8Kb 140 56 phiV10 (32) 51.89% 
PT22 
58.3Kb 132 52 SPN1S (46) 50.79% 
53Kb 150 56 Gifsy 2 (33) 51.13% 
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PT23 
44.9Kb 150 60 Gifsy 2 (34) 51.03% 
52.1Kb 121 45 SPN1S (42) 52.67% 
9.8Kb 100 16 Gifsy 1 (1) 51.41% 
PT24 
33.3Kb 100 18 Fels 1 (5) 49.39% 
44.1Kb 120 57 phiV10 (33) 51.99% 
9.8Kb 100 16 Gifsy 1 (1) 51.41% 
PT25 
39Kb 150 52 Gifsy 2 (31) 51.32% 
51.3Kb 115 44 SPN1S (40) 52.94% 
PT26 
58.3Kb 132 52 SPN1S (46) 50.79% 
44.9Kb 150 60 Gifsy 2 (34) 51.03% 
PT27 
42.3Kb 132 52 SPN1S (46) 50.53% 
37.8Kb 100 58 
UAB Phi20 
(34) 
47.52% 
44.9Kb 150 60 Gifsy 2 (34) 51.03% 
PT28 
42.2Kb 110 58 
vB SemP 
Emek (15) 
46.73% 
33.3Kb 100 18 Fels 1 (5) 49.39% 
44.8Kb 140 56 phiV10 (32) 51.89% 
PT29 
45.4Kb 150 57 Gifsy 2 (33) 51.25% 
9.8Kb 100 16 Gifsy 1 (1) 51.41% 
PT30 
44.9Kb 150 60 Gifsy 2 (34) 51.03% 
43.7Kb 92 57 phiV10 (33) 51.01% 
9.8Kb 100 16 Sfi19 (1) 51.41% 
PT31 
44.8Kb 140 56 phiV10 (32) 51.89% 
41.3Kb 120 62 
ENT47670 
(14) 
52.30% 
35.6Kb 150 51 SfII (38) 51.71% 
39.9Kb 150 35 Fels 2 (28) 52.18% 
33.3Kb 100 17 Fels 1 (5) 49.39% 
9.8Kb 100 17 Gifsy 1 (1) 51.41% 
PT32 
44.8Kb 140 56 phiV10 (32) 51.89% 
9.8Kb 100 17 Gifsy 1 (1) 51.41% 
33.3Kb 100 18 Fels 1 (5) 49.39% 
36.4Kb 150 48 P88 (35) 52.87% 
24Kb 100 22 SSU5 (21) 53.63% 
PT33 
33.3Kb 100 17 Fels 1 (5) 49.39% 
39.9Kb 150 35 Fels 2 (27) 52.18% 
44.8Kb 140 56 phiV10 (32) 51.89% 
9.8Kb 100 17 Gifsy 1 (1) 51.41% 
PT34 42.8Kb 150 55 Gifsy 2 (33) 51.54% 
PT35 
31Kb 150 38 Gifsy 2 (29) 52.44% 
9.8Kb 100 16 Sfi19 (1) 51.41% 
PT36 
31.5Kb 100 35 SPN1S (35) 49.98% 
34.8Kb 150 47 Gifsy 2 (30) 51.95% 
 
